|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Aug―23 |
SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity |
Elizabeth J. Martinez, William C. Chang, Wei-Hung Chen, Agnes Hajduczki, Paul V. Thomas, Jaime L. Jensen, et al. (+30) Misook Choe, Rajeshwer S. Sankhala, Caroline E. Peterson, Phyllis A. Rees, Jordan Kimner, Sandrine Soman, Caitlin Kuklis, Letzibeth Mendez-Rivera, Vincent Dussupt, Jocelyn King, Courtney Corbett, Sandra V. Mayer, Aldon Fernandes, Kripa Murzello, Tres Cookenham, Janine Hvizdos, Larry Kummer, Tricia Hart, Kathleen Lanzer, Julian Gambacurta, Matthew Reagan, Debbie Duso, Sandhya Vasan, Natalie D. Collins, Nelson L. Michael, Shelly J. Krebs, Gregory D. Gromowski, Kayvon Modjarrad, John Kaundinya, M. Gordon Joyce |
2 |
[GO] |
2024―Aug―17 |
Drug Susceptibility and the Potential for Drug-Resistant SARS-CoV-2 Emergence in Immunocompromised Animals |
Maki Kiso, Ryuta Uraki, Seiya Yamayoshi, Masaki Imai, Yoshihiro Kawaoka |
3 |
[GO] |
2024―Aug―14 |
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants. |
Javier García-Pérez, Alberto M. Borobia, Mayte Pérez-Olmeda, Antonio Portolés, Luis Castaño, Magdalena Campins-Artí, et al. (+24) María Jesús Bertrán, Mercedes Bermejo, José Ramón Arribas, Andrea López, Ana Ascaso-del-Rio, Eunate Arana-Arri, Inmaculada Fuentes Camps, Anna Vilella, Almudena Cascajero, María Teresa García-Morales, María Castillo de la Osa, Carla Pérez Ingidua, David Lora, Paloma Jiménez-Santana, Silvia Pino-Rosa, Agustín Gómez de la Cámara, Erick De La Torre-Tarazona, Esther Calonge, Raquel Cruces, Cristóbal Belda-Iniesta, José Alcamí, Jesús Frías, Antonio J. Carcas, Francisco Díez-Fuertes |
4 |
[GO] |
2024―Aug―09 |
Association of inflammatory cytokines with lung function, chronic lung diseases and COVID-19 |
Marina O. Rontogianni, Dipender Gill, Emmanouil Bouras, Alexandros-Georgios Asimakopoulos, Ioanna Tzoulaki, Olli Raitakari, et al. (+14) Matthias Wielscher, Veikko Salomaa, Sirpa Jalkanen, Marko Salmi, Markku Timonen, James Yarmolinsky, Jing Chen, Martin D. Tobin, Abril G. Izquierdo, Karl-Heinz Herzig, Anne E. Ioannides, Marjo-Riitta Jarvelin, Abbas Dehghan, Konstantinos K. Tsilidis |
5 |
[GO] |
2024―Jul―27 |
Proteome and Ubiquitinome Analyses of the Brain Cortex in K18-hACE2 Mice Infected with SARS-CoV-2 |
Qiaochu Wang, Wanjun Peng, Yehong Yang, Yue Wu, Rong Han, Tao Ding, et al. (+4) Xutong Zhang, Jiangning Liu, Juntao Yang, Jiangfeng Liu |
6 |
[GO] |
2024―Jul―17 |
Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection |
Lisa M. Arkin, Ana C. Costa-da-Silva, Justin Frere, Ashley Ng, Rubina Sharma, John J. Moon, et al. (+23) Hailey E. Bussan, Clara H. Kim, Ayesha Javaid, Olivia R. Steidl, Ahmad Yatim, Fanny Saidoune, Michel Gilliet, Joe T. Nguyen, Aman Nihal, George Luong, Meaghan Kenfield, Lucia Carrau, Jennifer M. Tran, Molly A. Hinshaw, Erin G. Brooks, Jose M. Ayuso, David H. O'Connor, Jean-Laurent Casanova, Edward W. Cowen, Beth A. Drolet, Anne Marie Singh, Benjamin tenOever, Jacqueline W. Mays |
7 |
[GO] |
2024―Jul―14 |
Differential Immunometabolic Responses to Delta and Omicron SARS-CoV-2 Variants in Golden Syrian Hamsters |
Rajesh Rajaiah, Kabita Pandey, Arpan Acharya, Anoop Ambikan, Narendra Kumar, Reema Guda, et al. (+5) Sean N. Avedissian, Luis J. Montaner, Samuel M. Cohen, Ujjwal Neogi, Siddappa N. Byrareddy |
8 |
[GO] |
2024―Jul―10 |
Multi-variate analyses and machine learning link sex and age with antibody responses to SARS-CoV-2 and vaccination |
Miroslava Cuperlovic-Culf, Steffany A.L. Bennett, Yannick Galipeau, Pauline S. McCluskie, Corey Arnold, Salman Bagheri, et al. (+5) Curtis L. Cooper, Marc-André Langlois, Jörg Fritz, Ciriaco A. Piccirillo, Angela M. Crawley |
9 |
[GO] |
2024―Jul―08 |
Genome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection. |
Madoka Sakai, Yoshie Masuda, Yusuke Tarumoto, Naoyuki Aihara, Yugo Tsunoda, Michiko Iwata, et al. (+6) Yumiko Kamiya, Ryo Komorizono, Takeshi Noda, Kosuke Yusa, Keizo Tomonaga, Akiko Makino |
10 |
[GO] |
2024―Jun―28 |
Genomic analysis of Staphylococcus aureus isolates from bacteremia reveals genetic features associated with the COVID-19 pandemic |
Miquel Sánchez-Osuna, Marc Pedrosa, Paula Bierge, Inmaculada Gómez-Sánchez, Marina Alguacil-Guillén, Mateu Espasa, et al. (+3) Ivan Erill, Oriol Gasch, Oscar Q. Pich |
11 |
[GO] |
2024―Jun―27 |
SLC38A9 regulates SARS-CoV-2 viral entry |
Gaurav Datta, Neda Rezagholizadeh, Wendie A. Hasler, Nabab Khan, Xuesong Chen |
12 |
[GO] |
2024―Jun―24 |
Total plasma N-glycomic signature of SARS-CoV-2 infection |
Marco R. Bladergroen, Tamas Pongracz, Wenjun Wang, Simone Nicolardi, Sesmu M. Arbous, Anna Roukens, Manfred Wuhrer |
13 |
[GO] |
2024―Jun―22 |
Broad Sarbecovirus Neutralization by Combined Memory B-cell Antibodies to Ancestral SARS-CoV-2 |
Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, Timothée Bruel, Pierre Rosenbaum, Maxime Beretta, et al. (+19) Jordan D. Dimitrov, Laurine Conquet, Flora Donati, Matthieu Prot, Françoise Porrot, Delphine Planas, Isabelle Staropoli, Florence Guivel-Benhassine, Eduard Baquero, Sylvie van der Werf, Ahmed Haouz, Etienne Simon-Lorière, Xavier Montagutelli, Bernard Maillère, Félix A. Rey, Pablo Guardado-Calvo, Hervé Nozach, Olivier Schwartz, Hugo Mouquet |
14 |
[GO] |
2024―Jun―21 |
Pulmonary and Renal Long COVID at Two-year Revisit |
Jing Wang, Xiao Liang, Yufen Zheng, Yi Zhu, Kai Zhou, Xiaomai Wu, et al. (+34) Rui Sun, Yifan Hu, Xiaoli Zhu, Hongbo Chi, Shanjun Chen, Mengge Lyu, Yuting Xie, Xiao Yi, Wei Liu, Xue Cai, Sainan Li, Qiushi Zhang, Chunlong Wu, Yingqiu Shi, Donglian Wang, Minfei Peng, Ying Zhang, Huafen Liu, Chao Zhang, Sheng Quan, Ziqing Kong, Zhouyang Kang, Guangjun Zhu, Hongguo Zhu, Shiyong Chen, Junbo Liang, Hai Yang, Jianxin Pang, Yicheng Fang, Haixiao Chen, Jun Li, Jiaqin Xu, Tiannan Guo, Bo Shen |
15 |
[GO] |
2024―Jun―13 |
Advancing Health Equity in the Aftermath of COVID-19: Confronting Intensifying Racial Disparities |
Kristen R. Prentice, B. Adam B. Williams, Jane M. True, Charles H. Jones |
16 |
[GO] |
2024―Jun―13 |
A cryptic site in Class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates |
Lingyan Cui, Tingting Li, Miaolin Lan, Ming Zhou, Wenhui Xue, Sibo Zhang, et al. (+11) Hong Wang, Minqing Hong, Yali Zhang, Lunzhi Yuan, Hui Sun, Jianghui Ye, Qingbing Zheng, Yi Guan, Ying Gu, Ningshao Xia, Shaowei Li |
17 |
[GO] |
2024―Jun―05 |
EVALUATION OF AN RBD-NUCLEOCAPSID FUSION PROTEIN AS A BOOSTER CANDIDATE FOR COVID-19 VACCINE |
Bruno Vinicius Santos Valiate, Julia Teixeira De Castro, Tomás Gazzinelli Marçal, Luis Adan Flores Andrade, Livia Isabela De Oliveira, Gabriela Barbi Freire Maia, et al. (+8) Lídia Paula Faustino, Natalia S. Hojo-Souza, Marconi Augusto Aguiar Dos Reis, Flávia Fonseca Bagno, Natalia Salazar, Santuza R. Teixeira, Gregório Guilherme Almeida, Ricardo Tostes Gazzinelli |
18 |
[GO] |
2024―Jun―05 |
Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in Macaques |
Xin Tong, Qixin Wang, Wonyeong Jung, Taras M. Chicz, Ross Blanc, Lily J. Parker, et al. (+2) Dan H. Barouch, Ryan P. McNamara |
19 |
[GO] |
2024―Jun―01 |
sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID |
Lisa Hurler, Federica Mescia, Laura Bergamaschi, Erika Kajdácsi, György Sinkovits, László Cervenak, et al. (+3) Zoltán Prohászka, Paul A. Lyons, Erik J.M. Toonen |
20 |
[GO] |
2024―May―28 |
Evolution of protective SARS-CoV-2-specific B- and T-cell responses upon vaccination and Omicron breakthrough infection |
Mohamed I.M. Ahmed, Sebastian Einhauser, Clemens Peiter, Antonia Senninger, Olga Baranov, Tabea M. Eser, et al. (+14) Manuel Huth, Laura Olbrich, Noemi Castelletti, Raquel Rubio-Acero, George Carnell, Jonathan Heeney, Inge Kroidl, Kathrin Held, Andreas Wieser, Christian Janke, Michael Hoelscher, Jan Hasenauer, Ralf Wagner, Christof Geldmacher |
21 |
[GO] |
2024―May―27 |
The alarmin IL-33 exacerbates pulmonary inflammation and immune dysfunction in SARS-CoV-2 infection |
Hui Wang, Yashoda M. Hosakote, Paul J. Boor, Jun Yang, Yuanyi Zhang, Xiaoying Yu, et al. (+12) Casey Gonzales, Corri B. Levine, Susan McLellan, Nicole Cloutier, Xuping Xie, Pei-Yong Shi, Ping Ren, Haitao Hu, Keer Sun, Lynn Soong, Jiaren Sun, Yuejin Liang |
22 |
[GO] |
2024―May―25 |
Clinical features and Multiomics Profiles Indicate Coagulation and Platelet Dysfunction in COVID-19 Viral Sepsis |
Zhiqing Xiao, Minggui Lin, Ning Song, Xue Wu, Jingyu Hou, Lili Wang, et al. (+5) XinLun Tian, Chunge An, Charles S. Dela Cruz, Lokesh Sharma, De Chang |
23 |
[GO] |
2024―May―22 |
Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases |
Willem M. Kühtreiber, Emma R. Hostetter, Grace E. Wolfe, Maya S. Vaishnaw, Rachel Goldstein, Emily R. Bulczynski, et al. (+4) Neeshi S. Hullavarad, Joan E. Braley, Hui Zheng, Denise L. Faustman |
24 |
[GO] |
2024―May―17 |
High throughput screening identifies broad-spectrum Coronavirus entry inhibitors |
Suman Khan, Efrat Ozer Partuk, Jeanne Chiaravalli, Noga Kozer, Khriesto A. Shurrush, Yael Elbaz-Alon, et al. (+6) Nadav Scher, Emilie Giraud, Jaouen Tran-Rajau, Fabrice Agou, Haim Michael Barr, Ori Avinoam |
25 |
[GO] |
2024―May―17 |
Lack of memory recall in human CD4 T cells elicited by the first encounter with SARS-CoV-2 |
Katherine A. Richards, Siriruk Changrob, Paul G. Thomas, Patrick C. Wilson, Andrea J. Sant |
26 |
[GO] |
2024―May―17 |
Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia |
Jessie J.-Y. Chang, Samantha Grimley, Bang M. Tran, Georgia Deliyannis, Carolin Tumpach, An N.T. Nguyen, et al. (+12) Eike Steinig, JianShu Zhang, Jan Schröder, Leon Caly, Julie McAuley, Sharon L. Wong, Shafagh A. Waters, Timothy P. Stinear, Miranda E. Pitt, Damian Purcell, Elizabeth Vincan, Lachlan J.M. Coin |
27 |
[GO] |
2024―May―15 |
SARS-CoV-2 Envelope Protein Regulates Innate Immune Tolerance |
Eric S. Geanes, Rebecca McLennan, Stephen H. Pierce, Heather L. Menden, Oishi Paul, Venkatesh Sampath, Todd Bradley |
28 |
[GO] |
2024―May―03 |
Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion |
Lu Zhang, Alexandra Dopfer-Jablonka, Anne Cossmann, Metodi V. Stankov, Luise Graichen, Anna-Sophie Moldenhauer, et al. (+6) Christina Fichter, Anupriya Aggarwal, Stuart G. Turville, Georg M.N. Behrens, Stefan Pöhlmann, Markus Hoffmann |
29 |
[GO] |
2024―Apr―29 |
RNA editing in host lncRNAs as potential modulator in SARS-CoV-2 variants-host immune response dynamics |
Partha Chattopadhyay, Priyanka Mehta, Pallavi Mishra, Chinky Shiu Chen Liu, Bansidhar Tarai, Sandeep Budhiraja, Rajesh Pandey |
30 |
[GO] |
2024―Apr―27 |
Enhanced and copper concentration dependent virucidal effect against SARS-CoV-2 of electrospun poly(vinylidene difluoride) filter materials |
Hanna Bulgarin, Thomas Thomberg, Andres Lust, Jaak Nerut, Miriam Koppel, Tavo Romann, et al. (+11) Rasmus Palm, Martin Månsson, Marko Vana, Heikki Junninen, Marian Külaviir, Päärn Paiste, Kalle Kirsimäe, Marite Punapart, Liane Viru, Andres Merits, Enn Lust |
31 |
[GO] |
2024―Apr―10 |
Reinvestigate the performance of artificial intelligence classification algorithms on COVID-19 X-ray and CT images. |
Rui Cao, Yanan Liu, Xin Wen, Caiqing Liao, Xin Wang, Yuan Gao, Tao Tan |
32 |
[GO] |
2024―Apr―09 |
B Cell Somatic Hypermutation Following COVID-19 Vaccination with Ad26.COV2.S |
Catherine Jacob-Dolan, Michelle Lifton, Olivia C. Powers, Jessica Miller, Nicole P. Hachmann, Mya Vu, et al. (+10) Nehalee Surve, Camille R. Mazurek, Jana L. Fisher, Stefanie Rodrigues, Robert C. Patio, Trisha Anand, Mathieu Le Gars, Jerald Sadoff, Aaron G. Schmidt, Dan H. Barouch |
33 |
[GO] |
2024―Apr―09 |
Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid |
Xiaojuan Zhang, Stephanie Joy-Ann Lam, Jonathan Daniel Ip, Carol Ho-Yan Fong, Allen Wing-Ho Chu, Wan-Mui Chan, et al. (+12) Yoyo Suet-Yiu Lai, Hoi-Wah Tsoi, Brian Pui-Chun Chan, Lin-Lei Chen, Xinjie Meng, Shuofeng Yuan, Hanjun Zhao, Vincent Chi-Chung Cheng, Jacqueline Kwan Yuk Yuen, Kwok-Yung Yuen, Jie Zhou, Kelvin Kai-Wang To |
34 |
[GO] |
2024―Mar―29 |
Longitudinal analysis of genomic mutations in SARS-CoV-2 isolates from persistent COVID-19 patient |
Hiroki Futatsusako, Rina Hashimoto, Masaki Yamamoto, Jumpei Ito, Yasufumi Matsumura, Hajime Yoshifuji, et al. (+5) Kotaro Shirakawa, Akifumi Takaori-Kondo, Kei Sato, Miki Nagao, Kazuo Takayama |
35 |
[GO] |
2024―Mar―29 |
Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection |
Tomokazu Tamura, Hayato Ito, Shiho Torii, Lei Wang, Rigel Suzuki, Shuhei Tsujino, et al. (+12) Akifumi Kamiyama, Yoshitaka Oda, Masumi Tsuda, Yuhei Morioka, Saori Suzuki, Kotaro Shirakawa, Kei Sato, Kumiko Yoshimatsu, Yoshiharu Matsuura, Satoshi Iwano, Shinya Tanaka, Takasuke Fukuhara |
36 |
[GO] |
2024―Mar―26 |
Association of vascular netosis with COVID-19 severity in asymptomatic and symptomatic patients |
S. Kapoor, L. Mihalovičová, E. Pisareva, B. Pastor, A. Mirandola, B. Roch, et al. (+4) J. Bryant, A.P. Princy, S. Chouaib, A.R. Thierry |
37 |
[GO] |
2024―Mar―19 |
Long COVID across SARS-CoV-2 variants, lineages, and sublineages |
Sergio Padilla, Christian Ledesma, Javier García-Abellán, José Alberto García, Marta Fernández-González, Alba de la Rica, et al. (+3) Antonio Galiana, Félix Gutiérrez, Mar Masiá |
38 |
[GO] |
2024―Mar―04 |
COVID-19 vaccine effectiveness against the Omicron variant of SARS-CoV-2 in multimorbidity: a territory-wide case-control study |
Francisco Tsz Tsun Lai, Cuiling Wei, Franco Wing Tak Cheng, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, et al. (+3) Ching Lung Cheung, Ian Chi Kei Wong, Esther Wai Yin Chan |
39 |
[GO] |
2024―Feb―29 |
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies |
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, Yuko Okemoto-Nakamura, Yoshimi Shimizu, Motohiko Ogawa, et al. (+7) Taishi Onodera, Yoshimasa Takahashi, Takaji Wakita, Mika K. Kaneko, Masayoshi Fukasawa, Yukinari Kato, Kohji Noguchi |
40 |
[GO] |
2024―Feb―24 |
Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses |
Mikhail Lebedin, Christoph Ratswohl, Amar Garg, Marta Schips, Clara Vázquez García, Lisa Spatt, et al. (+13) Charlotte Thibeault, Benedikt Obermayer, January Weiner, Ilais Moreno Velásquez, Cathrin Gerhard, Paula Stubbemann, Leif-Gunnar Hanitsch, Tobias Pischon, Martin Witzenrath, Leif Erik Sander, Florian Kurth, Michael Meyer-Hermann, Kathrin de la Rosa |
41 |
[GO] |
2024―Feb―20 |
Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants |
Paola A. Lopez, Nadège Nziza, Tina Chen, Lydia L. Shook, Madeleine D. Burns, Stepan Demidkin, et al. (+8) Olyvia Jasset, Babatunde Akinwunmi, Lael M. Yonker, Kathryn J. Gray, Michal A. Elovitz, Douglas A. Lauffenburger, Boris D. Julg, Andrea G. Edlow |
42 |
[GO] |
2024―Feb―13 |
Simple Virus-free Mouse Models of COVID-19 Pathologies And Oral Therapeutic Intervention |
Huabin Zhu, Anuj K. Sharma, Karina Aguilar, Faizan Boghani, Semih Sarcan, Michelle George, et al. (+13) Janavi Ramesh, Joshua Van Der Eerden, Chandramukhi S. Panda, Aileen Lopez, Wenbo Zhi, Roni Bollag, Nikhil Patel, Kandace Klein, Joe White, Muthusamy Thangaraju, Bal L. Lokeshwar, Nagendra Singh, Vinata B. Lokeshwar |
43 |
[GO] |
2024―Feb―10 |
SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract. |
Alba Escalera, Amaya Rojo-Fernandez, Alexander Rombauts, Gabriela Abelenda-Alonso, Jordi Carratalà, Adolfo García-Sastre, Teresa Aydillo |
44 |
[GO] |
2024―Feb―08 |
Variant- and Vaccination-Specific Alternative Splicing Profiles in SARS-CoV-2 Infections |
Sung-Gwon Lee, Priscilla A. Furth, Lothar Hennighausen, Hye Kyung Lee |
45 |
[GO] |
2024―Feb―05 |
submission tANCHOR cell-based assay for SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains |
Daniel Ivanusic, Josef Maier, Suheda Icli, Valeria Falcone, Hubert Bernauer, Norbert Bannert |
46 |
[GO] |
2024―Feb―02 |
Systems-wide View of Host-Pathogen Interactions Across COVID-19 Severities Using Integrated Omics Analysis |
Mairembam Stelin Singh, Anand Pyati, R. Devika Rubi, Rajasekaran Subramanian, Vijaykumar Yogesh Muley, Mairaj Ahmed Ansari, Sailu Yellaboina |
47 |
[GO] |
2024―Feb―01 |
Wide-range and selective detection of SARS-CoV-2 DNA via surface modification of electrolyte-gated IGZO thin-film transistors |
Chuljin Hwang, Seokhyeon Baek, Yoonseok Song, Won-June Lee, Sungjun Park |
48 |
[GO] |
2024―Jan―30 |
Bioluminescence Imaging Reveals Enhanced SARS-CoV-2 Clearance in Mice with Combinatorial Regimens |
Irfan Ullah, Fanny Escudie, Ivan Scandale, Zoela Gilani, Gabrielle Gendron-Lepage, Fleur Gaudette, et al. (+8) Charles Mowbray, Laurent Fraisse, Renée Bazin, Andrés Finzi, Walther Mothes, Priti Kumar, Eric Chatelain, Pradeep D. Uchil |
49 |
[GO] |
2024―Jan―26 |
Exploring Indoor and Outdoor Dust as a Potential Tool for Detection and Monitoring of COVID-19 Transmission |
Suparinthon Anupong, Sudarat Chadsuthi, Parichart Hongsing, Cameron Hurst, Phatthranit Phattharapornjaroen, Rad S.M. Ali Hosseini, et al. (+32) Stefan Fernandez, Angkana T. Huang, Porames Vatanaprasan, Thammakorn Saethang, Sirirat Luk-in, Robin James Storer, Puey Ounjai, Naveen Kumar Devanga Ragupathi, Phitsanuruk Kanthawee, Natharin Ngamwongsatit, Vishnu Nayak Badavath, Wanwara Thuptimdang, Asada Leelahavanichkul, Talerngsak Kanjanabuch, Kazuhiko Miyanaga, Longzhu Cui, Asuka Nanbo, Kenji Shibuya, Rosalyn Kupwiwat, Daisuke Sano, Takashi Furukawa, Kazunari Sei, Paul G. Higgins, Anthony Kicic, Andrew C. Singer, Tanittha Chatsuwan, Sam Trowsdale, Shuichi Abe, Hitoshi Ishikawa, Mohan Amarasiri, Charin Modchang, Dhammika Leshan Wannigama |
50 |
[GO] |
2024―Jan―25 |
Machine learning coupled with causal inference to identify COVID-19 related chemicals that pose a high concern to drinking water |
Min Han, Jun Liang, Biao Jin, Ziwei Wang, Wanlu Wu, Hans Peter H. Arp |
51 |
[GO] |
2024―Jan―22 |
Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine |
Masayuki Aboshi, Kenta Matsuda, Daisuke Kawakami, Kaoru Kono, Yoko Kazami, Takashi Sekida, et al. (+9) Mai Komori, Amber L. Morey, Shigeru Suga, Jonathan F. Smith, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Nobuaki Sato, Wataru Akahata |
52 |
[GO] |
2024―Jan―21 |
Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human mAbs |
Youngchang Kim, Natalia Maltseva, Christine Tesar, Robert Jedrzejczak, Michael Endres, Heng Ma, et al. (+11) Haley L. Dugan, Christopher T. Stamper, Changsoo Chang, Lei Li, Siriruk Changrob, Nai-Ying Zheng, Min Huang, Arvind Ramanathan, Patrick Wilson, Karolina Michalska, Andrzej Joachimiak |
53 |
[GO] |
2024―Jan―20 |
UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease |
Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, Yu-Hsin Ho, Yi-Hua Pan, Ya-Ting Yang, et al. (+3) Hsi-Chi Chang, Lin-Fang Fu, Wen-Jiun Peng |
54 |
[GO] |
2024―Jan―08 |
Plasma and urine proteomics and gut microbiota analysis reveal potential factors affecting COVID-19 vaccination response |
Changjiang Hu, Weichao Hu, Bo Tang, Qiyu Bao, Xingyu Jiang, Li Tang, et al. (+13) He Wang, Lijiao He, Moyang Lv, Yufeng Xiao, Cheng Liu, Xinzhe Li, Yunyi Liu, Jie Li, Guiping Huang, Zhen Dong, Zhongjun Li, Tiannan Guo, Shiming Yang |
55 |
[GO] |
2023―Dec―22 |
Predicted risk of heart failure pandemic due to persistent SARS-CoV-2 infection using a three-dimensional cardiac model |
Kozue Murata, Akiko Makino, Keizo Tomonaga, Hidetoshi Masumoto |
56 |
[GO] |
2023―Dec―20 |
COVID-19 Test-to-Stay Program for K-12 Schools: Opt-In Versus Opt-Out Consent Model |
Anton Ivanov, Ujjal Kumar Mukherjee, Subhonmesh Bose, Sridhar Seshadri, Ronald Watkins, Albert Charles England, et al. (+3) Jacqueline Suriano, Mehmet Eren Ahsen, Sebastian Souyris |
57 |
[GO] |
2023―Dec―14 |
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity. |
Ntombi Benede, Marius B. Tincho, Avril Walters, Vennesa Subbiah, Amkele Ngomti, Richard Baguma, et al. (+25) Claire Butters, Lina Hahnle, Mathilda Mennen, Sango Skelem, Marguerite Adriaanse, Heidi Facey-Thomas, Christiaan Scott, Jonathan Day, Timothy F. Spracklen, Strauss van Graan, Sashkia R. Balla, Thandeka Moyo-Gwete, Penny L. Moore, Rae MacGinty, Maresa Botha, Lesley Workman, Marina Johnson, David Goldblatt, Heather J. Zar, Ntobeko A.B. Ntusi, Liesl Zühlke, Kate Webb, Catherine Riou, Wendy A. Burgers, Roanne S. Keeton |
58 |
[GO] |
2023―Dec―13 |
SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infection |
Elise J. Tucker, Soon Wei Wong, Shashikanth Marri, Saira Ali, Anthony O. Fedele, Michael Z. Michael, et al. (+4) Darling Rojas-Canales, Jordan Y. Li, Chuan Kok Lim, Jonathan M. Gleadle |
59 |
[GO] |
2023―Dec―12 |
SARS-CoV-2 Antigen-Carrying Extracellular Vesicles Activate T Cell Responses in a Human Immunogenicity Model |
Sarah E. Cummings, Sean P. Delaney, Frederic St-Denis Bissonnette, Andrew Stalker, Gauri Muradia, Jelica Mehic, et al. (+3) Tyson E. Graber, Tommy Alain, Jessie R. Lavoie |
60 |
[GO] |
2023―Dec―07 |
Association between SARS-CoV-2 RNAemia, skewed T-cell responses, inflammation and disease severity in hospitalized COVID-19 people living with HIV |
Matteo Augello, Valeria Bono, Roberta Rovito, Camilla Tincati, Silvia Bianchi, Lucia Taramasso, et al. (+6) Antonio Di Biagio, Annapaola Callegaro, Franco Maggiolo, Elisa Borghi, Antonella d’Arminio Monforte, Giulia Marchetti |
61 |
[GO] |
2023―Dec―07 |
Glymphatic system dysfunction in recovered patients with mild COVID-19: A DTI-ALPS study |
Lin Wu, Zhi Zhang, Xiao Liang, Yao Wang, Yuan Cao, Meng Li, Fuqing Zhou |
62 |
[GO] |
2023―Nov―29 |
Epigenetic and transcriptional responses in circulating leukocytes are associated with future decompensation during SARS-CoV-2 infection |
Micah T. McClain, Ilya Zhbannikov, Lisa L. Satterwhite, Ricardo Henao, Nicholas S. Giroux, Shengli Ding, et al. (+7) Thomas W. Burke, Ephraim L. Tsalik, Christina Nix, Jorge Prado Balcazar, Elizabeth A. Petzold, Xiling Shen, Christopher W. Woods |
63 |
[GO] |
2023―Nov―24 |
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection |
Ellie N. Ivanova, Jasmine Shwetar, Joseph C. Devlin, Terkild B. Buus, Sophie Gray-Gaillard, Akiko Koide, et al. (+15) Amber Cornelius, Marie I. Samanovic, Alberto Herrera, Eleni P. Mimitou, Chenzhen Zhang, Trishala Karmacharya, Ludovic Desvignes, Niels Ødum, Peter Smibert, Robert J. Ulrich, Mark J. Mulligan, Shohei Koide, Kelly V. Ruggles, Ramin S. Herati, Sergei B. Koralov |
64 |
[GO] |
2023―Nov―23 |
Decoding Acute Myocarditis in COVID-19 Patients: Early Detection through Machine Learning and Hematological Indices |
Haiyang Li, Zhangkai J. Cheng, Xing Fu, Mingtao Liu, Peng Liu, Wenhan Cao, et al. (+3) Zhiman Liang, Fei Wang, Baoqing Sun |
65 |
[GO] |
2023―Nov―22 |
Intranasal murine pneumonia virus-vectored SARS-CoV-2 vaccine induces mucosal and serum antibodies in macaques |
Jaclyn A. Kaiser, Xueqiao Liu, Cindy Luongo, Yumiko Matsuoka, Celia Santos, Lijuan Yang, et al. (+9) Richard Herbert, Ashley Castens, David W. Dorward, Reed F. Johnson, Hong-Su Park, Sharmin Afroz, Shirin Munir, Cyril Le Nouën, Ursula J. Buchholz |
66 |
[GO] |
2023―Nov―21 |
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents |
Helen Ratcliffe, Karen S. Tiley, Stephanie Longet, Claire Tonry, Cathal Roarty, Chris Watson, et al. (+35) Gayatri Amirthalingam, Iason Vichos, Ella Morey, Naomi L. Douglas, Spyridoula Marinou, Emma Plested, Parvinder K. Aley, Eva Galiza, Saul N. Faust, Stephen Hughes, Clare Murray, Marion R. Roderick, Fiona Shackley, Sam Oddie, Tim W.R. Lee, David P.J. Turner, Mala Raman, Stephen Owens, Paul J. Turner, Helen Cockerill, Jamie Lopez Bernal, Samreen Ijaz, John Poh, Justin Shute, Ezra Linley, Ray Borrow, Katja Hoschler, Kevin E. Brown, Miles W. Carroll, Paul Klenerman, Susanna J. Dunachie, Mary Ramsay, Merryn Voysey, Thomas Waterfield, Matthew D. Snape |
67 |
[GO] |
2023―Nov―15 |
Influenza A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics |
Nerea Martín Almazán, Afsar Rahbar, Marcus Carlsson, Tove Hoffman, Linda Kolstad, Bengt Rönnberg, et al. (+12) Mattia Russel Pantalone, Ilona Lewensohn Fuchs, Anna Nauclér, Mats Ohlin, Mariusz Sacharczuk, Piotr Religa, Stefan Amér, Christian Molnár, Åke Lundkvist, Andres Susrud, Birger Sörensen, Cecilia Söderberg-Nauclér |
68 |
[GO] |
2023―Nov―15 |
Breakthrough SARS-COV-2 infection induces broad anti-viral T cell immunity |
Katie Lineburg, Pauline Crooks, Jyothy Raju, Laetitia Le Texier, Panteha Khaledi, Kiana Berry, et al. (+7) Srividhya Swaminathan, Archana Panikkar, Sweera Rehan, Kristyan Guppy-Coles, Michelle Anne Neller, Rajiv Khanna, Corey Smith |
69 |
[GO] |
2023―Nov―13 |
Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway towards SARS-CoV-2 |
Anvita Bhargava, Ugo Szachnowski, Maxime Chazal, Dominika Foretek, Vincent Caval, Sophie-Marie Aicher, et al. (+6) Juliana Pipoli da Fonseca, Patricia Jeannin, Guillaume Beauclair, Marc Monot, Antonin Morillon, Nolwenn Jouvenet |
70 |
[GO] |
2023―Nov―01 |
Airway epithelial cells and macrophages trigger IL-6-CD95/CD95L axis and mediate initial immunopathology of COVID-19 |
Thais F.C. Fraga-Silva, Ualter G. Cipriano, Marcilio J. Fumagalli, Giseli F. Correa, Carlos A. Fuzo, Douglas dos-Santos, et al. (+12) Fabiola L.A. C. Mestriner, Christiane Becari, Andrea Teixeira-Carvalho, Jordana Coelho-dos-Reis, Mayra G. Menegueti, Luiz T.M. Figueiredo, Larissa Dias Cunha, Olindo A. Martins-Filho, Marcelo Dias-Baruffi, Maria Auxiliadora-Martins, Rita C. Tostes, Vania L.D. Bonato |
71 |
[GO] |
2023―Oct―30 |
Single-cell RNA-Seq reveals intracellular microbial diversity within Immune cells during SARS-CoV-2 Infection and Recovery |
Sunita Yadav, Priyanka Mehta, Jyoti Soni, Partha Chattopadhyay, Priti Devi, Thierry Habyarimana, et al. (+3) Kishore Tardalkar, Meghnad Joshi, Rajesh Pandey |
72 |
[GO] |
2023―Oct―27 |
Impact of Mutations Defining SARS-CoV-2 Omicron Subvariants BA.2.12.1 and BA.4/5 on Spike Function and Neutralization |
Chiara Pastorio, Sabrina Noettger, Rayhane Nchioua, Fabian Zech, Konstantin M.J. Sparrer, Frank Kirchhoff |
73 |
[GO] |
2023―Oct―27 |
Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 Pandemic to Epidemic transition |
Ranjeet Maurya, Aparna Swaminathan, Uzma Shamim, Smriti Arora, Pallavi Mishra, Aakarshan Raina, et al. (+4) Varsha Ravi, Bansidhar Tarai, Sandeep Budhiraja, Rajesh Pandey |
74 |
[GO] |
2023―Oct―24 |
Genomic and transcriptomic characterization of Delta SARS-CoV-2 infection in free-ranging white-tailed deer (Odocoileus virginianus) |
Jonathon D. Kotwa, Briallen Lobb, Ariane Massé, Marianne Gagnier, Patryk Aftanas, Arinjay Banerjee, et al. (+17) Andra Banete, Juliette Blais-Savoie, Jeff Bowman, Tore Buchanan, Hsien-Yao Chee, Peter Kruczkiewicz, Kuganya Nirmalarajah, Catherine Soos, Oksana Vernygora, Lily Yip, L. Robbin Lindsay, Allison J. McGeer, Finlay Maguire, Oliver Lung, Andrew C. Doxey, Bradley Pickering, Samira Mubareka |
75 |
[GO] |
2023―Oct―18 |
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 |
Qian Wang, Zhiteng Li, Yicheng Guo, Ian A. Mellis, Sho Iketani, Michael Liu, et al. (+7) Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Aubree Gordon, Lihong Liu, David D. Ho |
76 |
[GO] |
2023―Oct―18 |
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, Delta and Omicron BA1, BA2 spike trimers |
Narayanaiah Cheedarla, Hans P. Verkerke, Sindhu Potlapalli, Kaleb Benjamin McLendon, Anamika Patel, Filipp Frank, et al. (+21) William Henry O’Sick, Suneethamma Cheedarla, Tyler Jon Baugh, Gregory L. Damhorst, Huixia Wu, Daniel Graciaa, Fuad Hudaib, David N. Alter, Jeannette Bryksin, Eric A. Ortlund, Jeanette Guarner, Sara Auld, Sarita Shah, Wilbur Lam, Dawn Mattoon, Joseph M. Johnson, David H. Wilson, Madhav V. Dhodapkar, Sean R. Stowell, Andrew S. Neish, John D. Roback |
77 |
[GO] |
2023―Oct―12 |
Exploring disease-causing traits for drug repurposing in critically ill COVID-19 patients: a causal inference approach |
Hannes A. Baukmann, Justin L. Cope, Colin Bannard, Alexander R.E. C. Schwinges, Margaretha R.J. Lamparter, Sarah Groves, et al. (+4) Charles N.J. Ravarani, Borko Amulic, Joern E. Klinger, Marco F. Schmidt |
78 |
[GO] |
2023―Oct―11 |
Noninvasive diagnosis of secondary infections in COVID-19 by sequencing of plasma microbial cell-free DNA. |
Grace Lisius, Radha Duttagupta, Asim A. Ahmed, Matthew Hensley, Nameer Al-Yousif, Michael Lu, et al. (+18) William Bain, Faraaz Shah, Timothy A. Blauwkamp, Sivan Bercovici, Caitlin Schaefer, Shulin Qin, Xiaohong Wang, Yingze Zhang, Kevin J. Mitchell, Ellen K. Hughes, Jana L. Jacobs, Asma Naqvi, Ghady Haidar, John W. Mellors, Barbara Methé, Bryan J. McVerry, Alison Morris, Georgios D. Kitsios |
79 |
[GO] |
2023―Oct―05 |
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial |
Vincent Rathkolb, Marianna T. Traugott, Andreas Heinzel, Marko Poglitsch, Judith Aberle, Farsad Eskandary, et al. (+22) Agnes Abrahamowicz, Martin Mueller, Petra Knollmueller, Tarik Shoumariyeh, Jasmin Stuflesser, Ivan Seeber, Georg Gibas, Hannah Mayfurth, Viktoria Tinhof, Lukas Schmoelz, Markus Zeitlinger, Christian Schoergenhofer, Bernd Jilma, Bernd Genser, Wolfgang Hoepler, Sara Omid, Mario Karolyi, Christoph Wenisch, Rainer Oberbauer, Alexander Zoufaly, Manfred Hecking, Roman Reindl-Schwaighofer |
80 |
[GO] |
2023―Sep―30 |
Differential RNA editing landscapes in host cell versus the SARS-CoV-2 genome |
Małgorzata Kurkowiak, Sarah Fletcher, Alison Daniels, Paweł Mozolewski, Domenico Alessandro Silvestris, Ewelina Król, et al. (+3) Natalia Marek-Trzonkowska, Ted Hupp, Christine Tait-Burkard |
81 |
[GO] |
2023―Sep―28 |
The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination |
Esther J.M. Taks, Simone J.C.F.M. Moorlag, Konstantin Föhse, Elles Simonetti, Christa E. van der Gaast-de Jongh, Cornelis H. van Werkhoven, et al. (+5) Marc J.M. Bonten, Jaap ten Oever, Marien I. de Jonge, Janneke H.H.M. van de Wijgert, Mihai G. Netea |
82 |
[GO] |
2023―Sep―28 |
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity |
Hazel Stewart, Yongxu Lu, Sarah O’Keefe, Anusha Valpadashi, Luis Daniel Cruz-Zaragoza, Hendrik A. Michel, et al. (+16) Samantha K. Nguyen, George W. Carnell, Nina Lukhovitskaya, Rachel Milligan, Yasmin Adewusi, Irwin Jungreis, Valeria Lulla, David A. Matthews, Stephen High, Peter Rehling, Edward Emmott, Jonathan L. Heeney, Andrew D. Davidson, James R. Edgar, Geoffrey L. Smith, Andrew E. Firth |
83 |
[GO] |
2023―Sep―27 |
Glycosylated Delta-RBD mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge |
Xiaoqing Guan, Abhishek K. Verma, Gang Wang, Juan Shi, Stanley Perlman, Lanying Du |
84 |
[GO] |
2023―Sep―27 |
The KINETIC phase 2 randomised controlled trial of oral pamapimod-pioglitazone in non-critically ill COVID-19 inpatients |
Thierry Fumeaux, Claudia Berger, Alexander Bausch, Matthew Wright, Urosh Vilimanovich, Ivan Soldatovic, Maria J.G.T. Vehreschild |
85 |
[GO] |
2023―Sep―22 |
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual |
Denise Guerra, Tim Beaumont, Laura Radić, Gius Kerster, Karlijn van der Straten, Meng Yuan, et al. (+20) Jonathan L. Torres, Wen-Hsin Lee, Hejun Liu, Meliawati Poniman, Ilja Bontjer, Judith A. Burger, Mathieu Claireaux, Tom G. Caniels, Jonne L. Snitselaar, Tom P.L. Bijl, Sabine Kruijer, Gabriel Ozorowski, David Gideonse, Kwinten Sliepen, Andrew B. Ward, Dirk Eggink, Godelieve J. de Bree, Ian A. Wilson, Rogier W. Sanders, Marit J. van Gils |
86 |
[GO] |
2023―Sep―20 |
Mitochondrial dysfunction, lipids metabolism and amino acid biosynthesis are key pathways for COVID-19 recovery |
Alba Sánchez, Graciano García-Pardo, Fréderic Gómez-Bertomeu, Miguel López-Dupla, Elisabet Foguet-Romero, Maria José Buzón, et al. (+7) Benito Almirante, Montserrat Olona, Sonia Fernández-Veledo, Francesc Vidal, Silvia Chafino, Anna Rull, Joaquim Peraire |
87 |
[GO] |
2023―Sep―20 |
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults |
Devyani Joshi, Lindsay E. Nyhoff, Veronika I. Zarnitsyna, Alberto Moreno, Kelly Manning, Susanne Linderman, et al. (+9) Allison R. Burrell, Kathy Stephens, Carson Norwood, Grace Mantus, Rafi Ahmed, Evan J. Anderson, Mary A. Staat, Mehul S. Suthar, Jens Wrammert |
88 |
[GO] |
2023―Sep―19 |
Third COVID-19 vaccines dose boosts antibody function in Rwandans with high HIV viral load |
Cynthia L. Swan, Valentine Dushimiyimana, Pacifique Ndishimye, Rachelle Buchannan, Anthony Yourkowski, Sage Semafara, et al. (+11) Sabin Nsanzimana, Magen E. Francis, Brittany Thivierge, Jocelyne Lew, Antonio Facciuolo, Volker Gerdts, Darryl Falzarano, Calvin Sjaarda, David J. Kelvin, Leopold Bitunguhari, Alyson A. Kelvin |
89 |
[GO] |
2023―Sep―14 |
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV |
Vitaliy A. Matveev, Erik Z. Mihelic, Erika Benko, Patrick Budylowski, Sebastian Grocott, Terry Lee, et al. (+30) Chapin S. Korosec, Karen Colwill, Henry Stephenson, Ryan Law, Lesley A. Ward, Salma Sheikh-Mohamed, Geneviève Mailhot, Melanie Delgado-Brand, Adrian Pasculescu, Jenny H. Wang, Freda Qi, Tulunay Tursun, Lela Kardava, Serena Chau, Philip Samaan, Annam Imran, Dennis C. Copertino, Gary Chao, Yoojin Choi, Robert J. Reinhard, Rupert Kaul, Jane M. Heffernan, R. Brad Jones, Tae-Wook Chun, Susan Moir, Joel Singer, Jennifer Gommerman, Anne-Claude Gingras, Colin Kovacs, Mario Ostrowski |
90 |
[GO] |
2023―Sep―12 |
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface |
Tao Ni, Luiza Mendonça, Yanan Zhu, Andrew Howe, Julika Radecke, Pranav M. Shah, et al. (+11) Yuewen Sheng, Anna-Sophia Krebs, Helen M.E. Duyvesteyn, Elizabeth Allen, Teresa Lambe, Cameron Bisset, Alexandra Spencer, Susan Morris, David I. Stuart, Sarah Gilbert, Peijun Zhang |
91 |
[GO] |
2023―Sep―02 |
Understanding COVID-19 Progression with Longitudinal Peripheral Blood Mononuclear Cell Proteomics: Changes in the Cellular Proteome Over Time |
Giuseppe Gianini Figueirêdo Leite, Milena Karina Colo Brunialti, Paula M. Peçanha-Pietrobom, Paulo R. Abrão Ferreira, Jaquelina Sonoe Ota-Arakaki, Edecio Cunha-Neto, et al. (+4) Bianca Lima Ferreira, Graziella E. Ronsein, Alexandre Keiji Tashima, Reinaldo Salomão |
92 |
[GO] |
2023―Sep―01 |
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling |
Jason A. Hackney, Haridha Shivram, Jason Vander Heiden, Chris Overall, Luz Orozco, Xia Gao, et al. (+49) Eugene Kim, Nathan West, Aditi Qamra, Diana Chang, Arindam Chakrabarti, David F. Choy, Alexis J. Combes, Tristan Courau, Gabriela K. Fragiadakis, Arjun Arkal Rao, Arja Ray, Jessica Tsui, Kenneth Hu, Nicholas F. Kuhn, Matthew F. Krummel, David J. Erle, Kirsten Kangelaris, Aartik Sarma, Zoe Lyon, Carolyn S. Calfee, Prescott G. Woodruff, Rajani Ghale, Eran Mick, Ashley Byrne, Beth Shoshana Zha, Charles Langelier, Carolyn M. Hendrickson, Monique G.P. van der Wijst, George C. Hartoularos, Tianna Grant, Raymund Bueno, David S. Lee, John R. Greenland, Yang Sun, Richard Perez, Anton Ogorodnikov, Alyssa Ward, Chun Jimmie Ye, Thiru Ramalingam, Jacqueline M. McBride, Fang Cai, Anastasia Teterina, Min Bao, Larry Tsai, Ivan O. Rosas, Aviv Regev, Sharookh B. Kapadia, Rebecca N. Bauer, Carrie M. Rosenberger |
93 |
[GO] |
2023―Aug―31 |
COVID-19 and cholesterol biosynthesis: Towards innovative decision support systems |
Eva Kočar, Sonja Katz, Žiga Pušnik, Petra Bogovič, Gabriele Turel, Cene Skubic, et al. (+6) Tadeja Režen, Franc Strle, Vitor A.P. Martins dos Santos, Miha Mraz, Miha Moškon, Damjana Rozman |
94 |
[GO] |
2023―Aug―30 |
Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection |
Yarden Golan, Mikias Ilala, Lin Li, Caryl Gay, Soumya Hunagund, Christine Y. Lin, et al. (+9) Arianna G. Cassidy, Unurzul Jigmeddagva, Yusuke Matsui, Nida Ozarslan, Ifeyinwa V. Asiodu, Nadav Ahituv, Valerie J. Flaherman, Stephanie L. Gaw, Mary Prahl |
95 |
[GO] |
2023―Aug―30 |
Longitudinal study across SARS-CoV-2 variants identifies Transcriptionally Active Microbes (TAMs) associated with Delta severity |
Priti Devi, Pallawi Kumari, Aanchal Yadav, Bansidhar Tarai, Sandeep Budhiraja, Uzma Shamim, Rajesh Pandey |
96 |
[GO] |
2023―Aug―30 |
N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody |
Arne Zibat, Xiaoxiao Zhang, Antje Dickmanns, Kim M. Stegmann, Adrian Dobbelstein, Halima Alachram, et al. (+7) Rebecca Soliwoda, Gabriela Salinas, Uwe Groß, Dirk Görlich, Maik Kschischo, Bernd Wollnik, Matthias Dobbelstein |
97 |
[GO] |
2023―Aug―25 |
Genetic signature detected in T cell receptors from patients with severe COVID-19 |
Manuel Corpas, Carmen de Mendoza, Víctor Moreno-Torres, Ilduara Pintos, Pedro Seoane, James R. Perkins, et al. (+7) Juan A.G. Ranea, Segun Fatumo, Tamas Korcsmaros, José Manuel Martín-Villa, Pablo Barreiro, Octavio Corral, Vicente Soriano |
98 |
[GO] |
2023―Aug―24 |
Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells |
Alok K. Singh, Rulin Wang, Kara A. Lombardo, Monali Praharaj, C. Korin Bullen, Peter Um, et al. (+18) Manish Gupta, Geetha Srikrishna, Stephanie Davis, Oliver Komm, Peter B. Illei, Alvaro A. Ordonez, Melissa Bahr, Joy Huang, Anuj Gupta, Kevin J. Psoter, Patrick S. Creisher, Maggie Li, Andrew Pekosz, Sabra L. Klein, Sanjay K. Jain, Trinity J. Bivalacqua, Srinivasan Yegnasubramanian, William R. Bishai |
99 |
[GO] |
2023―Aug―23 |
SARS-CoV-2 Nsp15 suppresses type I interferon production by inhibiting IRF3 phosphorylation and nuclear translocation |
Dianqi Zhang, Likai Ji, Xu Chen, Yumin He, Yijie Sun, Li Ji, et al. (+7) Tiancheng Zhang, Quan Shen, Xiaochun Wang, Yan Wang, Shixing Yang, Wen Zhang, Chenglin Zhou |
100 |
[GO] |
2023―Aug―22 |
Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea |
Atanas V. Demirev, Kyuyoung Lee, Joon-Yong Bae, Heedo Park, Sejik Park, Hyunbeen Kim, et al. (+9) Jungmin Lee, Junhyung Cho, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee, Kisoon Kim, Philippe Lemey, Man-Seong Park, Jin Il Kim |
101 |
[GO] |
2023―Aug―19 |
Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2 |
Anthony Flamier, Punam Bisht, Alexsia Richards, Danielle L. Tomasello, Rudolf Jaenisch |
102 |
[GO] |
2023―Aug―16 |
A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals |
Matteo Breno, Marina Noris, Nadia Rubis, Aneliya Ilieva Parvanova, Davide Martinetti, Sara Gamba, et al. (+15) Lucia Liguori, Caterina Mele, Rossella Piras, Silvia Orisio, Elisabetta Valoti, Marta Alberti, Olimpia Diadei, Elena Bresin, Miriam Rigoldi, Silvia Prandini, Nadia Stucchi, Fabiola Carrara, Erica Daina, Ariela Benigni, Giuseppe Remuzzi |
103 |
[GO] |
2023―Aug―15 |
Antibody attributes, Fc receptor expression, gestation and maternal SARS-CoV-2 infection modulate HSV IgG placental transfer |
Aakash Mahant Mahant, Fatima Estrada Trejo, Jennifer T. Aguilan, Simone Sidoli, Sallie R. Permar, Betsy C. Herold |
104 |
[GO] |
2023―Aug―14 |
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection |
Eva A.M. Baerends, Astrid K. Hvidt, Joanne Reekie, Ole S. Søgaard, Nina B. Stærke, Dorthe Raben, et al. (+21) Henrik Nielsen, Kristine T. Petersen, Maria R. Juhl, Isik S. Johansen, Susan O. Lindvig, Lone W. Madsen, Lothar Wiese, Lene S. Knudsen, Mette B. Iversen, Thomas Benfield, Kasper K. Iversen, Sidsel D. Andersen, Anna K. Juhl, Lisa L. Dietz, Signe R. Andreasen, Thea K. Fischer, Christian Erikstrup, Palle Valentiner-Branth, Jens Lundgren, Lars Østergaard, Martin Tolstrup |
105 |
[GO] |
2023―Aug―14 |
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines |
Julie Van Coillie, Tamas Pongracz, Tonći Šuštić, Wenjun Wang, Jan Nouta, Mathieu Le Gars, et al. (+20) Sofie Keijzer, Federica Linty, Olvi Cristianawati, Jim B.D. Keijser, Remco Visser, Lonneke A. van Vught, Marleen A. Slim, Niels van Mourik, Merel J. Smit, Adam Sander, David E. Schmidt, Maurice Steenhuis, Theo Rispens, Morten A. Nielsen, Benjamin G. Mordmüller, Alexander P.J. Vlaar, C.Ellen van der Schoot, Ramon Roozendaal, Manfred Wuhrer, Gestur Vidarsson |
106 |
[GO] |
2023―Aug―11 |
Transcriptomic and Proteomic Assessment of Tocilizumab Response in a Randomized Controlled Trial of Patients Hospitalized with COVID-19 |
Haridha Shivram, Jason A. Hackney, Carrie M. Rosenberger, Anastasia Teterina, Aditi Qamra, Olusegun Onabajo, et al. (+7) Jacqueline McBride, Fang Cai, Min Bao, Larry Tsai, Aviv Regev, Ivan O. Rosas, Rebecca N. Bauer |
107 |
[GO] |
2023―Aug―11 |
DEVELOPMENT OF MULTI-SCALE INDICES OF HUMAN MOBILITY RESTRICTION DURING THE COVID-19 BASED ON AIR QUALITY FROM LOCAL AND GLOBAL NO2 CONCENTRATION |
Larissa Haringer Martins da Silveira, Marcio Cataldi, William Cossich Marcial de Farias |
108 |
[GO] |
2023―Aug―11 |
BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine |
Dilhan J. Perera, Pilar Domenech, George Giorgi Babuadze, Maedeh Naghibosadat, Fernando Alvarez, Cal Koger-Pease, et al. (+13) Lydia Labrie, Matthew Stuible, Yves Durocher, Ciriaco A. Piccirillo, André Lametti, Pierre Olivier Fiset, Seyyed Mehdy Elahi, Gary P. Kobinger, Rénald Gilbert, Martin Olivier, Robert Kozak, Michael B. Reed, Momar Ndao |
109 |
[GO] |
2023―Aug―10 |
Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication |
Lin Lin, Da-Yuan Chen, Christina Scartelli, Huanzhang Xie, Glenn Merrill-Skoloff, Moua Yang, et al. (+3) Lijun Sun, Mohsan Saeed, Robert Flaumenhaft |
110 |
[GO] |
2023―Aug―09 |
Development of a loop-mediated isothermal amplification (LAMP)-based electrochemical test for rapid detection of SARS-CoV-2 |
Khushboo Borah Slater, Muhammad Ahmad, Aurore Poirier, Ash Stott, Bianca Sica Siedler, Matthew Brownsword, et al. (+7) Jai Mehat, Joanna Urbaniec, Nicolas Locker, Yunlong Zhao, Roberto La Ragione, S. Ravi P. Silva, Johnjoe McFadden |
111 |
[GO] |
2023―Aug―08 |
Explicit Modelling of Antibody Levels for Infectious Disease Simulations in the Context of SARS-CoV-2 |
Sebastian A. Müller, Sydney Paltra, Jakob Rehmann, Kai Nagel, Tim O.F. Conrad |
112 |
[GO] |
2023―Aug―07 |
MAP3K19 regulatory variation in populations with African ancestry may increase COVID-19 severity |
Zhongshan Cheng, Yi Cai, Ke Zhang, Jingxuan Zhang, Hongsheng Gui, Yu-Si Luo, et al. (+2) Jie Zhou, Brian DeVeale |
113 |
[GO] |
2023―Aug―07 |
Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants |
Veronica J. Gonzalez, Lin Li, Sirirak Buarpung, Mary Prahl, Joshua F. Robinson, Stephanie L. Gaw |
114 |
[GO] |
2023―Aug―06 |
Intracellular peptides in SARS-CoV-2-infected patients |
Luiz Felipe Martucci, Rosangela A.S. Eichler, Renée N.O. Silva, Tiago J. Costa, Rita C. Tostes, Geraldo F. Busatto, et al. (+4) Marilia C.L. Seelaender, Alberto J.S. Duarte, Heraldo P. Souza, Emer S. Ferro |
115 |
[GO] |
2023―Jul―29 |
A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers |
Xunying Zhao, Xueyao Wu, Jinyu Xiao, Li Zhang, Yu Hao, Chenghan Xiao, et al. (+3) Ben Zhang, Jiayuan Li, Xia Jiang |
116 |
[GO] |
2023―Jul―27 |
Spatial, temporal and motivational changes due to the COVID-19 pandemic in a nature-based leisure activity - a global survey of birders |
Christoph Randler, Jukka Jokimäki, Maria de Salvo, Renan de Almeida Barbosa, Naomi Staller, Piotr Tryjanowski, et al. (+5) Marja-Liisa Kaisanlahti-Jokimäki, Jo-Szu Tsai, Raúl Ortiz-Pulido, Arash Rahafar, Laura Giuffrida |
117 |
[GO] |
2023―Jul―25 |
Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concern |
Yu Onodera, Jady Liang, Yuchong Li, Bryan Griffin, Thenuka Thanabalasingam, Cong Lu, et al. (+19) JiaYi Zhu, Mingyao Liu, Theo Moraes, Wenhua Zheng, Jasmin Khateeb, Julie Khang, Yongbo Huang, Mirjana Jerkic, Masaki Nakane, Andrew Baker, Beverley Orser, Ya-Wen Chen, Gerald Wirnsberger, Josef M. Penninger, Ori D. Rotstein, Arthur S. Slutsky, Yimin Li, Samira Mubareka, Haibo Zhang |
118 |
[GO] |
2023―Jul―22 |
Porcine reproductive and respiratory syndrome virus upregulates SMPDL3B to promote viral replication by modulating lipid metabolism |
Huan-Huan Shen, Qin Zhao, Yi-Ping Wen, Rui Wu, Sen-Yan Du, Xiao-Bo Huang, et al. (+4) Xin-Tian Wen, San-Jie Cao, Lei Zeng, Qi-Gui Yan |
119 |
[GO] |
2023―Jul―18 |
F-actin nanostructures rearrangements and regulation are essential for SARS-CoV2 particle production in host pulmonary cells. |
Jitendriya Swain, Peggy Merida, Karla Rubio, David Bracquemond, Aymeric Neyret, Israel Aguilar-Ordoñez, et al. (+3) Stefan Günther, Guillermo Barreto, Delphine Muriaux |
120 |
[GO] |
2023―Jul―13 |
Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia |
Diana Cadena Castaneda, Sonia Jangra, Marina Yurieva, Jan Martinek, Megan Callender, Matthew Coxe, et al. (+18) Angela Choi, Juan García-Bernalt Diego, Jianan Lin, Te-Chia Wu, Florentina Marches, Damien Chaussabel, Peter Yu, Andrew Salner, Gabrielle Aucello, Jonathan Koff, Briana Hudson, Sarah E. Church, Kara Gorman, Esperanza Anguiano, Adolfo García-Sastre, Adam Williams, Michael Schotsaert, Karolina Palucka |
121 |
[GO] |
2023―Jul―13 |
Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping and sequence analysis. |
Arnaud N’Guessan, Senthilkumar Kailasam, Fatima Mostefai, Raphael Poujol, Jean-Christophe Grenier, Nailya Ismailova, et al. (+9) Paola Contini, Raffaele De Palma, Carsten Haber, Volker Stadler, Guillaume Bourque, Julie G. Hussin, B. Jesse Shapiro, Jörg H. Fritz, Ciriaco A. Piccirillo |
122 |
[GO] |
2023―Jul―04 |
Extracellular vesicles in COVID-19 convalescence can regulate T cell metabolism and function |
Molly S. George, Jenifer Sanchez, Christina Rollings, David Fear, Peter Irving, Linda V. Sinclair, Anna Schurich |
123 |
[GO] |
2023―Jun―28 |
Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-Spike antibodies |
Elena Montes-Cobos, Victoria C. Bastos, Clarice Monteiro, João CR. de Freitas, Heiny DP. Fernandes, Clarice S. Constancio, et al. (+18) Danielle AS. Rodrigues, Andreza MDS. Gama, Vinicius M. Vidal, Leticia S. Alves, Laura Zalcberg-Renault, Guilherme S. de Lira, Victor A. Ota, Carolina Caloba, Luciana Conde, Isabela C. Leitão, Amilcar Tanuri, Orlando DC. Ferreira, Renata M. Pereira, André M. Vale, Terezinha M. Castiñeiras, Dominique Kaiserlian, Juliana Echevarria-Lima, Marcelo T. Bozza |
124 |
[GO] |
2023―Jun―28 |
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates |
Antoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, Antonio Barreiro, Alex Fernández, Manuel Cañete, et al. (+19) Mercè Roca, Luis González-González, Carme Garriga, Joachim Confais, Marion Toussenot, Hugues Contamin, Andrés Pizzorno, Manuel Rosa-Calatrava, Edwards Pradenas, Silvia Marfil, Julià Blanco, Paula Cebollada Rica, Marta Sisteré-Oró, Andreas Meyerhans, Cristina Lorca, Joaquim Segalés, Teresa Prat, Ricard March, Laura Ferrer |
125 |
[GO] |
2023―Jun―25 |
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination |
Shinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, Yuko Sakai-Tagawa, Ichiro Nakachi, Rie Baba, et al. (+21) Shigenobu Kamimoto, Takayuki Ogura, Shigehiro Hagiwara, Hideaki Kato, Hideaki Nakajima, Yoshifumi Uwamino, Kazuma Yagi, Norio Sugaya, Hiroyuki Nagai, Makoto Saito, Eisuke Adachi, Michiko Koga, Takeya Tsutsumi, Calvin Duong, Moe Okuda, Jurika Murakami, Yuri Furusawa, Michiko Ujie, Kiyoko Iwatsuki-Horimoto, Hiroshi Yotsuyanagi, Yoshihiro Kawaoka |
126 |
[GO] |
2023―Jun―25 |
Circulating Cellular Clusters Are Associated with Thrombotic Complications and Clinical Outcomes in COVID-19 |
Ander Dorken-Gallastegi, Yao Lee, Guansheng Li, He Li, Leon Naar, Xuejin Li, et al. (+10) Ting Ye, Elizabeth Van Cott, Rachel Rosovsky, David Gregory, Ronald Tompkins, George Karniadakis, Haytham MA. Kaafarani, George C. Velmahos, Jarone Lee, Galit H. Frydman |
127 |
[GO] |
2023―Jun―19 |
Pandemics erode poverty alleviation process: Impact on productive livelihood and poverty return |
Bo Wang, Han Shi, Zhaohua Wang, Shuling Xu, Nana Deng, Yueming (Lucy) Qiu, Bin Zhang |
128 |
[GO] |
2023―Jun―16 |
Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2 |
Praveen Neeli, Dafei Chai, Xu Wang, Navid Sobhani, George Udeani, Yong Li |
129 |
[GO] |
2023―Jun―16 |
SARS-CoV-2 ORF3c impairs mitochondrial respiratory metabolism, oxidative stress, and autophagic flux |
Alessandra Mozzi, Monica Oldani, Matilde E. Forcella, Chiara Vantaggiato, Gioia Cappelletti, Chiara Pontremoli, et al. (+7) Francesca Valenti, Diego Forni, Marina Saresella, Mara Biasin, Manuela Sironi, Paola Fusi, Rachele Cagliani |
130 |
[GO] |
2023―Jun―10 |
Impact of peripheral mitochondrial DNA level on immune response after COVID-19 vaccination |
Hiroaki Ikezaki, Hideyuki Nomura, Nobuyuki Shimono |
131 |
[GO] |
2023―Jun―10 |
Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies |
Anette S.B. Wolff, Lena Hansen, Marianne Aa. Grytaas, Bergithe E. Oftedal, Lars Breivik, Fan Zhou, et al. (+11) Karl Ove Hufthammer, Thea Sjøgren, Jan Stefan Olofsson, Mai Chi Trieu, Anthony Meager, Anders P. Jørgensen, Kari Lima, Kristin Greve-Isdahl Mohn, Nina Langeland, Rebecca Jane Cox, Eystein S. Husebye |
132 |
[GO] |
2023―Jun―10 |
Title: A nanobody recognizes a unique conserved epitope and potently neutralizes against the SARS-CoV-2 omicron variants |
Naphak Modhiran, Simon Malte Lauer, Alberto A. Amarilla, Peter Hewins, Sara Irene Lopes van den Broek, Yu Shang Low, et al. (+32) Nazia Thakur, Benjamin Liang, Guillermo Valenzuela Nieto, James Jung, Devina Paramitha, Ariel Isaacs, Julian D.J. Sng, David Song, Jesper Tranekjær Jørgensen, Yorka Cheuquemilla, Jörg Bürger, Ida Vang Andersen, Johanna Himelreichs, Ronald Jara, Ronan MacLoughlin, Zaray Miranda-Chacon, Pedro Chana-Cuevas, Vasko Kramer, Christian M.T. Spahn, Thorsten Mielke, Alexander A. Khromykh, Trent Munro, Martina L. Jones, Paul R. Young, Keith Chappell, Dalan Bailey, Andreas Kjaer, Matthias Manfred Herth, Kellie Ann Jurado, David Schwefel, Alejandro Rojas-Fernandez, Daniel Watterson |
133 |
[GO] |
2023―Jun―09 |
COVID-19 monitoring with sparse sampling of sewered and non-sewered wastewater in urban and rural communities |
Dhammika Leshan Wannigama, Mohan Amarasiri, Parichart Hongsing, Cameron Hurst, Charin Modchang, Sudarat Chadsuthi, et al. (+27) Suparinthon Anupong, Phatthranit Phattharapornjaroen, Ali Hosseini Rad S.M., Stefan Fernandez, Angkana T. Huang, Porames Vatanaprasan, Dylan John Jay, Thammakorn Saethang, Sirirat Luk-in, Robin James Storer, Puey Ounjai, Naveen Kumar Devanga Ragupathi, Phitsanuruk Kanthawee, Daisuke Sano, Takashi Furukawa, Kazunari Sei, Asada Leelahavanichkul, Talerngsak Kanjanabuch, Nattiya Hirankarn, Paul G. Higgins, Anthony Kicic, Andrew C. Singer, Tanittha Chatsuwan, Sam Trowsdale, Shuichi Abe, Alexander D. McLellan, Hitoshi Ishikawa |
134 |
[GO] |
2023―Jun―09 |
CDC (Cindy and David’s Conversations) Game: Advising President to Survive Pandemic |
Zhanshan (Sam) Ma, Liexun Yang |
135 |
[GO] |
2023―Jun―07 |
Establishing SARS-CoV-2 Membrane protein-specific antibodies as a valuable serological target via high-content microscopy |
Daniel M. Williams, Hailey R. Hornsby, Ola M. Shehata, Rebecca Brown, Marta Gallis, Naomi Meardon, et al. (+16) Thomas A.H. Newman, Megan Plowright, Domen Zafred, Amber S.M. Shun-Shion, Anthony J. Hodder, Deepa Bliss, Andrew Metcalfe, James R. Edgar, David E. Gordon, Jon R. Sayers, Martin J. Nicklin, Miles Carroll, Paul J. Collini, Stephen Brown, Thushan I. de Silva, Andrew A. Peden |
136 |
[GO] |
2023―May―25 |
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents |
Masaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, Takehisa Matsumoto, Chieko Makino-Okamura, Qingshun Lin, et al. (+23) Machie Sakuma, Eiki Kawahara, Isato Yamazaki, Tomomi Uchikubo-Kamo, Yuri Tomabechi, Kazuharu Hanada, Tamao Hisano, Saya Moriyama, Yoshimasa Takahashi, Mutsumi Ito, Masaki Imai, Tadashi Maemura, Yuri Furusawa, Seiya Yamayoshi, Yoshihiro Kawaoka, Mikako Shirouzu, Makoto Ishii, Hideyuki Saya, Yasushi Kondo, Yuko Kaneko, Katsuya Suzuki, Koichi Fukunaga, Tsutomu Takeuchi |
137 |
[GO] |
2023―May―25 |
SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production |
Naomi Oka, Kazuya Shimada, Azusa Ishii, Nobuyuki Kobayashi, Kazuhiro Kondo |
138 |
[GO] |
2023―May―22 |
Exploring genetic associations between allergic diseases and indicators of COVID-19 using Mendelian randomization |
Yujie Wang, Xiaoyu Gu, Xinquan Wang, Wu Zhu, Juan Su |
139 |
[GO] |
2023―May―22 |
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection. |
Martina Milighetti, Yanchun Peng, Cedric Tan, Michal Mark, Gayathri Nageswaran, Suzanne Byrne, et al. (+29) Tahel Ronel, Tom Peacock, Andreas Mayer, Aneesh Chandran, Joshua Rosenheim, Matthew Whelan, Xuan Yao, Guihai Liu, Suet Ling Felce, Tao Dong, Alexander J. Mentzer, Julian C. Knight, Francois Balloux, Erez Greenstein, Shlomit Reich-Zeliger, Corrina Pade, Joseph M. Gibbons, Amanda Semper, Tim Brooks, Ashley Otter, Daniel M. Altmann, Rosemary J. Boyton, Mala K. Maini, Aine McKnight, Charlotte Manisty, Thomas A. Treibel, James C. Moon, Mahdad Noursadeghi, Benny Chain |
140 |
[GO] |
2023―May―21 |
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations |
Camilla Tiezzi, Andrea Vecchi, Marzia Rossi, Davide Cavazzini, Angelo Bolchi, Diletta Laccabue, et al. (+24) Sara Doselli, Amalia Penna, Luca Sacchelli, Federica Brillo, Tiziana Meschi, Andrea Ticinesi, Antonio Nouvenne, Gaetano Donofrio, Paola Zanelli, Magda Benecchi, Silvia Giuliodori, Paola Fisicaro, Ilaria Montali, Camilla Ceccatelli Berti, Valentina Reverberi, Anna Montali, Simona Urbani, Giuseppe Pedrazzi, Gabriele Missale, Amalio Telenti, Davide Corti, Simone Ottonello, Carlo Ferrari, Carolina Boni |
141 |
[GO] |
2023―May―18 |
Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in severe patients with COVID-19 |
Xiaosheng Wu, Michelle K. Manske, Gordon J. Ruan, Taylor L. Witter, Kevin E. Nowakowski, Jithma P. Abeykoon, et al. (+13) Xinyi Tang, Yue Yu, Kimberly A. Gwin, Annie Wu, Vanessa Taupin, Vaishali Bhardwaj, Jonas Paludo, Surendra Dasari, Haidong Dong, Stephen M. Ansell, Andrew D. Badley, Matthew J. Schellenberg, Thomas E. Witzig |
142 |
[GO] |
2023―May―18 |
Biological mechanisms underpinning the development of Long COVID |
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, Dave Wilkins, Alfredo Garzino-Demo, Christian Brechot, et al. (+2) Anders Vahlne, Janko Nikolich |
143 |
[GO] |
2023―May―04 |
Diverged landscape of restaurant recovery from the COVID-19 pandemic in the United States |
Siqin Wang, Xiao Huang, Bing She, Zhenlong Li |
144 |
[GO] |
2023―May―04 |
Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers |
Christine Bäuerl, Joao Zulaica, Luciana Rusu, Alicia Rodríguez Moreno, Francisco J. Pérez-Cano, Carles Lerin, et al. (+6) Desirée Mena-Tudela, Laia Aguilar-Camprubí, Anna Parra-Llorca, Cecilia Martínez-Costa, Ron Geller, Maria Carmen Collado |
145 |
[GO] |
2023―May―02 |
Metatranscriptomics analysis reveals a novel transcriptional and translational landscape during Middle East Respiratory Syndrome Coronavirus infection |
Ethan J. Fritch, Wes Sanders, Amy C. Sims, Laura E. Herring, Natalie K. Barker, Athena A. Schepmoes, et al. (+9) Karl K. Weitz, Jordan R. Texier, Dirk P. Dittmer, Lee M. Graves, Richard D. Smith, Katrina M. Waters, Nathaniel J. Moorman, Ralph S. Baric, Rachel L. Graham |
146 |
[GO] |
2023―Apr―27 |
HLA Diversity across the HLA-DP locus is associated with improved response to SARS-CoV-2 vaccine in hematopoietic stem cell transplant recipients. |
Juliette Villemonteix, Vincent Allain, Emma Verstraete, Debora Jorge-Cordeiro, Gérard Socié, Alienor Xhaard, et al. (+2) Cyrille Feray, Sophie Caillat-Zucman |
147 |
[GO] |
2023―Apr―25 |
Randomized clinical trials of COVID-19 vaccines: do adenovirus-vector vaccines have beneficial non-specific effects? |
Christine S. Benn, Frederik Schaltz-Buchholzer, Sebastian Nielsen, Mihai G. Netea, Peter Aaby |
148 |
[GO] |
2023―Apr―23 |
Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections |
Stefania Arsuffi, Emanuele Sansone, Emanuele Focà, Samuele Storti, Teresa Diaferia, Carlo Bonfanti, et al. (+6) Luigina Terlenghi, Arnaldo Caruso, Emma Sala, Francesco Castelli, Giuseppe De Palma, Eugenia Quiros-Roldan |
149 |
[GO] |
2023―Apr―20 |
COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient |
Ryo Morita, Ritsuko Kubota-Koketsu, Xiuyuan Lu, Tadahiro Sasaki, Emi E. Nakayama, Yu-chen Liu, et al. (+11) Daisuke Okuzaki, Daisuke Motooka, James Badger Wing, Yasunori Fujikawa, Yuji Ichida, Kiyoko Amo, Tetsushi Goto, Junichi Hara, Michinori Shirano, Sho Yamasaki, Tatsuo Shioda |
150 |
[GO] |
2023―Apr―19 |
Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: implications for vaccine dose interval |
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, et al. (+16) Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Maeda Ken, Tadaki Suzuki |
151 |
[GO] |
2023―Apr―12 |
Multiplexed On-Yeast Serological Assay for Immune Escape Screening of SARS-CoV-2 Variants |
Joanan Lopez-Morales, Rosario Vanella, Tamara Utzinger, Valentin Schittny, Julia Hirsiger, Michael Osthoff, et al. (+3) Christoph Berger, Yakir Guri, Michael A. Nash |
152 |
[GO] |
2023―Apr―10 |
Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus |
Da-Yuan Chen, Jacquelyn Turcinovic, Shuchen Feng, Devin J. Kenney, Chue Vin Chin, Manish C. Choudhary, et al. (+13) Hasahn L. Conway, Marc Semaan, Brianna J. Close, Alexander H. Tavares, Scott Seitz, Nazimuddin Khan, Sebastian Kapell, Nicholas A. Crossland, Jonathan Z. Li, Florian Douam, Susan C. Baker, John H. Connor, Mohsan Saeed |
153 |
[GO] |
2023―Apr―09 |
The Human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein. |
Charles Zou, Hojong Yoon, Paul M.C. Park, J.J. Patten, Jesse Pellman, Jeannie Carreiro, et al. (+11) Jonathan M. Tsai, Yen-Der Li, Shourya S. Roy Burman, Katherine A. Donovan, Jessica Gasser, Adam S. Sperling, Radosław P. Nowak, Eric S. Fischer, Robert A. Davey, Benjamin L. Ebert, Mikołaj Słabicki |
154 |
[GO] |
2023―Apr―08 |
Mycobacterium tuberculosis and SARS-CoV-2 co-infections: the knowns and unknowns |
Kim R. Chiok, Neeraj Dhar, Arinjay Banerjee |
155 |
[GO] |
2023―Apr―07 |
Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions |
Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, Hailong Gao, Wei Shi, Abishek Chandrashekar, et al. (+4) Ai-ris Y. Collier, Bing Chen, Dan H. Barouch, Galit Alter |
156 |
[GO] |
2023―Apr―07 |
SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients |
Benjamin Charvet, Joanna Brunel, Justine Pierquin, Mathieu Iampietro, Didier Decimo, Nelly Queruel, et al. (+15) Alexandre Lucas, María del Mar Encabo-Berzosa, Izaskun Arenaz, Tania Perez Marmolejo, Arturo Ivan Gonzalez, Armando Castorena Maldonado, Cyrille Mathieu, Patrick Küry, Jose Flores-Rivera, Fernanda Torres-Ruiz, Santiago Avila-Rios, Gonzalo Salgado Montes de Oca, Jon Schoorlemmer, Hervé Perron, Branka Horvat |
157 |
[GO] |
2023―Apr―01 |
19n01, a broadly neutralizing antibody against Omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern |
Melissa García-Vega, Edgar A. Melgoza-González, Sofía Hernández-Valenzuela, Diana Hinojosa-Trujillo, Mónica Reséndiz-Sandoval, Mara Anais Llamas-Covarrubias, et al. (+17) Martín Loza-Lopez, Olivia Valenzuela, Alan Soto-Gaxiola, Miguel A. Hernández-Oñate, Verónica Mata-Haro, Irene Cassaniti, Josè Camilla Sammartino, Alessandro Ferrari, Luca Simonelli, Mattia Pedotti, Rui Sun, Fanglei Zuo, Fausto Baldanti, Luca Varani, Harold Marcotte, Qiang Pan-Hammarström, Jesús Hernández |
158 |
[GO] |
2023―Mar―28 |
COVID-19 Vaccine Antibody Responses in Community Dwelling Adults to 48 weeks Post Primary Vaccine Series |
Sharon L Walmsley, Leah Szadkowski, Bradly Wouters, Rosemarie Clarke, Karen Cowill, Paula Rochon, et al. (+14) Michael Brudno, Rizanni Ravindran, Janet Raboud, Allison McGeer, Amit Oza, Christopher Graham, Amanda Silva, Dorin Manase, Peter Maksymowsky, Laura Parente, Roaya Monica Dayam, Jacqueline Simpson, Adrian Pasculescu, Dr.Anne-Claude Gingras |
159 |
[GO] |
2023―Mar―21 |
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization |
Edwards Pradenas, Silvia Marfil, Víctor Urrea, Macedonia Trigueros, Tetyana Pidkova, Anna Pons-Grífols, et al. (+15) Raquel Ortiz, Carla Rovirosa, Ferran Tarrés-Freixas, Carmen Aguilar-Gurrieri, Ruth Toledo, Anna Chamorro, Marc Noguera-Julian, Lourdes Mateu, Ignacio Blanco, Eulàlia Grau, Marta Massanella, Jorge Carrillo, Bonaventura Clotet, Benjamin Trinité, Julià Blanco |
160 |
[GO] |
2023―Mar―15 |
A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease |
Alexandra Alvergne, Gabriella Kountourides, M. Austin Argentieri, Lisa Agyen, Natalie Rogers, Dawn Knight, et al. (+3) Gemma C Sharp, Jacqueline A Maybin, Zuzanna Olszewska |
161 |
[GO] |
2023―Mar―15 |
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 Omicron sub-lineages |
Franck Touret, Emilie Giraud, Jérôme Bourret, Flora Donati, Jaouen Tran-Rajau, Jeanne Chiaravalli, et al. (+5) Frédéric Lemoine, Fabrice Agou, Etienne Simon-Lorière, Sylvie van der Werf, Xavier de Lamballerie |
162 |
[GO] |
2023―Mar―14 |
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathways |
Lihua Wang, Daniel Western, Jigyasha Timsina, Charlie Repaci, Won-Min Song, Joanne Norton, et al. (+16) Pat Kohlfeld, John Budde, Sharlee Climer, Omar H. Butt, Daniel Jacobson, Michael Garvin, Alan R Templeton, Shawn Campagna, Jane O’Halloran, Rachel Presti, Charles W. Goss, Philip A. Mudd, Beau M. Ances, Bin Zhang, Yun Ju Sung, Carlos Cruchaga |
163 |
[GO] |
2023―Mar―06 |
Changes in serum neutralizing antibody potency and breadth post SARS-CoV-2 mRNA vaccine boost |
Manoj S. Nair, Ruy M. Ribeiro, Maple Wang, Anthony D. Bowen, Lihong Liu, Yicheng Guo, et al. (+7) Jennifer Y. Chang, Pengfei Wang, Zizhang Sheng, Magdalena E. Sobieszczyk, Alan S. Perelson, Yaoxing Huang, David D. Ho |
164 |
[GO] |
2023―Mar―02 |
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the Sotrovimab face but is escaped by Omicron |
Jakob Kreye, S Momsen Reincke, Stefan Edelburg, Lara M Jeworowski, Hans-Christian Kornau, Jakob Trimpert, et al. (+19) Peter Hombach, Sophia Halbe, Volker Nölle, Martin Meyer, Stefanie Kattenbach, Elisa Sánchez-Sendin, Marie L Schmidt, Tatjana Schwarz, Ruben Rose, Andi Krumbholz, Sophie Merz, Julia M. Adler, Kathrin Eschke, Azza Abdelgawad, Dietmar Schmitz, Leif E Sander, Uwe Janssen, Victor M Corman, Harald Prüss |
165 |
[GO] |
2023―Feb―28 |
Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T-cells against SARS-CoV-2 variants |
Kate A. Parham, Gyoung Nyoun Kim, Connor G. Richer, Marina Ninkov, Kunyu Wu, Nasrin Saeedian, et al. (+7) Yue Li, Rasheduzzaman Rashu, Stephen D. Barr, Eric J. Arts, S.M. Mansour Haeryfar, C. Yong Kang, Ryan M. Troyer |
166 |
[GO] |
2023―Feb―28 |
Coronavirus accessory protein ORF3 biology and its contribution to viral behavior and pathogenesis |
Fusheng Si, Shuai Song, Ruisong Yu, Zhen Li, Wenqiang Wei, Chao Wu |
167 |
[GO] |
2023―Feb―28 |
FDA-Approved Abl/EGFR/PDGFR Kinase Inhibitors Show Potent Efficacy Against Pandemic and Seasonal Influenza A Virus infections of human lung explants |
Robert Meineke, Sonja Stelz, Maximilian Busch, Christopher Werlein, Mark Kühnel, Danny Jonigk, et al. (+2) Guus F. Rimmelzwaan, Husni Elbahesh |
168 |
[GO] |
2023―Feb―27 |
Artificial Intelligence-based HDX (AI-HDX) Prediction Reveals Fundamental Characteristics to Protein Dynamics: Mechanisms on SARS-CoV-2 Immune Escape |
Jiali Yu, Ugur Uzuner, Bin Long, Zachary Wang, Joshua S Yuan, Susie Y Dai |
169 |
[GO] |
2023―Feb―25 |
Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization |
Debjani Pal, Kuntal De, Timothy B. Yates, Jaydeep Kolape, Wellington Muchero |
170 |
[GO] |
2023―Feb―22 |
Demultiplexing Ig repertoires by parallel mRNA/DNA sequencing shows major differential alterations in severe COVID-19 |
Virginie Pascal, Marine Dupont, Paco de Rouault, David Rizzo, Delphine Rossille, Robin Jeannet, et al. (+14) Thomas Daix, Bruno François, Steve Genebrier, Marie Cornic, Guillaume Monneret, Fabienne Venet, Juliette Ferrant, Mikael Roussel, Florian Reizine, Mathieu Le Souhaitier, Jean-Marc Tadié, Karin Tarte, Jean Feuillard, Michel Cogné |
171 |
[GO] |
2023―Feb―21 |
Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2 |
Ruoxu Li, Ning Su, Xiaodong Ren, Xiange Sun, Wenman Li, Yuwei Li, et al. (+6) Jin Li, Chen Chen, Hong Wang, Weiping Lu, Shaoli Deng, Qing Huang |
172 |
[GO] |
2023―Feb―20 |
Incorporation of SARS-CoV-2 spike NTD to RBD Protein Vaccine Improves Immunity Against Viral Variants |
Isabelle Montgomerie, Thomas W. Bird, Olga R. Palmer, Ngarangi C. Mason, Theresa E. Pankhurst, Blair Lawley, et al. (+19) Leonor C. Hernández, Rhodri Harfoot, Astrid Authier-Hall, Danielle E. Anderson, Kerry L. Hilligan, Kaitlin H. Buick, Naasson M. Mbenza, Gerd Mittelstädt, Samara Maxwell, Shubhra Sinha, Joanna Kuang, Kanta Subbarao, Emily J. Parker, Alan Sher, Ian F. Hermans, James E. Ussher, Miguel E. Quiñones-Mateu, Davide Comoletti, Lisa M. Connor |
173 |
[GO] |
2023―Feb―18 |
Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission |
Matthew Cotten, My V.T. Phan |
174 |
[GO] |
2023―Feb―16 |
Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene |
Kosuke Takada, Mahoko Takahashi Ueda, Shintaro Shichinohe, Yurie Kida, Chikako Ono, Yoshiharu Matsuura, et al. (+2) Tokiko Watanabe, So Nakagawa |
175 |
[GO] |
2023―Feb―15 |
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021 |
Pierre Gallian, Nathanaël Hozé, Nadège Brisbarre, Paola Mariela Saba Villarroel, Elif Nurtop, Christine Isnard, et al. (+5) Boris Pastorino, Pascale Richard, Pascal Morel, Simon Cauchemez, Xavier de Lamballerie |
176 |
[GO] |
2023―Feb―10 |
SARS-CoV-2 leverages airway epithelial protective mechanism for viral infection |
Allison Marie Greaney, Micha Sam Brickman Raredon, Maria P. Kochugaeva, Laura E. Niklason, Andre Levchenko |
177 |
[GO] |
2023―Feb―09 |
COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbionts |
William Parker, Esha Patel, Kateřina Jirků-Pomajbíková, Jon D. Laman |
178 |
[GO] |
2023―Feb―04 |
Probing the Affinity of Noble Metal Nanoparticles to the Segments of the SARS-CoV-2 Spike Protein |
Qiuyang Lu, Baiyang Zhang, Mingzi Sun, Lu Lu, Baian Chen, Hon Ho Wong, et al. (+3) Cheuk Hei Chan, Tong Wu, Bolong Huang |
179 |
[GO] |
2023―Feb―03 |
Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants |
Camille Chauvin, Laurine Levillayer, Mathilde Roumier, Hubert Nielly, Claude Roth, Anupama Karnam, et al. (+23) Srinivasa Reddy Bonam, Anne Bourgarit, Clément Dubost, Aurore Bousquet, Sébastien Le Burel, Raphaële Mestiri, Damien Sene, Joris Galland, Marc Vasse, Mathieu Groh, Mathilde Le Marchand, Camille Vassord-Dang, Jean-François Gautier, Nhan Pham-Thi, Christiane Verny, Bruno Pitard, Cyril Planchais, Hugo Mouquet, Richard Paul, Etienne Simon-Loriere, Jagadeesh Bayry, Laurent Gilardin, Anavaj Sakuntabhai |
180 |
[GO] |
2023―Feb―02 |
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 |
Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, Mercè Roca, Eva Perozo Mur, Ricard March, et al. (+40) Luis González-González, Laia Madrenas, Júlia Corominas, Alex Fernández, Alexandra Moros, Manuel Cañete, Mercè Molas, Thais Pentinat-Pelegrin, Clara Panosa, Alberto Moreno, Ester Puigvert Molas, Eva Pol Vilarrassa, Jordi Palmada, Carme Garriga, Teresa Prat Cabañas, Javier Iglesias-Fernández, Júlia Vergara-Alert, Cristina Lorca-Oró, Núria Roca, Leira Fernández-Bastit, Jordi Rodon, Mònica Pérez, Joaquim Segalés, Edwards Pradenas, Silvia Marfil, Benjamin Trinité, Raquel Ortiz, Bonaventura Clotet, Julià Blanco, Jorge Díaz Pedroza, Rosa Ampudia Carrasco, Yaiza Rosales Salgado, Jordina Loubat-Casanovas, Sara Capdevila Larripa, Julia Garcia Prado, Jordi Barretina, Marta Sisteré-Oró, Paula Cebollada Rica, Andreas Meyerhans, Laura Ferrer |
181 |
[GO] |
2023―Jan―31 |
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy |
Takuya Tada, Belinda M. Dcosta, Hao Zhou, Nathaniel R. Landau |
182 |
[GO] |
2023―Jan―24 |
Targeting intracellular Neu1 for Coronavirus Infection Treatment |
Darong Yang, Yin Wu, Isaac Turan, Joseph Keil, Kui Li, Michael H. Chen, et al. (+4) Runhua Liu, Lizhong Wang, Xue-Long Sun, Guo-Yun Chen |
183 |
[GO] |
2023―Jan―20 |
Omicron Mutations Increase Interdomain Interactions and Reduce Epitope Exposure in the SARS-CoV-2 Spike |
Miłosz Wieczór, Phu K. Tang, Modesto Orozco, Pilar Cossio |
184 |
[GO] |
2023―Jan―16 |
SARS-CoV-2 N protein mediates intercellular nucleic acid dispersion, a feature reduced in Omicron |
Jung-Lin Wu, I.-I. Kuan, Jing-You Guo, Wei-Chia Hsu, Wei-Chun Tang, Hsin-Ju Chan, et al. (+4) Yu-Ju Chen, Bi-Chang Chen, Han-Chung Wu, James C. Liao |
185 |
[GO] |
2023―Jan―13 |
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization |
Sho Miyamoto, Takeshi Arashiro, Akira Ueno, Takayuki Kanno, Shinji Saito, Harutaka Katano, et al. (+13) Shun Iida, Akira Ainai, Seiya Ozono, Takuya Hemmi, Yuichiro Hirata, Saya Moriyama, Ryutaro Kotaki, Hitomi Kinoshita, Souichi Yamada, Masaharu Shinkai, Shuetsu Fukushi, Yoshimasa Takahashi, Tadaki Suzuki |
186 |
[GO] |
2023―Jan―13 |
SARS-CoV-2 variants induce distinct disease and impact in the bone marrow and thymus of mice |
Rute Gonçalves, Joana Couto, Pedro Ferreirinha, José Maria Costa, Diogo Silvério, Marta L. Silva, et al. (+5) Ana Isabel Fernandes, Pedro Madureira, Nuno L. Alves, Sofia Lamas, Margarida Saraiva |
187 |
[GO] |
2023―Jan―10 |
An inactivated SARS-CoV-2 vaccine induced cross-neutralising persisting antibodies and protected upon challenge in small animals |
Anna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, Pavel Marichal-Gallardo, Kenn Holmbeck, Anne Finne Pihl, et al. (+14) Carlota Fernandez-Antunez, Garazi Peña Alzua, Katrine Top Hartmann, Long V. Pham, Yuyong Zhou, Karen Anbro Gammeltoft, Ulrik Fahnøe, Uffe Vest Schneider, Gabriel Kristian Pedersen, Henrik Elvang Jensen, Jan Pravsgaard Christensen, Santseharay Ramirez, Jens Bukh, Judith Margarete Gottwein |
188 |
[GO] |
2023―Jan―07 |
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform |
Denisa Bojkova, Philipp Reus, Leona Panosch, Marco Bechtel, Tamara Rothenburger, Joshua D. Kandler, et al. (+19) Annika Pfeiffer, Julian U.G. Wagner, Mariana Shumliakivska, Stefanie Dimmeler, Ruth Olmer, Ulrich Martin, Florian W.R. Vondran, Tuna Toptan, Florian Rothweiler, Richard Zehner, Holger F. Rabenau, Karen L. Osman, Steven T. Pullan, Miles W. Carroll, Richard Stack, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl jr. |
189 |
[GO] |
2023―Jan―05 |
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region |
Marc Emmenegger, Elena De Cecco, David Lamparter, Raphaël P.B. Jacquat, Julien Riou, Dominik Menges, et al. (+58) Tala Ballouz, Daniel Ebner, Mathias M. Schneider, Itzel Condado Morales, Berre Doğançay, Jingjing Guo, Anne Wiedmer, Julie Domange, Marigona Imeri, Rita Moos, Chryssa Zografou, Leyla Batkitar, Lidia Madrigal, Dezirae Schneider, Chiara Trevisan, Andres Gonzalez-Guerra, Alessandra Carrella, Irina L. Dubach, Catherine K. Xu, Georg Meisl, Vasilis Kosmoliaptsis, Tomas Malinauskas, Nicola Burgess-Brown, Ray Owens, Stephanie Hatch, Juthathip Mongkolsapaya, Gavin R. Screaton, Katharina Schubert, John D. Huck, Feimei Liu, Florence Pojer, Kelvin Lau, David Hacker, Elsbeth Probst-Müller, Carlo Cervia, Jakob Nilsson, Onur Boyman, Lanja Saleh, Katharina Spanaus, Arnold von Eckardstein, Dominik J. Schaer, Nenad Ban, Ching-Ju Tsai, Jacopo Marino, Gebhard F.X. Schertler, Nadine Ebert, Volker Thiel, Jochen Gottschalk, Beat M. Frey, Regina R. Reimann, Simone Hornemann, Aaron M. Ring, Tuomas P.J. Knowles, Milo A. Puhan, Christian L. Althaus, Ioannis Xenarios, David I. Stuart, Adriano Aguzzi |
190 |
[GO] |
2022―Dec―29 |
Extended SARS-CoV-2 mRNA vaccine prime-boost intervals enhances B cell immunity with limited impact on T cells |
Alexandre Nicolas, Gérémy Sannier, Mathieu Dubé, Manon Nayrac, Alexandra Tauzin, Mark M. Painter, et al. (+16) Rishi R. Goel, Mélanie Laporte, Gabrielle Gendron-Lepage, Halima Medjahed, Justine C. Williams, Nathalie Brassard, Julia Niessl, Laurie Gokool, Chantal Morrisseau, Pascale Arlotto, Cécile Tremblay, Valérie Martel-Laferrière, Andrés Finzi, Allison R. Greenplate, E. John Wherry, Daniel E. Kaufmann |
191 |
[GO] |
2022―Dec―28 |
Nonstructural protein 1 (nsp1) widespread RNA decay phenotype varies among Coronaviruses. |
Yahaira Bermudez, Jacob Miles, Mandy Muller |
192 |
[GO] |
2022―Dec―28 |
MultiOMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells |
Sneha M. Pinto, Yashwanth Subbannayya, Hera Kim, Lars Hagen, Maria W. Górna, Anni I. Nieminen, et al. (+4) Magnar Bjørås, Terje Espevik, Denis Kainov, Richard K. Kandasamy |
193 |
[GO] |
2022―Dec―26 |
Network analysis uncovers the communication structure of SARS-CoV-2 Spike protein identifying sites for immunogen design |
Pedro D. Manrique, Srirupa Chakraborty, Rory Henderson, Robert J. Edwards, Rachael Mansbach, Kien Nguyen, et al. (+6) Victoria Stalls, Carrie Saunders, Katayoun Mansouri, Priyamvada Acharya, Bette Korber, S. Gnanakaran |
194 |
[GO] |
2022―Dec―26 |
Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19 |
Louise Pierneef, Anouk van Hooij, Danielle de Jong, Elisa M. Tjon Kon Fat, Krista E. van Meijgaarden, Elisa Petruccioli, et al. (+48) Valentina Vanini, Anna H.E. Roukens, Delia Goletti, Paul L.A.M. Corstjens, Simone A. Joosten, Annemieke Geluk, M.S. Arbous, B.M. van den Berg, S. Cannegieter, C.M. Cobbaert, A. van der Does, J.J.M. van Dongen, J. Eikenboom, M.C.M. Feltkamp, A. Geluk, J.J. Goeman, M. Giera, T. Hankemeier, M.H.M. Heemskerk, P.S. Hiemstra, C.H. Hokke, J.J. Janse, S.P. Jochems, S.A. Joosten, M. Kikkert, L. Lamont, J. Manniën, T.H.M. Ottenhoff, M.R. del Prado, N. Queralt Rosinach, M. Roestenberg, M. Roos, A.H.E. Roukens, H.H. Smits, E.J. Snijder, F.J.T. Staal, L.A. Trouw, R. Tsonaka, A. Verhoeven, L.G. Visser, J.J.C. de Vries, D.J. van Westerloo, J. Wigbers, H.J. van der Wijk, R.C. van Wissen, M. Wuhrer, M. Yazdanbakhsh, M. Zlei |
195 |
[GO] |
2022―Dec―24 |
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death |
Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, et al. (+17) Christine Lacabaratz, Matthieu Perreau, Emile Foucat, Marie Déchenaud, Pascaline Tisserand, Fabiola Blengio, Benjamin Hivert, Marine Gauthier, Minerva Cervantes-Gonzalez, Delphine Bachelet, Cédric Laouénan, Lila Bouadma, Jean-François Timsit, Yazdan Yazdanpanah, Giuseppe Pantaleo, Hakim Hocini, Rodolphe Thiébaut |
196 |
[GO] |
2022―Dec―24 |
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles |
Emma Touizer, Aljawharah Alrubbayi, Rosemarie Ford, Noshin Hussain, Pehuén Pereyra Gerber, Hiu-Long Shum, et al. (+24) Chloe Rees-Spear, Luke Muir, Ester Gea-Mallorquí, Jakub Kopycinski, Dylan Jankovic, Anna Jeffery-Smith, Christopher L. Pinder, Thomas A. Fox, Ian Williams, Claire Mullender, Irfaan Maan, Laura Waters, Margaret Johnson, Sara Madge, Michael Youle, Tristan J. Barber, Fiona Burns, Sabine Kinloch, Sarah Rowland-Jones, Richard Gilson, Nicholas J. Matheson, Emma Morris, Dimitra Peppa, Laura E. McCoy |
197 |
[GO] |
2022―Dec―09 |
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD |
Yaozong Chen, Jérémie Prévost, Irfan Ullah, Hugo Romero, Veronique Lisi, William D. Tolbert, et al. (+35) Jonathan R. Grover, Shilei Ding, Shang Yu Gong, Guillaume Beaudoin-Bussières, Romain Gasser, Mehdi Benlarbi, Dani Vézina, Sai Priya Anand, Debashree Chatterjee, Guillaume Goyette, Michael W. Grunst, Ziwei Yang, Yuxia Bo, Fei Zhou, Kathie Béland, Xiaoyun Bai, Allison R. Zeher, Rick K. Huang, Dung N. Nguyen, Rebekah Sherburn, Di Wu, Grzegorz Piszczek, Bastien Paré, Doreen Matthies, Di Xia, Jonathan Richard, Priti Kumar, Walther Mothes, Marceline Côté, Pradeep D. Uchil, Vincent-Philippe Lavallée, Martin A. Smith, Marzena Pazgier, Elie Haddad, Andrés Finzi |
198 |
[GO] |
2022―Dec―08 |
Engineering Probiotic-derived Outer Membrane Vesicles as Functional Vaccine Carriers to Enhance Immunity against SARS-CoV-2 |
Jing Wo, Zhao-Yong Lv, Jia-Nan Sun, Hao Tang, Nan Qi, Bang-Ce Ye |
199 |
[GO] |
2022―Dec―07 |
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination |
Daryl Geers, Roos S.G. Sablerolles, Debbie van Baarle, Neeltje A. Kootstra, Wim J.R. Rietdijk, Katharina S. Schmitz, et al. (+18) Lennert Gommers, Susanne Bogers, Nella J. Nieuwkoop, Laura L.A. van Dijk, Eva van Haren, Melvin Lafeber, Virgil A.S.H. Dalm, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Anke L.W. Huckriede, Alessandro Sette, Alba Grifoni, Rik L. de Swart, Marion P.G. Koopmans, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel, Rory D. de Vries |
200 |
[GO] |
2022―Dec―07 |
Stimulation of IFN-β responses by aberrant SARS-CoV-2 small viral RNAs acting as RIG-I agonists |
Yasuha Arai, Itaru Yamanaka, Toru Okamoto, Ayana Isobe, Naomi Nakai, Naoko Kamimura, et al. (+7) Tatsuya Suzuki, Tomo Daidoji, Takao Ono, Takaaki Nakaya, Kazuhiko Matsumoto, Daisuke Okuzaki, Yohei Watanabe |
201 |
[GO] |
2022―Dec―06 |
Early alveolar epithelial cell necrosis is a potential driver of COVID-19-induced acute respiratory distress syndrome |
Kentaro Tojo, Natsuhiro Yamamoto, Nao Tamada, Takahiro Mihara, Miyo Abe, Mototsugu Nishii, et al. (+2) Ichiro Takeuchi, Takahisa Goto |
202 |
[GO] |
2022―Dec―05 |
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape |
Roberta Marzi, Jessica Bassi, Chiara Silacci Fregni, Istvan Bartha, Francesco Muoio, Katja Culap, et al. (+33) Nicole Sprugasci, Gloria Lombardo, Christian Saliba, Elisabetta Cameroni, Antonino Cassotta, Jun Siong Low, Alexandra C. Walls, Matthew McCallum, M. Alejandra Tortorici, John E. Bowen, Exequiel A. Dellota, Josh R. Dillen, Nadine Czudnochowski, Laura Pertusini, Tatiana Terrot, Valentino Lepori, Maciej Tarkowski, Agostino Riva, Maira Biggiogero, Alessandra Franzetti Pellanda, Christian Garzoni, Paolo Ferrari, Alessandro Ceschi, Olivier Giannini, Colin Havenar-Daughton, Amalio Telenti, Ann Arvin, Herbert W. Virgin, Federica Sallusto, David Veesler, Antonio Lanzavecchia, Davide Corti, Luca Piccoli |
203 |
[GO] |
2022―Dec―05 |
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant |
Izumi Kimura, Daichi Yamasoba, Hesham Nasser, Jiri Zahradnik, Yusuke Kosugi, Jiaqi Wu, et al. (+20) Kayoko Nagata, Keiya Uriu, Yuri L. Tanaka, Jumpei Ito, Ryo Shimizu, Toong Seng Tan, Erika P. Butlertanaka, Hiroyuki Asakura, Kenji Sadamasu, Kazuhisa Yoshimura, Takamasa Ueno, Akifumi Takaori-Kondo, Gideon Schreiber, Mako Toyoda, Kotaro Shirakawa, Takashi Irie, Akatsuki Saito, So Nakagawa, Terumasa Ikeda, Kei Sato |
204 |
[GO] |
2022―Dec―05 |
A multi-omics based anti-inflammatory immune signature characterizes Long COVID Syndrome |
Johannes J. Kovarik, Andrea Bileck, Gerhard Hagn, Samuel M. Meier-Menches, Tobias Frey, Anna Kaempf, et al. (+12) Marlene Hollenstein, Tarik Shoumariyeh, Lukas Skos, Birgit Reiter, Marlene C. Gerner, Andreas Spannbauer, Ena Hasimbegovic, Doreen Schmidl, Gerhard Garhöfer, Mariann Gyöngyösi, Klaus G. Schmetterer, Christopher Gerner |
205 |
[GO] |
2022―Dec―02 |
Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes |
Qian Wu, Naresh Kumar, William P. Lafuse, Omar Santiagonunez Ahumada, Noushin Saljoughian, Elizabeth Whetstone, et al. (+11) Ashley Zani, Ashley K. Patton, Mona El Refaey, Amy Webb, Maciej Pietrzak, Lianbo Yu, Mahesh KC, Mark E. Peeples, Latha P. Ganesan, Jacob S. Yount, Murugesan V.S. Rajaram |
206 |
[GO] |
2022―Dec―01 |
mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 Omicron subvariants and other variants of concern |
Gang Wang, Juan Shi, Abhishek K. Verma, Xiaoqing Guan, Stanley Perlman, Lanying Du |
207 |
[GO] |
2022―Nov―30 |
Conformational stability of SARS-CoV-2 glycoprotein spike variants |
Hiam R.S. Arruda, Tulio M. Lima, Renata G.F. Alvim, Fernanda B.A. Victorio, Daniel P.B. Abreu, Federico F. Marsili, et al. (+9) Karen D. Cruz, Mayra A. Marques, Patricia Sosa-Acosta, Mauricio Quinones-Vega, Jéssica de S. Guedes, Fábio C.S. Nogueira, Jerson L. Silva, Leda R. Castilho, Guilherme A.P. de Oliveira |
208 |
[GO] |
2022―Nov―19 |
Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity |
Annika Nelde, Jonas Rieth, Malte Roerden, Marissa L. Dubbelaar, Naomi Hoenisch Gravel, Jens Bauer, et al. (+9) Reinhild Klein, Tobias Hoheisel, Hartmut Mahrhofer, Siri Göpel, Michael Bitzer, Sebastian Hörber, Andreas Peter, Jonas S. Heitmann, Juliane S. Walz |
209 |
[GO] |
2022―Nov―16 |
Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models. |
Masaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, Takehisa Matsumoto, Chieko Makino-Okamura, Tomomi Uchikubo-Kamo, et al. (+25) Yuri Tomabechi, Kazuharu Hanada, Saya Moriyama, Yoshimasa Takahashi, Hirohito Ishigaki, Misako Nakayama, Cong Thanh Nguyen, Yoshinori Kitagawa, Yasushi Itoh, Masaki Imai, Tadashi Maemura, Yuri Furusawa, Hiroshi Ueki, Kiyoko Iwatsuki-Horimoto, Mutsumi Ito, Seiya Yamayoshi, Yoshihiro Kawaoka, Mikako Shirouzu, Makoto Ishii, Hideyuki Saya, Yasushi Kondo, Yuko Kaneko, Katsuya Suzuki, Koichi Fukunaga, Tsutomu Takeuchi |
210 |
[GO] |
2022―Nov―16 |
IMMUNE PROFILES TO DISTINGUISH HOSPITALIZED VERSUS AMBULATORY COVID-19 CASES IN OLDER PATIENTS |
Jéromine Klingler, Gregory S. Lambert, Juan C. Bandres, Rozita Emami-Gorizi, Arthur Nádas, Kasopefoluwa Y. Oguntuyo, et al. (+9) Fatima Amanat, Maria C. Bermúdez-González, Charles Gleason, Giulio Kleiner, Viviana Simon, Benhur Lee, Susan Zolla-Pazner, Chitra Upadhyay, Catarina E. Hioe |
211 |
[GO] |
2022―Nov―13 |
Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells |
Taewoo Kim, Kyoung Il Min, Jeong-Sun Yang, Jun Won Kim, Junhyung Cho, Yun Ho Kim, et al. (+7) Jeong Seok Lee, Young Tae Kim, Kyung-Chang Kim, Jeong Yeon Kim, Kwon Joong Na, Joo-Yeon Lee, Young Seok Ju |
212 |
[GO] |
2022―Nov―11 |
Skewed Fate and Hematopoiesis of CD34+ HSPCs in Umbilical Cord Blood Amid the COVID-19 Pandemic |
Benjamin K. Estep, Charles J. Kuhlmann, Satoru Osuka, Gajendra W. Suryavanshi, Yoshiko Nagaoka-Kamata, Ciearria N. Samuel, et al. (+4) Madison T. Blucas, Chloe E. Jepson, Paul A. Goepfert, Masakazu Kamata |
213 |
[GO] |
2022―Nov―07 |
Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general population |
Lena Tschiderer, Lisa Seekircher, Lukas Richter, Dorothee von Laer, Cornelia Lass-Flörl, Lukas Forer, et al. (+7) Sebastian Schönherr, Florian Krammer, Sabine Embacher-Aichhorn, Herbert Tilg, Günter Weiss, Franz Allerberger, Peter Willeit |
214 |
[GO] |
2022―Nov―05 |
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 Delta and beyond |
Hyung-Joon Kwon, Martina Kosikova, Weichun Tang, Uriel Ortega-Rodriguez, Peter Radvak, Ruoxuan Xiang, et al. (+16) Kelly E. Mercer, Levan Muskhelishvili, Kelly Davis, Jerrold M. Ward, Ivan Kosik, Jaroslav Holly, Insung Kang, Jonathan W. Yewdell, Ewan P. Plant, Wilbur H. Chen, Mallory C. Shriver, Robin S. Barnes, Marcela F. Pasetti, Bin Zhou, David E. Wentworth, Hang Xie |
215 |
[GO] |
2022―Nov―02 |
Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in Syrian hamster model |
Lunzhi Yuan, Huachen Zhu, Ming Zhou, Jian Ma, Xuan Liu, Kun Wu, et al. (+11) Jianghui Ye, Huan Yu, Peiwen Chen, Rirong Chen, Jia Wang, Yali Zhang, Shengxiang Ge, Quan Yuan, Tong Cheng, Yi Guan, Ningshao Xia |
216 |
[GO] |
2022―Nov―02 |
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice |
Feng-Xia Gao, Rui-Xin Wu, Mei-Ying Shen, Jing-Jing Huang, Ting-Ting Li, Chao Hu, et al. (+11) Fei-Yang Luo, Shu-Yi Song, Song Mu, Ya-Nan Hao, Xiao-Jian Han, Ying-Ming Wang, Luo Li, Sheng-Long Li, Qian Chen, Wang Wang, Ai-Shun Jin |
217 |
[GO] |
2022―Nov―01 |
Potent and biostable inhibitors of the main protease of SARS-CoV-2 |
Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, et al. (+19) Takato Onishi, Hiroki Nakano, Naoya Wada, Miki Hori, Kouki Shinohara, Yutaro Miura, Takuma Kawada, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Debananda Das, Nobutoki Takamune, Naoki Kishimoto, Junji Saruwatari, Tadashi Okamura, Kenta Nakano, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura |
218 |
[GO] |
2022―Oct―31 |
Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster |
Pai Peng, Cheng-qian Feng, Jie Hu, Chang-long He, Hai-jun Deng, Qing-hong Fan, et al. (+9) Jin Xiang, Guo-fang Tang, Meng-ling Jiang, Feng-yu Hu, Feng Li, Kai Wang, Ni Tang, Xiao-ping Tang, Ai-long Huang |
219 |
[GO] |
2022―Oct―30 |
Vimentin is an important ACE2 co-receptor for SARS-CoV-2 in epithelial cells |
Jeffrey Arrindell, Perla Abou Atmeh, Laurie Jayet, Youssouf Sereme, Jean-Louis Mege, Benoit Desnues |
220 |
[GO] |
2022―Oct―28 |
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals. |
Erola Ainsua-Enrich, Núria Pedreño-Lopez, Carmen Bracke, Carlos Ávila-Nieto, María Luisa Rodríguez de la Concepción, Edwards Pradenas, et al. (+26) Benjamin Trinité, Silvia Marfil, Cristina Miranda, Sandra González, Ruth Toledo, Marta Font, Susana Benet, Tuixent Escribà, Esther Jimenez-Moyano, Ruth Peña, Samandhy Cedeño, Julia G. Prado, Beatriz Mothe, Christian Brander, Nuria Izquierdo-Useros, Julia Vergara-Alert, Joaquim Segalés, Marta Massanella, Rosa María Benitez, Alba Romero, Daniel Molina-Morant, Julià Blanco, Bonaventura Clotet, Lourdes Mateu, María Luisa Pedro-Botet, Jorge Carrillo |
221 |
[GO] |
2022―Oct―26 |
Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b |
Tránsito García-García, Raúl Fernández-Rodríguez, Natalia Redondo, Ana de Lucas-Rius, Sara Zaldívar-López, Blanca Dies López-Ayllón, et al. (+4) José M. Suárez-Cárdenas, Ángeles Jiménez-Marín, María Montoya, Juan J. Garrido |
222 |
[GO] |
2022―Oct―25 |
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants |
Hebah A. Al-Khatib, Maria K. Smatti, Fatma H. Ali, Hadeel T. Zedan, Swapna Thomas, Muna N. Ahmed, et al. (+7) Reham A. El kahlout, Mashael A. Al Bader, Dina Elgakhlab, Peter V. Coyle, Laith J. Abu-Raddad, Asma A. Al Thani, Hadi M. Yassine |
223 |
[GO] |
2022―Oct―22 |
Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection |
Renxing Yi, Rina Hashimoto, Ayaka Sakamoto, Yasufumi Matsumura, Miki Nagao, Kazutoshi Takahashi, Kazuo Takayama |
224 |
[GO] |
2022―Oct―20 |
Swine Acute Diarrhea Syndrome Coronavirus Induces Autophagy to Promote Its Replication via the Akt/mTOR Pathway |
Siying Zeng, Yan Zhao, Ouyang Peng, Yu Xia, Qiuping Xu, Hongmei Li, et al. (+3) Chunyi Xue, Yongchang Cao, Hao Zhang |
225 |
[GO] |
2022―Oct―20 |
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity |
Akiho Yoshida, Shinya Okamura, Shiho Torii, Sayuri Komatsu, Paola Miyazato, Hitomi Sasaki, et al. (+8) Shiori Ueno, Hidehiko Suzuki, Wataru Kamitani, Chikako Ono, Yoshiharu Matsuura, Shiro Takekawa, Koichi Yamanishi, Hirotaka Ebina |
226 |
[GO] |
2022―Oct―17 |
Susceptibility to SARS-CoV-2 Omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination |
Jia Xin Chua, Lindy Gillian Durrant, Yin Ling Chok, Oi Ming Lai |
227 |
[GO] |
2022―Oct―14 |
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients |
Hye Kyung Lee, Ludwig Knabl, Mary Walter, Priscilla A. Furth, Lothar Hennighausen |
228 |
[GO] |
2022―Oct―13 |
Threats of COVID-19 arouse public awareness of climate change risks |
Yuanchao Gong, Yang Li, Linxiu Zhang, Tien Ming Lee, Yan Sun |
229 |
[GO] |
2022―Oct―13 |
Rational drug repositioning for coronavirus-associated diseases using directional mapping and side effect inference |
Jianhua Wang, Jiaojiao Liu, Menghan Luo, Hui Cui, Wenwen Zhang, Ke Zhao, et al. (+7) Hongji Dai, Fangfang Song, Kexin Chen, Ying Yu, Dongming Zhou, Mulin Jun Li, Hongxi Yang |
230 |
[GO] |
2022―Oct―12 |
Linking contact tracing with genomic surveillance to deconvolute SARS-CoV-2 transmission on a university campus |
Jacquelyn Turcinovic, Kayla Kuhfeldt, Madison Sullivan, Lena Landaverde, Judy T. Platt, Lynn Doucette-Stamm, et al. (+5) William P. Hanage, Davidson H. Hamer, Catherine Klapperich, Hannah E. Landsberg, John H. Connor |
231 |
[GO] |
2022―Oct―10 |
LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19 |
Hideyuki Shimizu, Manabu Kodama, Masaki Matsumoto, Yasuko Orba, Michihito Sasaki, Akihiko Sato, et al. (+2) Hirofumi Sawa, Keiichi I. Nakayama |
232 |
[GO] |
2022―Oct―10 |
Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19 |
Qiuchen Zhao, Zhenyang Yu, Shengyuan Zhang, Xu-Rui Shen, Hao Yang, Yangyang Xu, et al. (+14) Yang Liu, Lin Yang, Qing Zhang, Jiaqi Chen, Mengmeng Lu, Fei Luo, Mingming Hu, Yan Gong, Conghua Xie, Peng Zhou, Li Wang, Lishan Su, Zheng Zhang, Liang Cheng |
233 |
[GO] |
2022―Oct―10 |
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron |
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, Kathy Fu, Rory P. Mulloy, Alexandra Phan, et al. (+15) Ardeshir Ariana, Corina M. Stewart, Jérémie Prévost, Guillaume Beaudoin-Bussières, Redaet Daniel, Yuxia Bo, Omar El Ferri, Julien Yockell-Lelièvre, William L. Stanford, Patrick M. Giguère, Samira Mubareka, Andrés Finzi, Gregory A. Dekaban, Jimmy D. Dikeakos, Marceline Côté |
234 |
[GO] |
2022―Oct―07 |
An overview and thematic analysis of research on cities and the COVID-19 pandemic: Toward just, resilient, and sustainable urban planning and design |
Ayyoob Sharifi |
235 |
[GO] |
2022―Oct―07 |
Host transcriptional responses in nasal swabs identifies potential SARS-CoV-2 infection in PCR negative patients |
Amanda M. Saravia-Butler, Jonathan C. Schisler, Deanne Taylor, Afshin Beheshti, Dan Butler, Cem Meydan, et al. (+5) Jonathon Foox, Kyle Hernandez, Chris Mozsary, Christopher E. Mason, Robert Meller |
236 |
[GO] |
2022―Oct―04 |
Neurofilament light chain and vaccination status associate with clinical outcomes in severe COVID-19 |
Young Erben, Mercedes Prudencio, Christopher P. Marquez, Karen R. Jansen-West, Michael G. Heckman, Launia J. White, et al. (+16) Judith A. Dunmore, Casey N. Cook, Meredith T. Lilley, Neda Qosja, Yuping Song, Rana Hanna Al Shaikh, Lillian M. Daughrity, Jordan L. Bartfield, Gregory S. Day, Björn Oskarsson, Katharine A. Nicholson, Zbigniew K. Wszolek, Jonathan B. Hoyne, Tania F. Gendron, James F. Meschia, Leonard Petrucelli |
237 |
[GO] |
2022―Oct―04 |
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralise SARS-CoV-2 |
Phillip Pymm, Samuel J. Redmond, Olan Dolezal, Francesca Mordant, Ester Lopez, James P. Cooney, et al. (+18) Kathryn C. Davidson, Ebene Haycroft, Chee Wah Tan, Rebecca Seneviratna, Samantha L. Grimley, Damian F.J. Purcell, Stephen J. Kent, Adam K. Wheatley, Lin-Fa Wang, Andrew Leis, Alisa Glukhova, Marc Pellegrini, Amy W. Chung, Kanta Subbarao, Adam P. Uldrich, Wai-Hong Tham, Dale I. Godfrey, Nicholas A. Gherardin |
238 |
[GO] |
2022―Oct―02 |
Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses |
Kwiwan Jeong, Jinhee Kim, JuOae Chang, Subin Hong, Inseo Kim, Sunghyun Oh, et al. (+5) Sangeun Jeon, Joo Chan Lee, Hyun-Ju Park, Seungtaek Kim, Wonsik Lee |
239 |
[GO] |
2022―Sep―28 |
Detecting time-evolving phenotypic components of adverse reactions against BNT162b2 mRNA SARS-CoV-2 vaccine via non-negative tensor factorization. |
Kei Ikeda, Taka-Aki Nakada, Takahiro Kageyama, Shigeru Tanaka, Naoki Yoshida, Tetsuo Ishikawa, et al. (+11) Yuki Goshima, Natsuko Otaki, Shingo Iwami, Teppei Shimamura, Toshibumi Taniguchi, Hidetoshi Igari, Hideki Hanaoka, Koutaro Yokote, Koki Tsuyuzaki, Hiroshi Nakajima, Eiryo Kawakami |
240 |
[GO] |
2022―Sep―23 |
Profiling of exhaled volatile organics in the screening scenario of a COVID-19 test center |
Rasmus Remy, Nele Kemnitz, Phillip Trefz, Patricia Fuchs, Julia Bartels, Ann-Christin Klemenz, et al. (+4) Leo Rührmund, Pritam Sukul, Wolfram Miekisch, Jochen K. Schubert |
241 |
[GO] |
2022―Sep―23 |
Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to Variants of Concern |
Peifang Sun, Irene Ramos, Camila H. Coelho, Alba Grifoni, Corey A. Balinsky, Sindhu Vangeti, et al. (+20) Alison Tarke, Nathaniel I. Bloom, Vihasi Jani, Silvia J. Jakubski, David A. Boulifard, Elizabeth Cooper, Carl W. Goforth, Jan Marayag, Amethyst Marrone, Edgar Nunez, Lindsey White, Chad K. Porter, Victor A. Sugiharto, Megan Schilling, Avinash S. Mahajan, Charmagne Beckett, Alessandro Sette, Stuart C. Sealfon, Shane Crotty, Andrew G. Letizia |
242 |
[GO] |
2022―Sep―16 |
SARS-CoV-2 infection of human pluripotent stem cell-derived liver organoids reveals potential mechanisms of liver pathology |
Alexsia Richards, Max Friesen, Andrew Khalil, M. Inmaculada Barrasa, Lee Gehrke, Rudolf Jaenisch |
243 |
[GO] |
2022―Sep―09 |
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection |
AH Ayesha Lavell, Jonne J. Sikkens, Arthur WD. Edridge, Karlijn van der Straten, Ferdyansyah Sechan, Melissa Oomen, et al. (+13) David TP. Buis, Michiel Schinkel, Judith A. Burger, Meliawati Poniman, Jacqueline van Rijswijk, Menno D. de Jong, Godelieve J. de Bree, Edgar JG. Peters, Yvo M. Smulders, Rogier W. Sanders, Marit J. van Gils, Lia van der Hoek, Marije K. Bomers |
244 |
[GO] |
2022―Sep―06 |
CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry |
Elena-Sofia Heinl, Sebastian Lorenz, Barbara Schmidt, Nouf Nasser M Laqtom, Joseph R. Mazzulli, Laetitia Francelle, et al. (+11) Timothy W. Yu, Benjamin Greenberg, Stephan Storch, Ines Tegtmeier, Helga Othmen, Katja Maurer, Malin Steinfurth, Ralph Witzgall, Vladimir Milenkovic, Christian H. Wetzel, Markus Reichold |
245 |
[GO] |
2022―Sep―06 |
TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model |
Nunziata Maio, Sara Cherry, David C. Schultz, Brett L. Hurst, W. Marston Linehan, Tracey A. Rouault |
246 |
[GO] |
2022―Sep―05 |
Epidemiologic Information Discovery from Open-Access COVID-19 Case Reports via Pretrained Language Model |
Zhizheng Wang, Xiao Fan Liu, Zhanwei Du, Lin Wang, Ye Wu, Petter Holme, et al. (+5) Michael Lachmann, Hongfei Lin, Zoie S.Y. Wong, Xiao-Ke Xu, Yuanyuan Sun |
247 |
[GO] |
2022―Sep―03 |
Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants |
Jing Xing, Rama Shankar, Meehyun Ko, Keke Zhang, Sulin Zhang, Aleksandra Drelich, et al. (+8) Shreya Paithankar, Eugene Chekalin, Mei-Sze Chua, Surender Rajasekaran, Chien-Te Kent Tseng, Mingyue Zheng, Seungtaek Kim, Bin Chen |
248 |
[GO] |
2022―Sep―03 |
The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling |
Emmanuel Laplantine, Christine Chable-Bessia, Anne Oudin, Jitendryia Swain, Adèle Soria, Peggy Merida, et al. (+15) Manon Gourdelier, Sarra Mestiri, Indira Besseghe, Erwan Bremaud, Aymeric Neyret, Sebastien Lyonnais, Cyril Favard, Philippe Benaroch, Mathieu Hubert, Olivier Schwartz, Maryse Guerin, Anne Danckaert, Elaine Del Nery, Delphine Muriaux, Robert Weil |
249 |
[GO] |
2022―Sep―02 |
Obesity and metabolic dysfunction drive sex-associated differential disease profiles in hACE2-mice challenged with SARS-CoV-2 |
Katherine S. Lee, Brynnan P. Russ, Ting Y. Wong, Alexander M. Horspool, Michael T. Winters, Mariette Barbier, et al. (+4) Justin R. Bevere, Ivan Martinez, F. Heath Damron, Holly A. Cyphert |
250 |
[GO] |
2022―Sep―02 |
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants |
Qiuli Chen, Jiawei Zhang, Peter Wang, Zuyong Zhang |
251 |
[GO] |
2022―Aug―31 |
Cystatin C is associated with adverse COVID-19 outcomes in diverse populations |
Sam O. Kleeman, Mattia Cordioli, Paul R.H. J. Timmers, Atlas Khan, Pinkus Tober-Lau, Florian Kurth, et al. (+8) Vadim Demichev, Hannah V. Meyer, James F. Wilson, Markus Ralser, Krzysztof Kiryluk, Andrea Ganna, Kenneth Baillie, Tobias Janowitz |
252 |
[GO] |
2022―Aug―30 |
A Microarray Patch SARS-CoV-2 Vaccine Induces Sustained Antibody Responses and Polyfunctional Cellular Immunity |
Stephen C. Balmert, Zohreh Gholizadeh Ghozloujeh, Cara Donahue Carey, Li’an H. Williams, Jiying Zhang, Preeti Shahi, et al. (+5) Maher Amer, Tina L. Sumpter, Geza Erdos, Emrullah Korkmaz, Louis D. Falo |
253 |
[GO] |
2022―Aug―24 |
The amount of SARS-CoV-2 RNA in wastewater relates to the development of the pandemic and its burden on the health system |
Hao Wang, Marianela Patzi Churqui, Timur Tunovic, Lucica Enache, Anette Johansson, Ambjörn Kärmander, et al. (+7) Staffan Nilsson, Martin Lagging, Maria Andersson, Leif Dotevall, Thomas Brezicka, Kristina Nyström, Heléne Norder |
254 |
[GO] |
2022―Aug―23 |
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients |
Alexandra Tauzin, Guillaume Beaudoin-Bussières, Shang Yu Gong, Debashree Chatterjee, Gabrielle Gendron-Lepage, Catherine Bourassa, et al. (+14) Guillaume Goyette, Normand Racine, Zineb Khrifi, Julie Turgeon, Cécile Tremblay, Valérie Martel-Laferrière, Daniel E. Kaufmann, Héloïse Cardinal, Marc Cloutier, Renée Bazin, Ralf Duerr, Mélanie Dieudé, Marie-Josée Hébert, Andrés Finzi |
255 |
[GO] |
2022―Aug―17 |
MedML: Fusing Medical Knowledge and Machine Learning Models for Early Pediatric COVID-19 Hospitalization and Severity Prediction |
Junyi Gao, Chaoqi Yang, Joerg Heintz, Scott Barrows, Elise Albers, Mary Stapel, et al. (+3) Sara Warfield, Adam Cross, Jimeng Sun |
256 |
[GO] |
2022―Aug―17 |
SARS-CoV-2 specific CD4+ T cell longevity correlates with Th17-like phenotype |
Kazutaka Terahara, Takashi Sato, Yu Adachi, Keisuke Tonouchi, Taishi Onodera, Saya Moriyama, et al. (+9) Lin Sun, Tomohiro Takano, Ayae Nishiyama, Ai Kawana-Tachikawa, Tetsuro Matano, Takayuki Matsumura, Masaharu Shinkai, Masanori Isogawa, Yoshimasa Takahashi |
257 |
[GO] |
2022―Aug―14 |
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern |
Abigael E. Chaouat, Limor Kliker, Or Alfi, Michal Mandelboim, Dana Wolf, Laith Tafish, et al. (+3) Inbal Kol, Stipan Jonjic, Ofer Mandelboim |
258 |
[GO] |
2022―Aug―13 |
Host and microbiome features of secondary infections in lethal covid-19 |
Martin Zacharias, Karl Kashofer, Philipp Wurm, Peter Regitnig, Moritz Schütte, Margit Neger, et al. (+19) Sandra Ehmann, Leigh M. Marsh, Grazyna Kwapiszewska, Martina Loibner, Anna Birnhuber, Eva Leitner, Andrea Thüringer, Elke Winter, Stefan Sauer, Marion J. Pollheimer, Fotini R. Vagena, Carolin Lackner, Barbara Jelusic, Lesley Ogilvie, Marija Durdevic, Bernd Timmermann, Hans Lehrach, Kurt Zatloukal, Gregor Gorkiewicz |
259 |
[GO] |
2022―Aug―13 |
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization. |
J.J. Patten, Patrick T. Keiser, Deisy Morselli-Gysi, Giulia Menichetti, Hiroyuki Mori, Callie J. Donahue, et al. (+20) Xiao Gan, Italo do Valle, Kathleen Geoghegan-Barek, Manu Anantpadma, RuthMabel Boytz, Jacob L. Berrigan, Sarah H. Stubbs, Tess Ayazika, Colin O’Leary, Sallieu Jalloh, Florence Wagner, Seyoum Ayehunie, Stephen J. Elledge, Deborah Anderson, Joseph Loscalzo, Marinka Zitnik, Suryaram Gummuluru, Mark N. Namchuk, Albert-László Barabási, Robert A. Davey |
260 |
[GO] |
2022―Aug―11 |
TITLE: Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways |
Fangzhu Zhao, Celina Keating, Gabriel Ozorowski, Namir Shaabani, Irene M. Francino-Urdaniz, Shawn Barman, et al. (+17) Oliver Limbo, Alison Burns, Panpan Zhou, Michael J. Ricciardi, Jordan Woehl, Quoc Tran, Hannah L. Turner, Linghang Peng, Deli Huang, David Nemazee, Raiees Andrabi, Devin Sok, John R. Teijaro, Timothy A. Whitehead, Andrew B. Ward, Dennis R. Burton, Joseph G. Jardine |
261 |
[GO] |
2022―Aug―09 |
Neutralizing immunity against SARS-CoV-2 Omicron BA.1 by infection and vaccination |
Li-Jun Duan, Wen-Guo Jiang, Zhuang-Ye Wang, Lin Yao, Ka-Li Zhu, Qing-Chuan Meng, et al. (+4) Bao-Shan Wang, Li-Bo Li, Guo-Lin Wang, Mai-Juan Ma |
262 |
[GO] |
2022―Aug―06 |
Impacts of the COVID-19 on all aircraft emissions of international routes in South America |
Qiang Cui, Yilin Lei, Ye Li, Peter F. Wanke |
263 |
[GO] |
2022―Aug―02 |
Increased induction of serum ANCA and ANCA-associated vasculitis after mass vaccination against SARS-CoV-2 |
Juan Irure-Ventura, Elena González-López, Carolina Castro-Hernández, Emilio Rodrigo-Calabia, Milagros Heras-Vicario, Juan Carlos Ruiz San Millán, Marcos López-Hoyos |
264 |
[GO] |
2022―Aug―01 |
Elevation of Neural injury markers in Patients with Neurologic Sequelae after Hospitalization for SARS-CoV-2 Infection |
Michail Spanos, Sigal Shachar, Thadryan Sweeney, H. Immo Lehmann, Priyanka Gokulnath, Guoping Li, et al. (+7) George B. Sigal, Rajini Nagaraj, Pradeepthi Bathala, Farhan Rana, Ravi V. Shah, David A. Routenberg, Saumya Das |
265 |
[GO] |
2022―Jul―20 |
Potent and Broad Neutralization of SARS-CoV-2 Variants of Concern (VOCs) including Omicron Sub-lineages BA.1 and BA.2 by Biparatopic Human VH Domains |
Chuan Chen, James W. Saville, Michelle M. Marti, Alexandra Schäfer, Mary Hongying Cheng, Dhiraj Mannar, et al. (+23) Xing Zhu, Alison M. Berezuk, Anupam Banerjee, Michele D. Sobolewski, Andrew Kim, Benjamin R. Treat, Priscila Mayrelle Da Silva Castanha, Nathan Enick, Kevin D. McCormick, Xianglei Liu, Cynthia Adams, Margaret Grace Hines, Zehua Sun, Weizao Chen, Jana L. Jacobs, Simon M. Barratt-Boyes, John W. Mellors, Ralph S. Baric, Ivet Bahar, Dimiter S. Dimitrov, Sriram Subramaniam, David R. Martinez, Wei Li |
266 |
[GO] |
2022―Jul―16 |
Procedure room innovation during the COVID-19 crisis: Protecting healthcare workers while learning from history |
Dinesh Vyas, Kayla K. Umemoto, Arpita Vyas, Deepak L. Bhatt |
267 |
[GO] |
2022―Jul―16 |
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants |
Marc Emmenegger, Sebastian Fiedler, Silvio D. Brugger, Sean R.A. Devenish, Alexey S. Morgunov, Alison Ilsley, et al. (+12) Francesco Ricci, Anisa Y. Malik, Thomas Scheier, Leyla Batkitar, Lidia Madrigal, Marco Rossi, Georg Meisl, Andrew K. Lynn, Lanja Saleh, Arnold von Eckardstein, Tuomas P.J. Knowles, Adriano Aguzzi |
268 |
[GO] |
2022―Jul―14 |
SARS-CoV-2 Delta Spike Protein Enhances the Viral Fusogenicity and Inflammatory Cytokine Production |
Zhujun Ao, Maggie Jing Ouyang, Titus Abiola Olukitibi, Xiaojian Yao |
269 |
[GO] |
2022―Jul―11 |
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants |
Flavia Chiuppesi, John A. Zaia, Katelyn Faircloth, Daisy Johnson, Minh Ly, Veronica Karpinski, et al. (+15) Corinna La Rosa, Jennifer Drake, Joan Marcia, Ann Marie Acosta, Shannon Dempsey, Randy A. Taplitz, Qiao. Zhou, Yoonsuh Park, Sandra Ortega Francisco, Teodora Kaltcheva, Paul H. Frankel, Steven Rosen, Felix Wussow, Sanjeet Dadwal, Don J. Diamond |
270 |
[GO] |
2022―Jul―09 |
Protein-protein conjugation enhances immunogenicity of SARS-CoV-2 Receptor Binding Domain (RBD) vaccines |
Puthupparampil V. Scaria, Chris G. Rowe, Beth B. Chen, Thayne H. Dickey, Jonathan P. Renn, Lynn E. Lambert, et al. (+4) Emma K. Barnafo, Kelly M. Rausch, Niraj H. Tolia, Patrick E. Duffy |
271 |
[GO] |
2022―Jul―05 |
Vaccination with a bacterial peptide conjugated to SARS-CoV-2 RBD accelerates immunity and protects against COVID-19 |
Athanasios Blanas, Haiko Karsjens, Aafke de Ligt, Elisabeth J.M. Huijbers, Karlijn van Loon, Stepan Denisov, et al. (+7) Canan Durukan, Diederik Engbersen, Jan Groen, Sven Hennig, Tilman Hackeng, Judy R. van Beijnum, Arjan W. Griffioen |
272 |
[GO] |
2022―Jul―04 |
Immune response to SARS-CoV-2 in severe disease and long COVID-19 |
Tomonari Sumi, Kouji Harada |
273 |
[GO] |
2022―Jul―04 |
Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking |
Chih-Feng Tien, Wan-Ting Tsai, Chun Hwa Chen, Hui-Ju Chou, Mingzi M. Zhang, Jhe-Jhih Lin, et al. (+8) En-Ju Lin, Shih-Syong Dai, Yueh-Hsin Ping, Chia-Yi Yu, Yi-Ping Kuo, Wei-Hsiang Tsai, Hsin-Wei Chen, Guann-Yi Yu |
274 |
[GO] |
2022―Jul―04 |
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model |
Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Dominique Van Looveren, et al. (+20) Winnie Kerstens, Madina Rasulova, Thomas Vercruysse, Sam Noppen, Rana Abdelnabi, Caroline Foo, Kevin Hollevoet, Piet Maes, Xin Zhang, Dirk Jochmans, Karen Ven, Jeroen Lammertyn, Karen Vanhoorelbeke, Nico Callewaert, Paul De Munter, Dominique Schols, Hendrik Jan Thibaut, Johan Neyts, Paul Declerck, Nick Geukens |
275 |
[GO] |
2022―Jul―04 |
Trimeric Receptor Binding Domain of SARS-CoV-2 Acts as a Potent Inhibitor of ACE2 Receptor-Mediated Viral Entry |
Shrikanth C. Basavarajappa, Angela Rose Liu, Anna Bruchez, Zhenlu Li, Vinicius G. Suzart, Zhonghua Liu, et al. (+4) Yinghua Chen, Tsan Sam Xiao, Matthias Buck, Parameswaran Ramakrishnan |
276 |
[GO] |
2022―Jul―04 |
Progressive membrane binding mechanism of SARS-CoV-2 variant spike proteins |
Michael Overduin, Troy A. Kervin, Anh Tran |
277 |
[GO] |
2022―Jun―30 |
Immunomodulatory LncRNA on Antisense Strand of ICAM-1 Augments SARS-CoV-2 Infection-associated Airway Mucoinflammatory Phenotype |
Dinesh Devadoss, Arpan Acharya, Marko Manevski, Dominika Houserova, Michael D. Cioffi, Kabita Pandey, et al. (+6) Madhavan Nair, Prem Chapagain, Mehdi Mirsaeidi, Glen M. Borchert, Siddappa N. Byrareddy, Hitendra S. Chand |
278 |
[GO] |
2022―Jun―20 |
The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex |
Limei Zou, Clara Moch, Marc Graille, Clément Chapat |
279 |
[GO] |
2022―Jun―17 |
Integrative Metabolomic and Proteomic Signatures Define Clinical Outcomes in Severe COVID-19 |
Mustafa Buyukozkan, Sergio Alvarez-Mulett, Alexandra C. Racanelli, Frank Schmidt, Richa Batra, Katherine L. Hoffman, et al. (+17) Hina Sarwath, Rudolf Engelke, Luis Gomez-Escobar, Will Simmons, Elisa Benedetti, Kelsey Chetnik, Guoan Zhang, Edward Schenck, Karsten Suhre, Justin J. Choi, Zhen Zhao, Sabrina Racine-Brzostek, He S. Yang, Mary E. Choi, Augustine M.K. Choi, Soo Jung Cho, Jan Krumsiek |
280 |
[GO] |
2022―Jun―16 |
SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis |
Wojciech J. Szlachcic, Agnieszka Dabrowska, Aleksandra Milewska, Natalia Ziojla, Katarzyna Blaszczyk, Emilia Barreto-Duran, et al. (+7) Marek Sanak, Marcin Surmiak, Katarzyna Owczarek, Dariusz Grzanka, Julia Durzynska, Krzysztof Pyrc, Malgorzata Borowiak |
281 |
[GO] |
2022―Jun―15 |
Optimal vaccine roll-out strategies including social distancing for pandemics |
Konstantinos Spiliotis, Constantinos Chr. Koutsoumaris, Andreas I. Reppas, Lito A. Papaxenopoulou, Jens Starke, Haralampos Hatzikirou |
282 |
[GO] |
2022―Jun―15 |
Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways |
Daniel Richard, Pushpanathan Muthuirulan, Jennifer Aguiar, Andrew C. Doxey, Arinjay Banerjee, Karen Mossman, et al. (+2) Jeremy Hirota, Terence D. Capellini |
283 |
[GO] |
2022―Jun―11 |
Sustainable social development promotes COVID-19 pandemic control |
Shilan Feng, Yingjia Zhai, Wendong Wei, Ya Tan, Yong Geng, Weiye Nie |
284 |
[GO] |
2022―Jun―03 |
VE607 Stabilizes SARS-CoV-2 Spike In the “RBD-up” Conformation and Inhibits Viral Entry |
Shilei Ding, Irfan Ullah, Shang Yu Gong, Jonathan Grover, Mohammadjavad Mohammadi, Yaozong Chen, et al. (+16) Dani Vézina, Guillaume Beaudoin-Bussières, Vijay Tailor Verma, Guillaume Goyette, Fleur Gaudette, Jonathan Richard, Derek Yang, Amos B. Smith, Marzena Pazgier, Marceline Côté, Cameron Abrams, Priti Kumar, Walther Mothes, Pradeep Uchil, Andrés Finzi, Christian Baron |
285 |
[GO] |
2022―Jun―02 |
Modeling mutational effects on biochemical phenotypes using convolutional neural networks: application to SARS-CoV-2 |
Bo Wang, Eric R. Gamazon |
286 |
[GO] |
2022―May―31 |
Machine learning of COVID-19 clinical data identifies population structures with therapeutic potential |
David Greenwood, Tom Taverner, Nicola J. Adderley, Malcolm Price, Krishna Gokhale, Chris Sainsbury, et al. (+9) Suzy Gallier, Carly Welch, Elizabeth Sapey, Duncan Murray, Hilary Fanning, Simon Ball, Krishnarajah Nirantharakumar, Wayne Croft, Paul Moss |
287 |
[GO] |
2022―May―30 |
Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data |
Daniele Ramazzotti, Davide Maspero, Fabrizio Angaroni, Silvia Spinelli, Marco Antoniotti, Rocco Piazza, Alex Graudenzi |
288 |
[GO] |
2022―May―25 |
Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection |
Dylan Sheerin, Nashied Peton, William Vo, Cody Charles Allison, Xutao Wang, W. Evan Johnson, Anna Kathleen Coussens |
289 |
[GO] |
2022―May―25 |
Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir treated rhesus macaques |
Ashish Goyal, Elizabeth R. Duke, E. Fabian Cardozo-Ojeda, Joshua T. Schiffer |
290 |
[GO] |
2022―May―23 |
The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro |
Lehtinen Markus J, Kumar Ritesh, Zabel Bryan, Mäkelä Sanna M, Nedveck Derek, Tang Peipei, et al. (+3) Latvala Sinikka, Guery Sebastien, Budinoff Charles R |
291 |
[GO] |
2022―May―23 |
COH04S1 and Beta Sequence Modified Vaccine Protect Hamsters From SARS-CoV-2 Variants |
Felix Wussow, Mindy Kha, Katelyn Faircloth, Vu H. Nguyen, Angelina Iniguez, Joy Martinez, et al. (+7) Yoonsuh Park, Jenny Nguyen, Swagata Kar, Hanne Andersen, Mark G. Lewis, Flavia Chiuppesi, Don J. Diamond |
292 |
[GO] |
2022―May―19 |
Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants |
Yaning Li, Qing Fan, Bing Zhou, Yaping Shen, Yuanyuan Zhang, Lin Cheng, et al. (+6) Furong Qi, Shuo Song, Yingying Guo, Renhong Yan, Bin Ju, Zheng Zhang |
293 |
[GO] |
2022―May―18 |
Pearson’s patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak |
Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Huiling Luo, Fang Fang, et al. (+8) Xuefei Lv, Dandan Zhang, Yu Sun, Na Li, Shaoping Hu, Jinghong Li, Nian Xiong, Zhicheng Lin |
294 |
[GO] |
2022―May―04 |
SARS-CoV-2-related pangolin coronavirus exhibits similar infection characteristics to SARS-CoV-2 and direct contact transmissibility in hamsters |
Zhendong Guo, Cheng Zhang, Chunmao Zhang, Huan Cui, Zhaoliang Chen, Xinyun Jiang, et al. (+8) Tiecheng Wang, Yuanguo Li, Jun Liu, Zhonghai Wan, Keyin Meng, Jiping Li, Yigang Tong, Yuwei Gao |
295 |
[GO] |
2022―Apr―28 |
EVIDENCE SHOWING LIPOTOXICITY WORSENS OUTCOMES IN COVID-19 PATIENTS AND INSIGHTS ABOUT THE UNDERLYING MECHANISMS |
Rodrigo Cartin-Ceba, Biswajit Khatua, Bara El-Kurdi, Shubham Trivedi, Sergiy Kostenko, Zaid Imam, et al. (+16) Ryan Smith, Christine Snozek, Sarah Navina, Vijeta Sharma, Bryce McFayden, Filip Ionescu, Eugene Stolow, Sylvia Keiser, Aziz Tejani, Allison Harrington, Phillip Acosta, Saatchi Kuwelker, Juan Echavarria, Girish B. Nair, Adam Bataineh, Vijay P. Singh |
296 |
[GO] |
2022―Apr―27 |
Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection |
Qiqi Zeng, Xin Qi, Junpeng Ma, Fang Hu, Xiaorui Wang, Hongyu Qin, et al. (+20) Mengyang Li, Shaoxin Huang, Yong Yang, Yixin Li, Han Bai, Meng Jiang, Doudou Ren, Ye Kang, Yang Zhao, Xiaobei Chen, Xi Ding, Di Ye, Yankui Wang, Jianguo Jiang, Dong Li, Xi Chen, Ke Hu, Binghong Zhang, Bingyin Shi, Chengsheng Zhang |
297 |
[GO] |
2022―Apr―26 |
The effect of the Delta SARS-CoV-2 variant in maternal infection and pregnancy |
Athina Samara, Asma Khalil, Patrick O’ Brien, Eric Herlenius |
298 |
[GO] |
2022―Apr―25 |
Inhibitors of dihydroorotate dehydrogenase cooperate with Molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication |
Kim M. Stegmann, Antje Dickmanns, Natalie Heinen, Claudia Blaurock, Tim Karrasch, Angele Breithaupt, et al. (+19) Robert Klopfleisch, Nadja Uhlig, Valentina Eberlein, Leila Issmail, Simon T. Herrmann, Amelie Schreieck, Evelyn Peelen, Hella Kohlhof, Balal Sadeghi, Alexander Riek, John R. Speakman, Uwe Groß, Dirk Görlich, Daniel Vitt, Thorsten Müller, Thomas Grunwald, Stephanie Pfaender, Anne Balkema-Buschmann, Matthias Dobbelstein |
299 |
[GO] |
2022―Apr―11 |
Synthetic Carbohydrate Binding Agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2. |
Oscar Francesconi, Lorena Donnici, Marco Fragai, Elisa Pesce, Mauro Bombaci, Alessandra Fasciani, et al. (+6) Lara Manganaro, Matteo Conti, Renata Grifantini, Raffaele De Francesco, Cristina Nativi, Stefano Roelens |
300 |
[GO] |
2022―Apr―11 |
Inflammatory Responses in the Placenta upon SARS-CoV-2 Infection Late in Pregnancy |
Lissenya B. Argueta, Lauretta A. Lacko, Yaron Bram, Takuya Tada, Lucia Carrau, André Figueiredo Rendeiro, et al. (+20) Tuo Zhang, Skyler Uhl, Brienne C. Lubor, Vasuretha Chandar, Cristianel Gil, Wei Zhang, Brittany J. Dodson, Jeroen Bastiaans, Malavika Prabhu, Sean Houghton, David Redmond, Christine M. Salvatore, Yawei J. Yang, Olivier Elemento, Rebecca N. Baergen, Benjamin R. tenOever, Nathaniel R. Landau, Shuibing Chen, Robert E. Schwartz, Heidi Stuhlmann |
301 |
[GO] |
2022―Apr―08 |
The value of longitudinal clinical data and paired CT scans in predicting the deterioration of COVID-19 revealed by an artificial intelligence system |
Xiaoyang Han, Ziqi Yu, Yaoyao Zhuo, Botao Zhao, Yan Ren, Lorenz Lamm, et al. (+6) Xiangyang Xue, Jianfeng Feng, Carsten Marr, Fei Shan, Tingying Peng, Xiao-Yong Zhang |
302 |
[GO] |
2022―Apr―04 |
Unraveling the motivational secrets of honey bee foraging during the COVID pandemic |
Louise Bestea, Marco Paoli, Patrick Arrufat, Brice Ronsin, Julie Carcaud, Jean-Christophe Sandoz, et al. (+3) Rodrigo Velarde, Martin Giurfa, Maria Gabriela de Brito Sanchez |
303 |
[GO] |
2022―Apr―02 |
Poly(I:C) Enhances Mesenchymal Stem Cell Control of Myeloid Cells From COVID-19 Patients |
Luciana Souza-Moreira, Yuan Tan, Yan Wang, Jia-Pey Wang, Mahmoud Salkhordeh, Jennifer Virgo, et al. (+7) Maria Florian, Aidan B.P. Murray, Irene Watpool, Lauralyn McIntyre, Shane English, Duncan J. Stewart, Shirley H.J. Mei |
304 |
[GO] |
2022―Mar―26 |
Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil |
Tiago Gräf, Gonzalo Bello, Felipe Gomes Naveca, Marcelo Gomes, Vanessa Leiko Oikawa Cardoso, Alexandre Freitas da Silva, et al. (+13) Filipe Zimmer Dezordi, Mirleide Cordeiro dos Santos, Katia Correa de Oliveira Santos, Érika Lopes Rocha Batista, Alessandro Leonardo Álvares Magalhães, Fernando Vinhal, Fábio Miyajima, Helisson Faoro, Ricardo Khouri, Gabriel Luz Wallau, Edson Delatorre, Marilda Mendonça Siqueira, Paola Cristina Resende |
305 |
[GO] |
2022―Mar―22 |
Identified human breastmilk compositions effectively inhibit SARS-CoV-2 and variants infection and replication |
Xinyuan Lai, Yanying Yu, Wei Xian, Fei Ye, Xiaohui Ju, Yuqian Luo, et al. (+8) Huijun Dong, Yi-Hua Zhou, Wenjie Tan, Hui Zhuang, Tong Li, Xiaoyun Liu, Qiang Ding, Kuanhui Xiang |
306 |
[GO] |
2022―Mar―17 |
Computed Tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates |
Thibaut Naninck, Nidhal Kahlaoui, Julien Lemaitre, Pauline Maisonnasse, Antoine De Mori, Quentin Pascal, et al. (+14) Vanessa Contreras, Romain Marlin, Francis Relouzat, Benoît Delache, Cécile Hérate, Yoann Aldon, Marit van Gils, Nerea Zabaleta, Raphaël Ho Tsong Fang, Nathalie Bosquet, Rogier W. Sanders, Luk H. Vandenberghe, Catherine Chapon, Roger Le Grand |
307 |
[GO] |
2022―Mar―17 |
Mono- and combinational drug therapies for global viral pandemic preparedness |
Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, Vegard Myhre, Erlend Ravlo, Gerda D. Kaynova, et al. (+12) Eva Zusinaite, Judith M. White, Stephen J. Polyak, Valentyn Oksenych, Marc P. Windisch, Qiuwei Pan, Eglė Lastauskienė, Astra Vitkauskienė, Algimantas Matukevičius, Tanel Tenson, Magnar Bjørås, Denis E. Kainov |
308 |
[GO] |
2022―Mar―14 |
Association of high SARS-CoV-2 RNAemia with diabetes and mortality in COVID-19 critically ill patient. |
Mehran Monchi, Thomas Bruneau, Sebastien Jochmans, David Veyer, Aurelia Pitsch, Olivier Ellrodt, et al. (+6) Marie Picque, Valérie Taly, Oumar Sy, Sandie Mazerand, Sylvain Diamantis, Hélène Péré |
309 |
[GO] |
2022―Mar―11 |
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants |
Qingtai Liang, Yifeng Wang, Shuyuan Zhang, Jing Sun, Wenbo Sun, Jizhou Li, et al. (+21) Yaping Liu, Mingxi Li, Lin Cheng, Yuhang Jiang, Ruoke Wang, Rui Zhang, Zihan Yang, Yifei Ren, Peng Chen, Peng Gao, Huayuan Yan, Zheng Zhang, Qi Zhang, Xuanling Shi, Jianbin Wang, Wanli Liu, Xinquan Wang, Bo Ying, Jincun Zhao, Hai Qi, Linqi Zhang |
310 |
[GO] |
2022―Mar―11 |
Detection of SARS-CoV-2 with RAPID: a prospective cohort study |
Marcelo D.T. Torres, Lucas F. de Lima, André L. Ferreira, William R. de Araujo, Paul Callahan, Antonio Dávila, et al. (+2) Benjamin S. Abella, Cesar de la Fuente-Nunez |
311 |
[GO] |
2022―Mar―10 |
ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis |
Jinhuan Wei, Rui Shang, Jiaqi Wang, Shengze Zhu, JianQiang Yin, Ying Chen, et al. (+2) Yayu Zhao, Gang Chen |
312 |
[GO] |
2022―Mar―07 |
An artificial intelligence deep learning platform achieves high diagnostic accuracy for Covid-19 pneumonia by reading chest X-ray images |
Dongguang Li, Shaoguang Li |
313 |
[GO] |
2022―Feb―26 |
When do children avoid infection risks: Lessons for schools during the COVID-19 pandemic |
Nina H. Fefferman, Katy-Ann Blacker, Charles A. Price, Vanessa LoBue |
314 |
[GO] |
2022―Feb―23 |
Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern |
Anuradha Rao, Leda Bassit, Jessica Lin, Kiran Verma, Heather B. Bowers, Kimberly Pachura, et al. (+10) Morgan Greenleaf, Julie Sullivan, Eric Lai, Richard S. Creager, Thomas Pribyl, John Blackwood, Anne L. Piantadosi, Raymond Schinazi, Greg S. Martin, Wilbur A. Lam |
315 |
[GO] |
2022―Feb―23 |
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19 |
Jun Wang, Prasanti Kotagiri, Paul A. Lyons, Rafia S. Al-Lamki, Federica Mescia, Laura Bergamaschi, et al. (+28) Lorinda Turner, Michael D. Morgan, Fernando J. Calero-Nieto, Karsten Bach, Nicole Mende, Nicola K. Wilson, Emily R. Watts, Patrick H. Maxwell, Patrick F. Chinnery, Nathalie Kingston, Sofia Papadia, Kathleen E. Stirrups, Neil Walker, Ravindra K. Gupta, David K. Menon, Kieren Allinson, Sarah J. Aitken, Mark Toshner, Michael P. Weekes, James A. Nathan, Sarah R. Walmsley, Willem H. Ouwehand, Mary Kasanicki, Berthold Göttgens, John C. Marioni, Kenneth G.C. Smith, Jordan S. Pober, John R. Bradley |
316 |
[GO] |
2022―Feb―22 |
Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses |
Zhao Ni Wang, Xiang Sheng Yang, Jing Sun, Jin Cun Zhao, Nan Shan Zhong, Xiao Xiao Tang |
317 |
[GO] |
2022―Feb―22 |
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants |
Jules B. Weinstein, Timothy A. Bates, Hans C. Leier, Savannah K. McBride, Eric Barklis, Fikadu G. Tafesse |
318 |
[GO] |
2022―Feb―19 |
No substantial pre-existing B cell immunity against SARS-CoV-2 in healthy adults |
Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, Nareshkumar Poopalasingam, Susanne Detmer, Manuel Koch, et al. (+14) Michael Korenkov, Sandro Halwe, Michael Klüver, Veronica Di Cristanziano, Hanna Janicki, Maike Schlotz, Johanna Worczinski, Birgit Gathof, Henning Gruell, Matthias Zehner, Stephan Becker, Kanika Vanshylla, Christoph Kreer, Florian Klein |
319 |
[GO] |
2022―Feb―17 |
Impact of New Variants on SARS-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions |
Mary Hongying Cheng, James M. Krieger, Anupam Banerjee, Yufei Xiang, Burak Kaynak, Yi Shi, et al. (+2) Moshe Arditi, Ivet Bahar |
320 |
[GO] |
2022―Feb―17 |
SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response |
Chanchan Xiao, Lipeng Mao, Zhigang Wang, Lijuan Gao, Guodong Zhu, Jun Su, et al. (+12) Xiongfei Chen, Jun Yuan, Yutian Hu, Zhinan Yin, Jun Xie, Weiqing Ji, Haitao Niu, Feng Gao, Oscar Junhong Luo, Lianbo Xiao, Pengcheng Wang, Guobing Chen |
321 |
[GO] |
2022―Feb―12 |
Modeling potential impact of COVID-19 pandemic on global electric vehicle supply chain |
Xin Sun, Gang Liu, Han Hao, Zongwei Liu, Fuquan Zhao |
322 |
[GO] |
2022―Feb―05 |
Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa |
Olayinka Sunday Okoh, Nicholas Israel Nii-Trebi, Abdulrokeeb Jakkari, Tosin Titus Olaniran, Tosin Yetunde Senbadejo, Anna Aba Kafintu-kwashie, et al. (+10) Emmanuel Oluwatobi Dairo, Tajudeen Oladunni Ganiyu, Ifiokakaninyene Ekpo Akaninyene, Louis Odinakaose Ezediuno, Idowu Jesulayomi Adeosun, Michael Asebake Ockiya, Esther Moradeyo Jimah, David J. Spiro, Elijah Kolawole Oladipo, Nídia S. Trovão |
323 |
[GO] |
2022―Feb―02 |
HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19 |
Liqun Zhang, Santosh K. Ghosh, Shrikanth C. Basavarajappa, Yinghua Chen, Pravesh Shrestha, Jackson Penfield, et al. (+4) Ann Brewer, Parameswaran Ramakrishnan, Matthias Buck, Aaron Weinberg |
324 |
[GO] |
2022―Jan―31 |
The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates the immunoregulatory/inflammatory signals |
Veronica Bordoni, Giulia Matusali, Davide Mariotti, Manuela Antonioli, Eleonora Cimini, Alessandra Sacchi, et al. (+9) Eleonora Tartaglia, Rita Casetti, Germana Grassi, Stefania Notari, Concetta Castilletti, Gian Maria Fimia, Maria Rosaria Capobianchi, Giuseppe Ippolito, Chiara Agrati |
325 |
[GO] |
2022―Jan―30 |
CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus |
Kazuto Yoshimi, Kohei Takeshita, Seiya Yamayoshi, Satomi Shibumura, Yuko Yamauchi, Masaki Yamamoto, et al. (+3) Hiroshi Yotsuyanagi, Yoshihiro Kawaoka, Tomoji Mashimo |
326 |
[GO] |
2022―Jan―28 |
Attenuation of SARS-CoV-2 Infection by Losartan in Human Kidney Organoids |
Waleed Rahmani, Hyunjae Chung, Sarthak Sinha, Maxwell Bui-Marinos, Rohit Arora, Arzina Jaffer, et al. (+3) Jennifer A. Corcoran, Jeff Biernaskie, Justin Chun |
327 |
[GO] |
2022―Jan―10 |
Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19. |
Nikhil Shri Sahajpal, Chi-Yu Jill Lai, Alex Hastie, Ashis K. Mondal, Siavash Raeisi Dehkordi, Caspar I. van der Made, et al. (+20) Olivier Fedrigo, Farooq Al-Ajli, Sawan Jalnapurkar, Marta Byrska-Bishop, Rashmi Kanagal-Shamanna, Brynn Levy, Maximilian Schieck, Thomas Illig, Silviu-Alin Bacanu, Janet S. Chou, Adrienne G. Randolph, Amyn M. Rojiani, Michael C. Zody, Catherine A. Brownstein, Alan H. Beggs, Vineet Bafna, Erich D. Jarvis, Alexander Hoischen, Alka Chaubey, Ravindra Kolhe |
328 |
[GO] |
2022―Jan―07 |
Immunity to SARS-CoV-2 up to 15 months after infection |
Harold Marcotte, Antonio Piralla, Fanglei Zuo, Likun Du, Irene Cassaniti, Hui Wan, et al. (+27) Makiko Kumagai-Braesh, Juni Andréll, Elena Percivalle, Josè Camilla Sammartino, Yating Wang, Stelios Vlachiotis, Janine Attevall, Federica Bergami, Alessandro Ferrari, Marta Colaneri, Marco Vecchia, Margherita Sambo, Valentina Zuccaro, Erika Asperges, Raffaele Bruno, Tiberio Oggionni, Federica Meloni, Hassan Abolhassani, Federico Bertoglio, Maren Schubert, Luigi Calzolai, Luca Varani, Michael Hust, Yintong Xue, Lennart Hammarström, Fausto Baldanti, Qiang Pan-Hammarström |
329 |
[GO] |
2022―Jan―05 |
Neutralization of SARS-CoV-2 Delta variant is increased after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination |
Markus Bauswein, David Peterhoff, Annelie Plentz, Andreas Hiergeist, Ralf Wagner, André Gessner, et al. (+3) Bernd Salzberger, Barbara Schmidt, Stilla Bauernfeind |
330 |
[GO] |
2022―Jan―01 |
SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics |
Karthik Ramachandran, Soumya Maity, Alagar R. Muthukumar, Soundarya Kandala, Dhanendra Tomar, Tarek Mohamed Abd El-Aziz, et al. (+16) Cristel Allen, Yuyang Sun, Manigandan Venkatesan, Travis R. Madaris, Kevin Chiem, Rachel Truitt, Neelanjan Vishnu, Gregory Aune, Allen Anderson, Luis Martinez, Wenli Yang, James D. Stockand, Brij B. Singh, Subramanya Srikantan, W. Brian Reeves, Muniswamy Madesh |
331 |
[GO] |
2021―Dec―31 |
ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection |
Zai Wang, Tingting Deng, Yulian Zhang, Wenquan Niu, Qiangqiang Nie, Shengnan Yang, et al. (+5) Peipei Liu, Pengfei Pei, Long Chen, Haibo Li, Bin Cao |
332 |
[GO] |
2021―Dec―24 |
Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection |
Qi Cui, Gustavo Garcia, Mingzi Zhang, Cheng Wang, Hongzhi Li, Tao Zhou, et al. (+3) Guihua Sun, Vaithilingaraja Arumugaswami, Yanhong Shi |
333 |
[GO] |
2021―Dec―24 |
Humoral and Cellular Immunogenicity two months after SARS-CoV-2 messenger RNA Vaccines in Patients with Cancer |
Natacha Bordry, Alfredo Addeo, Cyril Jaksic, Valérie Dutoit, Pascale Roux-Lombard, Dimpy P. Shah, et al. (+13) Pankil K. Shah, Angèle Gayet-Ageron, Alex Friedlaender, Sébastien Bugeia, Garance Gutknecht, Anna Battagin, Maragrazia Di Marco, Pierre-Francois Simand, Intidhar Ladibi-Galy, Sarah Fertani, José Sandoval, Pierre-Yves Dietrich, Nicolas Mach |
334 |
[GO] |
2021―Dec―20 |
Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19 |
Julie C. Wilson, David Kealy, Sally R. James, Tobias Plowman, Katherine Newling, Christopher Jagger, et al. (+15) Kara Filbey, Elizabeth R. Mann, Joanne E. Konkel, Madhvi Menon, Sean B. Knight, Angela Simpson, Aliya Prihartadi, Greg Forshaw, Neil Todd, David R.A. Yates, John R. Grainger, Tracy Hussell, Paul M. Kaye, Nathalie Signoret, Dimitris Lagos |
335 |
[GO] |
2021―Dec―20 |
ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 |
Naoki Iwanaga, Laura Cooper, Lijun Rong, Nicholas J. Maness, Brandon Beddingfield, Zhongnan Qin, et al. (+13) Jackelyn Crabtree, Ralph A. Tripp, Haoran Yang, Robert Blair, Sonia Jangra, Adolfo García-Sastre, Michael Schotsaert, Chandra Sruti, James E. Robinson, Akhilesh Srivastava, Felix Rabito, Xuebin Qin, Jay K. Kolls |
336 |
[GO] |
2021―Dec―20 |
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG |
Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, Heike Rübsamen, Ramona Gerhards, Celine Schneider, et al. (+8) Paul R. Wratil, Marcel Stern, Peter Eichhorn, Oliver T. Keppler, Matthias Klein, Simone Mader, Tania Kümpfel, Edgar Meinl |
337 |
[GO] |
2021―Dec―10 |
Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike |
Bailey Lubinski, Maureen H.V. Fernandes, Laura Frazier, Tiffany Tang, Susan Daniel, Diego G. Diel, et al. (+2) Javier A. Jaimes, Gary R. Whittaker |
338 |
[GO] |
2021―Dec―09 |
Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults |
Mònica Girona-Alarcon, Guillermo Argüello, Ana Esteve-Sole, Sara Bobillo-Perez, Xavier Paolo-Burgos, Elisenda Bonet-Carne, et al. (+6) Anna Mensa-Vilaró, Anna Codina, María Hernández-Garcia, Cristina Jou, Laia Alsina, Iolanda Jordan |
339 |
[GO] |
2021―Dec―08 |
Standardized two-step testing of antibody activity in COVID-19 convalescent plasma |
Pavlo Gilchuk, Isaac Thomsen, Sandra Yoder, Eric Brady, James D. Chappell, Laura J. Stevens, et al. (+16) Mark R. Denison, Rachel E. Sutton, Rita E. Chen, Laura A. VanBlargan, Naveen Suryadevara, Seth J. Zost, Jonathan Schmitz, Jill M. Pulley, Michael S. Diamond, Jillian P. Rhoads, Gordon R. Bernard, Wesley H. Self, Todd W. Rice, Allison P. Wheeler, James E. Crowe, Robert H. Carnahan |
340 |
[GO] |
2021―Dec―04 |
SARS-CoV-2 Nucleocapsid protein attenuates stress granules and interacts with mRNAs to impair host stress response |
Syed Nabeel-Shah, Hyunmin Lee, Nujhat Ahmed, Giovanni L. Burke, Shaghayegh Farhangmehr, Kanwal Ashraf, et al. (+10) Shuye Pu, Ulrich Braunschweig, Guoqing Zhong, Hong Wei, Hua Tang, Jianyi Yang, Edyta Marcon, Benjamin J. Blencowe, Zhaolei Zhang, Jack F. Greenblatt |
341 |
[GO] |
2021―Dec―03 |
Global Changes in Electricity Consumption During COVID-19 |
Elizabeth Buechler, Siobhan Powell, Tao Sun, Nicolas Astier, Chad Zanocco, Jose Bolorinos, et al. (+3) June Flora, Hilary Boudet, Ram Rajagopal |
342 |
[GO] |
2021―Dec―03 |
Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication |
Elizabeth Geerling, Amanda N. Pinski, Taylor E. Stone, Richard J. DiPaolo, Michael Z. Zulu, Kevin J. Maroney, et al. (+3) James D. Brien, Ilhem Messaoudi, Amelia K. Pinto |
343 |
[GO] |
2021―Dec―02 |
Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2 |
Srinivasulu Yerukala Sathipati, Sanjay K. Shukla, Shinn-Ying Ho |
344 |
[GO] |
2021―Nov―27 |
A Deep Learning Approach for Predicting Severity of COVID-19 Patients Using A Parsimonious Set of Laboratory Markers |
Vivek Singh, Rishi Kamaleswaran, Donald Chalfin, Antonio Buño-Soto, Janika San Roman, Edith Rojas-Kenney, et al. (+5) Ross Molinaro, Sabine von Sengbusch, Parsa Hodjat, Dorin Comaniciu, Ali Kamen |
345 |
[GO] |
2021―Nov―27 |
Host parameters and mode of infection influence outcome in SARS-CoV-2 infected hamsters |
Bryan D. Griffin, Bryce M. Warner, Mable Chan, Emelissa Valcourt, Nikesh Tailor, Logan Banadyga, et al. (+23) Anders Leung, Shihua He, Amrit S. Boese, Jonathan Audet, Wenguang Cao, Estella Moffat, Lauren Garnett, Kevin Tierney, Kaylie N. Tran, Alixandra Albietz, Kathy Manguiat, Geoff Soule, Alexander Bello, Robert Vendramelli, Jessica Lin, Yvon Deschambault, Wenjun Zhu, Heidi Wood, Samira Mubareka, David Safronetz, James E. Strong, Carissa Embury-Hyatt, Darwyn Kobasa |
346 |
[GO] |
2021―Nov―19 |
Pannexin-1 channel opening is critical for COVID-19 pathogenesis |
Ross Luu, Silvana Valdebenito, Eliana Scemes, Antonio Cibelli, David Spray, Maximiliano Rovegno, et al. (+11) Juan Tichauer, Andrea Cottignies-Calamarte, Arielle Rosenberg, Calude Capron, Sandrine Belouzard, Jean Dubuisson, Djallali Annane, Geoffroy Lorin de la Grandmaison, Elisabeth Cramer-Bordé, Morgane Bomsel, Eliseo Eugenin |
347 |
[GO] |
2021―Nov―18 |
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells |
Francisco J. Zapatero-Belinchón, Rebecca Moeller, Lisa Lasswitz, Marco van Ham, Miriam Becker, Graham Brogden, et al. (+11) Ebba Rosendal, Wenjie Bi, Belén Carriquí-Madroñal, Koushikul Islam, Annasara Lenman, Antonia P. Gunesch, Jared Kirui, Thomas Pietschmann, Anna K. Överby, Lothar Jänsch, Gisa Gerold |
348 |
[GO] |
2021―Nov―18 |
Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring towards glycolysis |
Hadar Medini, Amit Zirman, Dan Mishmar |
349 |
[GO] |
2021―Nov―17 |
Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2 |
Junpei Ohtsuka, Masaki Imai, Masayuki Fukumura, Mitsuyo Maeda, Asami Eguchi, Ryoichi Ono, et al. (+6) Tadashi Maemura, Mutsumi Ito, Seiya Yamayoshi, Yosky Kataoka, Yoshihiro Kawaoka, Tetsuya Nosaka |
350 |
[GO] |
2021―Nov―11 |
Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test |
Susana Eyheramendy, Pedro A. Saa, Eduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, et al. (+9) Javier Pizarro-Berdichevsky, Andrés Finkelstein-Kulka, Sandra Solari, Nicolás Salas, Pedro Bahamondes, Martín Ugarte, Pablo Barceló, Marcelo Arenas, Eduardo Agosin |
351 |
[GO] |
2021―Nov―11 |
Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors |
Lei Guo, Yan Liang, Heng Li, Huiwen Zheng, Zening Yang, Yanli Chen, et al. (+6) Xin Zhao, Jing Li, Binxiang Li, Haijing Shi, Ming Sun, Longding Liu |
352 |
[GO] |
2021―Nov―10 |
Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells |
Ria Goswami, Veronica S. Russell, Joshua J. Tu, Charlene Thomas, Philip Hughes, Francine Kelly, et al. (+6) Stephanie N. Langel, Justin Steppe, Scott M. Palmer, Timothy Haystead, Maria Blasi, Sallie R. Permar |
353 |
[GO] |
2021―Nov―01 |
Functional differences among the spike glycoproteins of multiple emerging SARS-CoV-2 variants of concern |
Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh Nguyen, Yaoxing Huang, et al. (+3) Lihong Liu, David D. Ho, Joseph G. Sodroski |
354 |
[GO] |
2021―Oct―28 |
The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells |
Thushan I. de Silva, Guihai Liu, Benjamin B. Lindsey, Danning Dong, Shona C. Moore, Nienyun Sharon Hsu, et al. (+16) Dhruv Shah, Dannielle Wellington, Alexander J. Mentzer, Adrienn Angyal, Rebecca Brown, Matthew D. Parker, Zixi Ying, Xuan Yao, Lance Turtle, Susanna Dunachie, Mala K. Maini, Graham Ogg, Julian C. Knight, Yanchun Peng, Sarah L. Rowland-Jones, Tao Dong |
355 |
[GO] |
2021―Oct―25 |
Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19 |
Christoph Schultheiß, Lisa Paschold, Edith Willscher, Donjete Simnica, Anna Wöstemeier, Franziska Muscate, et al. (+6) Maxi Wass, Stephan Eisenmann, Jochen Dutzmann, Gernot Keyßer, Nicola Gagliani, Mascha Binder |
356 |
[GO] |
2021―Oct―25 |
Partial Resistance of SARS-CoV-2 Delta Variants to Vaccine-elicited Antibodies and Convalescent sera |
Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau |
357 |
[GO] |
2021―Oct―25 |
DCcov: Repositioning of Drugs and Drug Combinations for SARS-CoV-2 Infected Lung through Constraint-Based Modeling |
Ali Kishk, Maria Pires Pacheco, Thomas Sauter |
358 |
[GO] |
2021―Oct―25 |
Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency |
Luis Eduardo R. Cunha, Adilson A. Stolet, Marcelo A. Strauch, Victor A.R. Pereira, Carlos H. Dumard, Andre M.O. Gomes, et al. (+27) Fábio L. Monteiro, Luiza M. Higa, Patrícia N.C. Souza, Juliana G. Fonseca, Francisco E. Pontes, Leonardo G.R. Meirelles, José W.M. Albuquerque, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Tulio M. Lima, Renata G.F. Alvim, Federico F. Marsili, Marcella Moreira Caldeira, Russolina B. Zingali, Guilherme A.P. de Oliveira, Thiago M.L. Souza, Alexandre S. Silva, Rodrigo Muller, Daniela del Rosário Flores Rodrigues, Luciana Jesus da Costa, Arthur Daniel R. Alves, Marcelo Alves Pinto, Andréa C. Oliveira, Herbert L.M. Guedes, Amilcar Tanuri, Leda R. Castilho, Jerson L. Silva |
359 |
[GO] |
2021―Oct―22 |
Endonuclease-based genotyping of the RBM as a method to track the emergence or evolution of SARS-CoV-2 variants |
Eva Lopez, Margot Barthélémy, Cécile Baronti, Shirley Masse, Alessandra Falchi, Fabien Durbesson, et al. (+4) Renaud Vincentelli, Xavier de Lamballerie, Rémi Charrel, Bruno Coutard |
360 |
[GO] |
2021―Oct―19 |
Effective chimeric antigen receptor T-cells (CAR-Ts) against SARS-CoV-2 |
Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, H. Uri Saragovi, Christopher E. Rudd |
361 |
[GO] |
2021―Oct―16 |
Increased gaze cueing of attention during COVID-19 lockdown |
Mario Dalmaso, Luigi Castelli, Giovanni Galfano |
362 |
[GO] |
2021―Oct―14 |
The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor |
Chuncui Huang, Zeshun Tan, Keli Zhao, Wenjun Zou, Hui Wang, Huanyu Gao, et al. (+4) Shiwei Sun, Dongbo Bu, Wengang Chai, Yan Li |
363 |
[GO] |
2021―Oct―08 |
Inequitable and Heterogeneous Impacts on Electricity Consumption from COVID-19 Mitigation Measures |
Jiehong Lou, Yueming (Lucy) Qiu, Arthur Lin Ku, Destenie Nock, Bo Xing |
364 |
[GO] |
2021―Oct―07 |
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease |
Bryce M. Warner, Lisa A. Santry, Alexander Leacy, Mable Chan, Phuc H. Pham, Robert Vendramelli, et al. (+26) Yanlong Pei, Nikesh Tailor, Emelissa Valcourt, Anders Leung, Shihua He, Bryan D. Griffin, Jonathan Audet, Marnie Willman, Kevin Tierney, Alixandra Albietz, Kathy L. Frost, Jacob G.E. Yates, Robert C. Mould, Lily Chan, Yeganeh Mehrani, Jason P. Knapp, Jessica A. Minott, Logan Banadyga, David Safronetz, Heidi Wood, Stephanie Booth, Pierre P. Major, Byram W. Bridle, Leonardo Susta, Darwyn Kobasa, Sarah K. Wootton |
365 |
[GO] |
2021―Oct―04 |
6-Thioguanine Blocks SARS-CoV-2 Replication by Inhibition of PLpro |
Caleb D. Swaim, Varun Dwivedi, Yi-Chieh Perng, Xu Zhao, Larissa A. Canadeo, Houda H. Harastani, et al. (+5) Tamarand L. Darling, Adrianus C.M. Boon, Deborah J. Lenschow, Viraj Kulkarni, Jon M. Huibregtse |
366 |
[GO] |
2021―Oct―04 |
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery. |
Eleni Syrimi, Eanna Fennell, Alex Richter, Pavle Vrljicak, Richard Stark, Sascha Ott, et al. (+17) Paul G. Murray, Eslam Al-Abadi, Ashish Chikermane, Pamela Dawson, Scott Hackett, Deepthi Jyothish, Hari Krishnan Kanthimathinathan, Sean Monaghan, Prasad Nagakumar, Barnaby R. Scholefield, Steven Welch, Naeem Khan, Sian Faustini, Kate Davies, Wioleta M. Zelek, Pamela Kearns, Graham S. Taylor |
367 |
[GO] |
2021―Sep―30 |
A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19 |
Friederike Krempe, Lara Schöler, Benjamin Katschinski, Anke Herrmann, Olympia E. Anastasiou, Carina Elsner, et al. (+6) R. Stefan Ross, Friedrich Scholz, Ulf Dittmer, Peter Miethe, Vu Thuy Khanh Le-Trilling, Mirko Trilling |
368 |
[GO] |
2021―Sep―30 |
Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19 |
Na Wang, Marta Vuerich, Ahmadreza Kalbasi, Jonathon J. Graham, Eva Csizmadia, Zachary James Manickas Hill, et al. (+8) Ann Woolley, Clement David, Eric M. Miller, Kara Gorman, Jonathan L. Hecht, Shahzad Shaefi, Simon C. Robson, Maria Serena Longhi |
369 |
[GO] |
2021―Sep―30 |
A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity |
Huanhuan Zhu, Fang Zheng, Linxuan Li, Yan Jin, Yuxue Luo, Zhen Li, et al. (+19) JingYu Zeng, Ling Tang, Zilong Li, Ningyu Xia, Panhong Liu, Dan Han, Ying Shan, Xiaoying Zhu, Siyang Liu, Rong Xie, Yilin Chen, Wen Liu, Longqi Liu, Xun Xu, Jian Wang, Huanming Yang, Xia Shen, Xin Jin, Fanjun Cheng |
370 |
[GO] |
2021―Sep―29 |
SARS-CoV-2 integral membrane proteins shape the serological responses of COVID-19 patients. |
Sophie Martin, Christopher Heslan, Gwénaële Jégou, Leif A. Eriksson, Matthieu Le Gallo, Vincent Thibault, et al. (+3) Eric Chevet, Florence Godey, Tony Avril |
371 |
[GO] |
2021―Sep―27 |
The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium |
Jeong Yeon Ji, Ara Jo, Jina Won, Chan Hee Gil, Haeun Shin, Sujin Kim, et al. (+2) Yung Jin Jeon, Hyun Jik Kim |
372 |
[GO] |
2021―Sep―16 |
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells |
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, Peter AC. Wing, Mirjam Schilling, James M. Harris, et al. (+21) Helene Borrmann, Sophie B. Morgan, Jennifer L. Cane, Laurent Mailly, Nazia Thakur, Carina Conceicao, Harshmeena Sanghani, Laura Heydmann, Charlotte Bach, Anna Ashton, Steven Walsh, Tiong Kit Tan, Kuan-Ying A Huang, Catherine Schuster, Koichi Watashi, Timothy SC. Hinks, Aarti Jagannath, Sridhar R. Vausdevan, Dalan Bailey, Thomas F. Baumert, Jane A. McKeating |
373 |
[GO] |
2021―Sep―11 |
5-Hydroxymethyltubercidin Exhibits Potent Antiviral Activity against Flaviviruses and Coronaviruses, including SARS-CoV-2 |
Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Takao Sanaki, Shinsuke Toba, Michihito Sasaki, et al. (+9) Akiho Murai, Noriko Saito-Tarashima, Noriaki Minakawa, Yasuko Orba, Hiroaki Kariwa, William W. Hall, Hirofumi Sawa, Akira Matsuda, Katsumi Maenaka |
374 |
[GO] |
2021―Sep―10 |
An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses |
Kang Jin, Eric E. Bardes, Alexis Mitelpunkt, Jake Y. Wang, Surbhi Bhatnagar, Soma Sengupta, et al. (+3) Daniel Pomeranz Krummel, Marc E. Rothenberg, Bruce J. Aronow |
375 |
[GO] |
2021―Sep―02 |
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B-cell depleting treatment in multiple sclerosis. |
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, Anna Månberg, Sophia Hober, Guro Gafvelin, et al. (+6) Hans Grönlund, Peter Nilsson, Mohsen Khademi, Tomas Olsson, Fredrik Piehl, Faiez Al Nimer |
376 |
[GO] |
2021―Aug―31 |
One common enemy, a pandemic, uniting interdisciplinary teams |
Marie-Elizabeth Barabas, Rituparna Chakrabarti, Michelle Muzzio |
377 |
[GO] |
2021―Aug―26 |
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2 |
Xingyue An, Melisa Martinez-Paniagua, Ali Rezvan, Samiur Rahman Sefat, Mohsen Fathi, Shailbala Singh, et al. (+5) Sujit Biswas, Melissa Pourpak, Cassian Yee, Xinli Liu, Navin Varadarajan |
378 |
[GO] |
2021―Aug―26 |
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19 |
Andrew Kosmopoulos, Deepak L. Bhatt, Gus Meglis, Raj Verma, Yi Pan, Adrian Quan, et al. (+26) Hwee Teoh, Maya Verma, Lixia Jiao, Robert Wang, Rebecca A. Juliano, Mahesh Kajil, Mikhail N. Kosiborod, Basel Bari, Abdullahi A. Berih, Mallory Aguilar, Antonnette Escano, Andrew Leung, Idelta Coelho, Makoto Hibino, Rafael Díaz, R. Preston Mason, Ph. Gabriel Steg, Tabassome Simon, Alan S. Go, Andrew P. Ambrosy, Richard Choi, Arthur M. Kushner, Lawrence A. Leiter, Mohammed Al-Omran, Subodh Verma, C. David Mazer |
379 |
[GO] |
2021―Aug―25 |
Single Cell Transcriptome Identifies FCGR3B Upregulated Subtype of Alveolar Macrophages in Patients with Critical COVID-19 |
Nasna Nassir, Richa Tambi, Asma Bankapur, Saba Al Heialy, Noushad Karuvantevida, Hamdah Hassan Khansaheb, et al. (+24) Binte Zehra, Ghausia Begum, Reem Abdel Hameid, Awab Ahmed, Zulfa Deesi, Abdulmajeed Alkhajeh, K M Furkan Uddin, Hosneara Akter, Seyed Ali Safizadeh Shabestari, Omar Almidani, Amirul Islam, Mellissa Gaudet, Richard Kumaran Kandasamy, Tom Loney, Ahmad Abou Tayoun, Norbert Nowotny, Marc Woodbury-Smith, Proton Rahman, Wolfgang M. Kuebler, Mahmood Al Mashshadani, Jean-Laurent Casanova, Bakhrom K. Berdiev, Alawi Alsheikh-Ali, Mohammed Uddin |
380 |
[GO] |
2021―Aug―20 |
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern |
Juanjie Tang, Youri Lee, Supriya Ravichandran, Gabrielle Grubbs, Chang Huang, Charles B. Stauft, et al. (+4) Tony Wang, Basil Golding, Hana Golding, Surender Khurana |
381 |
[GO] |
2021―Aug―11 |
Distinct Lipid Metabolic Dysregulation in Asymptomatic COVID-19 |
Yanhong Hao, Zheng Zhang, Guifang Feng, Moran Chen, Qiongqiong Wan, Jie Lin, et al. (+3) Liang Wu, Wenjing Nie, Suming Chen |
382 |
[GO] |
2021―Aug―09 |
Sensitive extraction-free SARS-CoV-2 RNA virus detection using a chelating resin |
Bin Guan, Karen M. Frank, José O. Maldonado, Margaret Beach, Eileen Pelayo, Blake M. Warner, Robert B. Hufnagel |
383 |
[GO] |
2021―Aug―04 |
Immunogenicity and Protective Efficacy of an Intranasal Live-attenuated Vaccine Against SARS-CoV-2 |
Jun-Guy Park, Fatai S. Oladunni, Mohammed A. Rohaim, Jayde Whittingham-Dowd, James Tollitt, Matthew D.J. Hodges, et al. (+13) Nadin Fathallah, Muhsref Bakri Assas, Wafaa Alhazmi, Abdullah Almilaibary, Munir Iqbal, Pengxiang Chang, Renee Escalona, Vinay Shivanna, Jordi B. Torrelles, John J. Worthington, Lucy H. Jackson-Jones, Luis Martinez-Sobrido, Muhammad Munir |
384 |
[GO] |
2021―Jul―31 |
Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms |
Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, Masood A. Shariff, Gagandeep Singh, Vidya Menon, Florian Krammer |
385 |
[GO] |
2021―Jul―30 |
JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules |
Jakub Jankowski, Hye Kyung Lee, Julia Wilflingseder, Lothar Hennighausen |
386 |
[GO] |
2021―Jul―26 |
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes |
Daniel Todt, Toni Luise Meister, Barbora Tamele, John Howes, Dajana Paulmann, Britta Becker, et al. (+12) Florian H. Brill, Mark Wind, Jack Schijven, Natalie Heinen, Volker Kinast, Baxolele Mhlekude, Christine Goffinet, Adalbert Krawczyk, Jörg Steinmann, Stephanie Pfaender, Yannick Brüggemann, Eike Steinmann |
387 |
[GO] |
2021―Jul―22 |
Effect of time and titer in convalescent plasma therapy for COVID-19 |
Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Rosalba La Grotta, Annunziata De Rosa, Agostina Pontarelli, et al. (+3) Roberto Parrella, Antonio Ceriello, Giuseppe Matarese |
388 |
[GO] |
2021―Jul―21 |
A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples |
Tiantian Liu, Zhong Chen, Wanqiu Chen, Xin Chen, Maryam Hosseini, Zhaowei Yang, et al. (+6) Jing Li, Diana Ho, David Turay, Ciprian P. Gheorghe, Wendell Jones, Charles Wang |
389 |
[GO] |
2021―Jul―14 |
The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir |
Yan Zhao, Jing Sun, Yunfei Li, Zhengxuan Li, Yu Xie, Ruoqing Feng, et al. (+2) Jincun Zhao, Yuhui Hu |
390 |
[GO] |
2021―Jul―10 |
Sensor Array and Gas Chromatographic Detection of the Blood Serum Volatolomic Signature of COVID-19 |
Yolande Ketchanji Mougang, Lorena Di Zazzo, Marilena Minieri, Rosamaria Capuano, Alexandro Catini, Jacopo Maria Legramente, et al. (+3) Roberto Paolesse, Sergio Bernardini, Corrado Di Natale |
391 |
[GO] |
2021―Jul―09 |
Multi-Omics analysis of respiratory specimen characterizes baseline molecular determinants which associate with SARS-CoV-2 infection and outcome. |
Jaswinder Singh Maras, Shvetank Sharma, Adil Bhat, Sheetalnath Rooge, Reshu aggrawal, Ekta Gupta, Shiv K. Sarin |
392 |
[GO] |
2021―Jun―26 |
Graphene Nanoplatelet and Graphene Oxide Functionalization of Face Mask Materials Inhibits Infectivity of Trapped SARS-CoV-2 |
Flavio De Maio, Valentina Palmieri, Gabriele Babini, Alberto Augello, Ivana Palucci, Giordano Perini, et al. (+10) Alessandro Salustri, Patricia Spilman, Marco De Spirito, Maurizio Sanguinetti, Giovanni Delogu, Laura Giorgia Rizzi, Giulio Cesareo, Patrick Soon-Shiong, Michela Sali, Massimiliano Papi |
393 |
[GO] |
2021―Jun―24 |
Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance |
Patrick J. Lenehan, Eshwan Ramudu, A.J. Venkatakrishnan, Gabriela Berner, Reid McMurry, John C. O’Horo, et al. (+4) Andrew D. Badley, William Morice, John Halamka, Venky Soundararajan |
394 |
[GO] |
2021―Jun―24 |
ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion |
Qiangmin Zhang, Julia Gefter, W. Bruce Sneddon, Tatyana Mamonova, Peter A. Friedman |
395 |
[GO] |
2021―Jun―19 |
Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19 |
Marcel S. Woo, Friedrich Haag, Axel Nierhaus, Dominik Jarczak, Kevin Roedl, Christina Mayer, et al. (+14) Thomas T. Brehm, Marc van der Meirschen, Annette Hennigs, Maximilian Christopeit, Walter Fiedler, Panagiotis Karagiannis, Christoph Burdelski, Alexander Schultze, Samuel Huber, Marylyn M. Addo, Stefan Schmiedel, Manuel A. Friese, Stefan Kluge, Julian Schulze zur Wiesch |
396 |
[GO] |
2021―Jun―17 |
Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution |
Kalon J. Overholt, Jonathan R. Krog, Ivan Zanoni, Bryan D. Bryson |
397 |
[GO] |
2021―Jun―10 |
Disease-dependent interaction policies to support health and economic outcomes during the COVID-19 epidemic |
Guanlin Li, Shashwat Shivam, Michael E. Hochberg, Yorai Wardi, Joshua S. Weitz |
398 |
[GO] |
2021―Jun―10 |
CD177, a specific marker of neutrophil activation, is associated with COVID-19 severity and death |
Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, et al. (+17) Christine Lacabaratz, Matthieu Perreau, Emile Foucat, Marie Déchenaud, Pascaline Tisserand, Fabiola Blengio, Benjamin Hivert, Marine Gauthier, Minerva Cervantes-Gonzalez, Delphine Bachelet, Cédric Laouénan, Lila Bouadma, Jean-François Timsit, Yazdan Yazdanpanah, Giuseppe Pantaleo, Hakim Hocini, Rodolphe Thiébaut |
399 |
[GO] |
2021―Jun―09 |
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens |
Ebony N. Gary, Bryce M. Warner, Elizabeth M. Parzych, Bryan D. Griffin, Xizhou Zhu, Nikesh Tailor, et al. (+21) Nicholas J. Tursi, Mable Chan, Mansi Purwar, Robert Vendramelli, Jihae Choi, Kathy L. Frost, Sophia Reeder, Kevin Liaw, Edgar Tello, Ali R. Ali, Kun Yun, Yanlong Pei, Sylvia P. Thomas, Amira D. Rghei, Matthew M. Guilleman, Kar Muthumani, Trevor Smith, Sarah K. Wootton, Ami Patel, David B. Weiner, Darwyn Kobasa |
400 |
[GO] |
2021―Jun―01 |
Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain |
Chao Wu, Abraham J. Qavi, Asmaa Hachim, Niloufar Kavian, Aidan R. Cole, Austin B. Moyle, et al. (+10) Nicole D. Wagner, Joyce Sweeney-Gibbons, Henry W. Rohrs, Michael L. Gross, J. S. Malik Peiris, Christopher F. Basler, Christopher W. Farnsworth, Sophie A. Valkenburg, Gaya K. Amarasinghe, Daisy W. Leung |
401 |
[GO] |
2021―May―24 |
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals |
Peter V. Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, et al. (+18) Nourah Younes, Ghada Ali A.A. Al Anssari, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Roberto Bertollini, Laith J. Abu-Raddad |
402 |
[GO] |
2021―May―18 |
Phenome-wide and eQTL Associations of COVID-19 Genetic Risk Loci |
Chang Moon, Brian M. Schilder, Towfique Raj, Kuan-lin Huang |
403 |
[GO] |
2021―May―07 |
Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids |
Huaying Zhao, Di Wu, Ai Nguyen, Yan Li, Regina C. Adão, Eugene Valkov, et al. (+3) George H. Patterson, Grzegorz Piszczek, Peter Schuck |
404 |
[GO] |
2021―May―01 |
Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients |
Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, et al. (+21) Shannon McGue, Braxton Jeffcoat, Jaclyn Dunne, Logan Johnson, Seungho Choi, Georges J. Nahhas, Amy S. Gandy, Nikolina Babic, Frederick S. Nolte, Philip Howe, Besim Ogretmen, Vamsi K. Gangaraju, Stephen Tomlinson, Brian Madden, Tracy Bridges, Patrick A. Flume, John Wrangle, Mark P. Rubinstein, Prabhakar K. Baliga, Satish N. Nadig, Shikhar Mehrotra |
405 |
[GO] |
2021―Apr―26 |
Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses |
Arinjay Banerjee, Nader El-Sayes, Patrick Budylowski, Rajesh Abraham Jacob, Daniel Richard, Hassaan Maan, et al. (+22) Jennifer A. Aguiar, Wael L. Demian, Kaushal Baid, Michael R. D’Agostino, Jann Catherine Ang, Tetyana Murdza, Benjamin J.-M. Tremblay, Sam Afkhami, Mehran Karimzadeh, Aaron T. Irving, Lily Yip, Mario Ostrowski, Jeremy A. Hirota, Robert Kozak, Terence D. Capellini, Matthew S. Miller, Bo Wang, Samira Mubareka, Allison J. McGeer, Andrew G. McArthur, Andrew C. Doxey, Karen Mossman |
406 |
[GO] |
2021―Apr―26 |
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice |
Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, et al. (+18) Moshe Aftalion, Reut Falach, Shani Leviatan Ben-Arye, Shirley Lazar, Ayelet Zauberman, Eyal Epstein, Theodor Chitlaru, Shay Weiss, Hagit Achdout, Jonathan D. Edgeworth, Raghavendra Kikkeri, Hai Yu, Xi Chen, Shmuel Yitzhaki, Shmuel C. Shapira, Vered Padler-Karavani, Ohad Mazor, Ronit Rosenfeld |
407 |
[GO] |
2021―Apr―21 |
Cell type resolved quantitative proteomics map of interferon response against SARS-CoV-2 |
Elisa Saccon, Xi Chen, Flora Mikaeloff, Jimmy Esneider Rodriguez, Laszlo Szekely, Beatriz Sá Vinhas, et al. (+7) Shuba Krishnan, Siddappa N. Byrareddy, Teresa Frisan, Ákos Végvári, Ali Mirazimi, Ujjwal Neogi, Soham Gupta |
408 |
[GO] |
2021―Apr―19 |
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells |
Emi Sano, Sayaka Deguchi, Ayaka Sakamoto, Natsumi Mimura, Ai Hirabayashi, Yukiko Muramoto, et al. (+3) Takeshi Noda, Takuya Yamamoto, Kazuo Takayama |
409 |
[GO] |
2021―Mar―19 |
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 |
Immacolata Andolfo, Roberta Russo, Vito Alessandro Lasorsa, Sueva Cantalupo, Barbara Eleni Rosato, Ferdinando Bonfiglio, et al. (+15) Giulia Frisso, Pasquale Abete, Gian Marco Cassese, Giuseppe Servillo, Gabriella Esposito, Ivan Gentile, Carmelo Piscopo, Romolo Villani, Giuseppe Fiorentino, Pellegrino Cerino, Carlo Buonerba, Biancamaria Pierri, Massimo Zollo, Achille Iolascon, Mario Capasso |
410 |
[GO] |
2021―Mar―19 |
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2 |
Ang Gao, Zhilin Chen, Assaf Amitai, Julia Doelger, Vamsee Mallajosyula, Emily Sundquist, et al. (+6) Florencia Pereyra Segal, Mary Carrington, Mark M. Davis, Hendrik Streeck, Arup K. Chakraborty, Boris Julg |
411 |
[GO] |
2021―Mar―14 |
The Silent Pandemic: Emergent Antibiotic Resistances Following the Global Response to SARS-CoV-2 |
Andrew R. Mahoney, Mohammad Moein Safaee, William M. Wuest, Ariel L. Furst |
412 |
[GO] |
2021―Mar―10 |
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway |
Grant R. Campbell, Rachel K. To, Jonathan Hanna, Stephen A. Spector |
413 |
[GO] |
2021―Mar―10 |
Title: ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway |
Xiaoyuan Lin, Beibei Fu, Songna Yin, Zhifeng Li, Huawen Liu, Haiwei Zhang, et al. (+12) Na Xing, Yu Wang, Weiwei Xue, Yan Xiong, Shanfu Zhang, Qingting Zhao, Shiyao Xu, Jing Zhang, Peihui Wang, Weiqi Nian, Xingsheng Wang, Haibo Wu |
414 |
[GO] |
2021―Mar―07 |
A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection |
Jane E. Sinclair, Yanshan Zhu, Gang Xu, Wei Ma, Haiyan Shi, Kun-Long Ma, et al. (+9) Chun-Feng Cao, Ling-Xi Kong, Ke-Qiang Wan, Juan Liao, Hai-Qiang Wang, Matt Arentz, Meredith A. Redd, Linda A. Gallo, Kirsty R. Short |
415 |
[GO] |
2021―Mar―01 |
Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19 |
Qu Deng, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, Irfan A. Asangani |
416 |
[GO] |
2021―Feb―23 |
Heuristic Thinking and Altruism towards Machines in People Impacted by Covid-19 |
Celso M. de Melo, Jonathan Gratch, Frank Krueger |
417 |
[GO] |
2021―Feb―16 |
Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors |
Timothy S. Chang, Yi Ding, Malika K. Freund, Ruth Johnson, Tommer Schwarz, Julie M. Yabu, et al. (+6) Chad Hazlett, Jeffrey N. Chiang, David A. Wulf, Daniel H. Geschwind, Manish J. Butte, Bogdan Pasaniuc |
418 |
[GO] |
2021―Feb―16 |
Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes |
Ziliang Zhou, Chunliu Huang, Zhechong Zhou, Zhaoxia Huang, Lili Su, Sisi Kang, et al. (+7) Xiaoxue Chen, Qiuyue Chen, Suhua He, Xia Rong, Fei Xiao, Jun Chen, Shoudeng Chen |
419 |
[GO] |
2021―Feb―10 |
Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without |
Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz |
420 |
[GO] |
2021―Feb―07 |
Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy |
Wyler Emanuel, Mösbauer Kirstin, Franke Vedran, Diag Asija, Gottula Lina Theresa, Arsiè Roberto, et al. (+22) Klironomos Filippos, Koppstein David, Hönzke Katja, Ayoub Salah, Buccitelli Christopher, Hoffmann Karen, Richter Anja, Legnini Ivano, Ivanov Andranik, Mari Tommaso, Del Giudice Simone, Papies Jan, Praktiknjo Samantha, F. Meyer Thomas, Müller Marcel Alexander, Niemeyer Daniela, Hocke Andreas, Selbach Matthias, Akalin Altuna, Rajewsky Nikolaus, Drosten Christian#, Landthaler Markus |
421 |
[GO] |
2021―Feb―06 |
Proteomic Investigation Reveals Dominant Alterations of Neutrophil Degranulation and mRNA Translation Pathways in COVID-19 Patients |
Renuka Bankar, Kruthi Suvarna, Saicharan Ghantasala, Arghya Banerjee, Deeptarup Biswas, Manisha Choudhury, et al. (+13) P. Viswanthram, Akanksha Salkar, Ayushi Verma, Avinash Singh, Amrita Mukherjee, Medha Gayathri J. Pai, Jyotirmoy Roy, Alisha Srivastava, Apoorva Badaya, Sachee Agrawal, Om Shrivastav, Jayanti Shastri, Sanjeeva Srivastava |
422 |
[GO] |
2021―Jan―28 |
Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity |
Alex Graudenzi, Davide Maspero, Fabrizio Angaroni, Rocco Piazza, Daniele Ramazzotti |
423 |
[GO] |
2021―Jan―22 |
The presentation of SARS-CoV-2 peptides by the common HLA-A*02:01 molecule |
Christopher Szeto, Demetra S.M. Chatzileontiadou, Andrea T. Nguyen, Hannah Sloane, Christian A. Lobos, Dhilshan Jayasinghe, et al. (+5) Hanim Halim, Corey Smith, Alan Riboldi-Tunnicliffe, Emma J. Grant, Stephanie Gras |
424 |
[GO] |
2021―Jan―20 |
The outbreak of COVID-19 altered the relationship between current negative memory biases and future depressive degree in nonclinical depression |
Pengyu Zhang, Yi Piao, Ying Chen, Jiecheng Ren, Longhua Zhang, Bensheng Qiu, et al. (+2) Zhengde Wei, Xiaochu Zhang |
425 |
[GO] |
2021―Jan―12 |
A high-throughput liquid bead-array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity |
Monique Bennett, Sandra Yoder, Eric Brady, Jill M. Pulley, Jillian P. Rhoads, Thomas G. Stewart, et al. (+4) Gordon R. Bernard, C. Buddy Creech, Allison P. Wheeler, Isaac Thomsen |
426 |
[GO] |
2021―Jan―10 |
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening |
Christoph Gorgulla, Krishna M. Padmanabha Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zi-Fu Wang, et al. (+31) Guilhem Tesseyre, Shreya Pandita, Alec Shnapir, Anthony Calderaio, Minko Gechev, Alexander Rose, Noam Lewis, Colin Hutcheson, Erez Yaffe, Roni Luxenburg, Henry D. Herce, Vedat Durmaz, Thanos D. Halazonetis, Konstantin Fackeldey, Justin J. Patten, Alexander Chuprina, Igor Dziuba, Alla Plekhova, Yurii Moroz, Dmytro Radchenko, Olga Tarkhanova, Irina Yavnyuk, Christian Gruber, Ryan Yust, Dave Payne, Anders M. Näär, Mark N. Namchuk, Robert A. Davey, Gerhard Wagner, Jamie Kinney, Haribabu Arthanari |
427 |
[GO] |
2020―Dec―27 |
High-Throughput Rational Design of the Remdesivir Binding Site in the RdRp of SARS-CoV-2: Implications for Potential Resistance |
Aditya K. Padhi, Rohit Shukla, Prakash Saudagar, Timir Tripathi |
428 |
[GO] |
2020―Dec―16 |
Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral Infections |
Simone A. Thair, Yudong D. He, Yehudit Hasin-Brumshtein, Suraj Sakaram, Rushika Pandya, Jiaying Toh, et al. (+13) David Rawling, Melissa Remmel, Sabrina Coyle, George N. Dalekos, Ioannis Koutsodimitropoulos, Glykeria Vlachogianni, Eleni Gkeka, Eleni Karakike, Georgia Damoraki, Nikolaos Antonakos, Purvesh Khatri, Evangelos J. Giamarellos-Bourboulis, Timothy E. Sweeney |
429 |
[GO] |
2020―Dec―07 |
Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19 |
Lucy CK. Bell, Cem Meydan, Jacob Kim, Jonathan Foox, Daniel Butler, Christopher E. Mason, et al. (+3) Sagi D. Shapira, Mahdad Noursadeghi, Gabriele Pollara |
430 |
[GO] |
2020―Dec―07 |
Structural characterization of Nonstructural protein 1 from SARS-CoV-2 |
Cameron Semper, Nobuhiko Watanabe, Alexei Savchenko |
431 |
[GO] |
2020―Nov―28 |
Remdesivir is effective in combating COVID-19 because it is a better substrate than ATP for the viral RNA-dependent RNA polymerase |
Tyler L. Dangerfield, Nathan Z. Huang, Kenneth A. Johnson |
432 |
[GO] |
2020―Nov―25 |
SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain |
Leon Fodoulian, Joel Tuberosa, Daniel Rossier, Madlaina Boillat, Chenda Kan, Véronique Pauli, et al. (+5) Kristof Egervari, Johannes A. Lobrinus, Basile N. Landis, Alan Carleton, Ivan Rodriguez |
433 |
[GO] |
2020―Nov―13 |
Innate and adaptive immunity of murine neural stem cell-derived piRNA exosomes/microvesicles against pseudotyped SARS-CoV-2 and HIV-based lentivirus |
Bin Yu, Shoeb Ikhlas, Chunsheng Ruan, Xingxing Zhong, Dongsheng Cai |
434 |
[GO] |
2020―Oct―28 |
The SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and Furin proteases |
Lulin Zhou, Zubiao Niu, Xiaoyi Jiang, Zhengrong Zhang, You Zheng, Zhongyi Wang, et al. (+5) Yichao Zhu, Lihua Gao, Hongyan Huang, Xiaoning Wang, Qiang Sun |
435 |
[GO] |
2020―Oct―26 |
Robust and specific secretory IgA against SARS-CoV-2 detected in human milk |
Alisa Fox, Jessica Marino, Fatima Amanat, Florian Krammer, Jennifer Hahn-Holbrook, Susan Zolla-Pazner, Rebecca L. Powell |
436 |
[GO] |
2020―Oct―05 |
Furin, a potential therapeutic target for COVID-19 |
Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, Mingxue Li, et al. (+10) Yang Liu, Qingzhe Zhang, Peng Zhang, Yali Wang, Qiqi Wang, Yang Xu, Yirong Zhou, Yonghui Zhang, Lixia Chen, Hua Li |
437 |
[GO] |
2020―Oct―05 |
Impact of COVID-19 measures on short-term electricity consumption in the most affected EU countries and USA states |
Javier López Prol, Sungmin O |
438 |
[GO] |
2020―Oct―05 |
SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum |
Chiara Bruzzone, Maider Bizkarguenaga, Rubén Gil-Redondo, Tammo Diercks, Eunate Arana, Aitor García de Vicuña, et al. (+13) Marisa Seco, Alexandre Bosch, Asís Palazón, Itxaso San Juan, Ana Laín, Jon Gil-Martínez, Ganeko Bernardo-Seisdedos, David Fernández-Ramos, Fernando Lopitz-Otsoa, Nieves Embade, Shelly Lu, José M. Mato, Oscar Millet |
439 |
[GO] |
2020―Sep―29 |
Mitochondria - in the crossfire of SARS-CoV-2 and immunity |
Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, Takumi Koshiba, Grégoire P. Millet |
440 |
[GO] |
2020―Sep―25 |
PPARγ cistrome repression during activation of lung monocyte-macrophages in severe COVID-19 |
Christophe Desterke, Ali G. Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli |
441 |
[GO] |
2020―Sep―23 |
SARS-CoV-2 infection boosts MX1 antiviral effector in COVID-19 patients |
Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, Sofía Lage-Vickers, Rosario Lavignolle, Ayelén Toro, et al. (+6) Santiago Olszevicki, Agustina Sabater, Florencia Cascardo, Elba Vazquez, Javier Cotignola, Geraldine Gueron |
442 |
[GO] |
2020―Sep―03 |
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis |
Nilesh Kumar, Bharat Mishra, Adeel Mehmood, Mohammad Athar |
443 |
[GO] |
2020―Jul―31 |
ACE2, Metformin, and COVID-19 |
Atul Malhotra, Mark Hepokoski, Karen C. McCowen, John Y-J Shyy |
444 |
[GO] |
2020―Jul―28 |
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike |
Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3) Shuyu Xin, Pengfei Cao, Jianhong Lu |
445 |
[GO] |
2020―Jul―25 |
Molecular and immunological diagnostic tests of COVID-19 - current status and challenges |
Tugba Kilic, Ralph Weissleder, Hakho Lee |
446 |
[GO] |
2020―Jul―18 |
ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic |
Maya Braun, Elad Sharon, Irene Unterman, Maya Miller, Anna Mellul Shtern, Shmuel Benenson, et al. (+2) Alexander Vainstein, Yuval Tabach |
447 |
[GO] |
2020―Jun―20 |
Current status of COVID-19 therapies and drug repositioning applications |
Ozlem Altay, Elyas Mohammadi, Simon Lam, Hasan Turkez, Jan Boren, Jens Nielsen, et al. (+2) Mathias Uhlen, Adil Mardinoglu |
448 |
[GO] |
2020―Jun―20 |
CORDITE: the curated CORona Drug InTERactions database for SARS-CoV-2 |
Roman Martin, Hannah F. Löchel, Marius Welzel, Georges Hattab, Anne-Christin Hauschild, Dominik Heider |
449 |
[GO] |
2020―Jun―09 |
Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9 |
Dene R. Littler, Benjamin S. Gully, Rhys N. Colson, Jamie Rossjohn |
450 |
[GO] |
2020―May―30 |
Mitigating coronavirus-induced acute respiratory distress syndrome by radiotherapy |
Jian Jian Li |
451 |
[GO] |
2020―May―28 |
Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site |
Javier A. Jaimes, Jean K. Millet, Gary R. Whittaker |
452 |
[GO] |
2020―May―13 |
The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike |
Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3) Shuyu Xin, Pengfei Cao, Jianhong Lu |
453 |
[GO] |
2020―May―12 |
In the Race to Help with Covid-19, Time Is Precious: Editorial Guidelines for Coronavirus Papers |
Simona Fiorani, Stefano Tonzani |
|